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As part of the ongoing development of a channel forming peptide with the potential to be used 
clinically to treat cystic fibrosis, a number of structural studies using solution NMR spectroscopy 
have been carried out on a number of the test sequences. Given their structural similarities of the 
monomers it is important to evaluate whether or not there is a compelling need to determine the 
solution NMR structure of next-generation peptides. The determination of the NMR monomeric 
solution structure of peptides NK4-M2GlyR-p22 and NK4-M2GlyR-p20 T17R S20W in TFE 
solution and SDS micelles sample shows predominantly -helical conformations for both 
sequences with an extended conformation for the N-terminal lysine residues. The Imax, K1/2 and 
Hill coefficient, derived from data on ion conductance across monolayers of MDCK cells, were 
used to compare the ion conductance properties of the peptide sequences. Peptide 
NK4-M2GlyR-p20 T17R S20W has both a higher IMAX (43.8 ± 2.8 μA/cm
2
) and a lower K1/2 (58 
± 8 μM) compared to other M2GlyR derived peptides with calculated NMR structures. All 
available molecular structures calculated by NMR for M2GlyR derived peptides were compared 
and the correlation of the structural changes observed in the NMR structures with the ion 
conductance changes was evaluated. The NMR structures were found to have limited predicting 
potential over the ion conduction data. NMR determined structures have provided an 
experimentally based starting point for studies of the channels formed by the family of M2GlyR 
peptides. Computer simulations account for inter peptide interactions and packing effects that are 
not experienced by the monomeric form of the peptides in the NMR samples that have been used 
until now. The determination of the structure of the oligomeric peptide channels is deemed 
needed to improve the relevance of future use of NMR in this project. The use of larger 
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Membrane active peptides from natural or synthetic origins serve a variety of biological 
purposes. They have been extensively studied for their involvement in immunity, diseases, and 
for their potential as medical therapeutics and research tools. In this report a classification of 
membrane active peptides is presented, categorizing membrane active peptides according to their 
function such as antimicrobial peptides, cell-penetrating peptides, channel forming peptides and 
amyloid peptides. For each group a historical overview of the development, the current 
knowledge about their functional mechanism, and recent advances are presented. The large 
volume of current research on the field of membrane active peptides would make the task of 
covering it all an overwhelming one, but a representative sample of the latest research in each 
category is presented here. A set of common features among peptide groups emerges as the 
understanding of their action mechanisms increase. The possibility of a membrane centric 




This review intends to give a general overview of peptides, natural and designed, having the 
ability to interact with cellular plasma membranes in a way that modifies the natural integrity 
and permeability of the lipid bilayer. Biological membranes are highly dynamic supramolecular 
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arrangements of lipids and proteins, which confine the cellular contents but also enforce a 
complex and highly regulated exchange with the surrounding environment (Bechinger, 2008).  
 
Membrane active peptides fulfill many important functions in nature as they act as 
antimicrobials, transporters, channels, or hormones (Last and Miranker, 2013). The study of 
membrane active peptides has increased the understanding of polypeptide-membrane interactions 
and present unique opportunities for the intentional modulation of many cellular activities, with 
potential applications in medicine and in biological research in general.  
 
As membrane active peptides with different activities were discovered new areas of study 
emerged and knowledge pertaining to each area developed mostly in an independent manner. It 
was not until recently that commonalities between peptides with different membrane activities 
have been widely recognized. Efforts to understand the interactions of these peptides with 
cellular membranes and develop a general peptide-membrane model have been published by 
others (Bechinger, 2008;Last and Miranker, 2013). In this report membrane active peptides are 
divided based on their reported function(s): antimicrobial peptides, cell-penetrating peptides, 
channel forming peptides and amyloid peptides.  
 
 General Properties 
 
Membrane active peptides are short (less than 50 amino acids, in general), and soluble in both 
aqueous and membrane environments. Many natural membrane active peptides are the product 
of the cleavage of a precursor protein, and can also be post translationally modified. The 
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sequences of non-natural membrane active peptides could be the product of de novo design based 
on basic principles, or could be derived from naturally occurring proteins by truncations and or 
substitutions. Membrane active peptides have been described from species in all natural 
kingdoms as well as viruses (Frankel and Pabo, 1988;Phoenix et al., 2013). Non-natural 
membrane active peptides can be chemically synthesized or can be express in cells using 
common molecular biology techniques (Carmona-Ribeiro and Carrasco, 2014). 
 
The current view of the structure of cellular membranes derives mainly from the fluid mosaic 
model proposed in 1972 (Singer and Nicolson, 1972). In this model the lipid bilayer forms a 
hydrophobic matrix with a distribution of embedded proteins of diverse functions in a mosaic-
type fashion. Lateral diffusion within the plane of the bilayer is considered to occur in a manner 
comparable to viscous flow, and movements in the normal direction of the membrane are much 
more restricted (Bechinger, 2008). Solid-state NMR studies and molecular modeling have 
indicated considerable conformational flexibility of the lipid molecules within the bilayer (Feller 
et al., 1999;Huster et al., 1999). Membrane active peptides interact with the lipid components of 
membranes; the nature of these interactions is determined by the peptide sequence as well as by 
the composition of the membrane. The forces that control the membrane-peptide interaction are 
electrostatic as well as hydrophobic. The spatial distribution of charge and, hydrophobic and 
hydrophilic groups in the peptide as well as in the bilayer are determinant of the interactions.  
 
Membrane active peptides are typically unstructured in aqueous solution, but undergo a 
disordered-to-ordered transition upon membrane association to either α-helical or β-strand 
secondary structural states that are generally amphipathic in nature (Herrera et al., 2010;Maler, 
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2013;Williamson et al., 2009). The amphipathic arrangement of the secondary structure allows 
the peptides to initially bind to membranes by orienting parallel to the plane of the bilayer with 
the polar side of the helix facing the lipid headgroups and the solvent, while the nonpolar side of 




Membrane active peptides can be classified in four broad categories according to their function: 
antimicrobial peptides, cell-penetrating peptides, channel/pore forming peptides and amyloid 
peptides. The classification used here is based in several factors including the function or activity 
for which each peptide is studied the most, common mechanisms of action within peptides 
groups, and the historical manner knowledge about each group of peptides developed. Some 
peptides could fit in more than one category depending on the context e.g. Tat peptide, a 
prototypical cell-penetrating peptide, is also known to have antimicrobial activity. As with any 
taxonomical effort the proposed boundaries between categories are a reflection of the limited 
knowledge available, and are subject to modification as greater understanding of the interactions 
between peptides and membranes becomes available. 
 
 Antimicrobial Peptides 
 
According to the “Threat Report” of 2013, each year in the United States at least 2 million 
people become infected with bacteria that are resistant to antibiotics and at least 23,000 people 
die annually as a direct result of these infections (Center for Disease Control and Prevention, 
5 
2013). The prevalence of antibiotic resistant microorganisms has motivated an increasing interest 
in looking back at innate immunity and more specifically to the gene encoded protein elements 
of it. Antimicrobial peptides (AMPs), also known as host defense peptides, are part of the innate 
immune response. These peptides are found among all classes of life. 
 
AMPs are generally defined as peptides consisting of less than 100 amino acid residues (usually 
between 12 and 50) with overall net charge of +2 to +9, due to the presence of positively charged 
amino acids such as lysine and arginine along with a substantial portion of hydrophobic residues 
(Pushpanathan et al., 2013). AMPs have been found to exist in a wide range of secondary 
structures such as α-helices, β-strands with one or more disulphide bridges, loops and extended 
structures (Hancock, 2001). AMPs present some degree of amphipathicity in the spatial 
distribution of its residue side chains. 
 
 Historical overview 
 
The first reference to the antimicrobial activity of biological secretions appeared in 1922 when 
Alexander Fleming published his observations “On a Remarkable Bacteriolytic Element found in 
Tissues and Secretions” (Fleming, 1922). In this study, the ability of “Lysozyme” to kill a wide 
range of bacteria, and the ubiquitous presence of the protein in body secretions was reported. 
Because lysozyme lacked in killing most pathogen bacteria the search for an antibiotic drug took 
the path that resulted in the development of the variety of antibiotics available today. Initially the 
bacteriolytic properties found for body secretions, were credited to a single element, named 
“Lysozyme”. In 1934 the nature of “Lysozyme” was studied in detail (Meyer et al., 1934) and it 
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was recognized as one or more protein enzymes. Through processes of purification and 
concentration the enzyme today know as lysozyme was isolated and characterized, but smaller 
non enzymatic antimicrobial agents present in low concentrations were ignored. The origins of 
research into AMPs came in the 1960s. In 1962, the first description of an animal AMP, named 
bombinin was reported in the orange speckled frog Bombina variegate (Bagnicka et al., 2011). 
The antimicrobial protein lactoferrin, isolated from milk (Groves et al., 1965) and small 
antimicrobial molecules observed to be induced in the hemolymph of wax moth larvae after 
challenge with Pseudomonas aeruginosa (Stephens and Marshall, 1962) were reported in during 
the 1960s as well (Phoenix et al., 2013).  
 
In the following years after the initial reports many more AMPs have been reported from a wide 
variety of species. The “Antimicrobial Peptide Database” (Wang et al., 2009) contained 2531 
entries from human, amphibians, fish, reptile, birds, arthropods, insects and more in its latest 
available statistic summary dated March 2015. Out of the 2531 entries in the database 340 have 
their atomic 3D structure determined. Antimicrobial peptides are evolutionarily ancient weapons; 
their widespread distribution throughout the animal and plant kingdoms suggests that they have 
served an important role in the successful evolution of complex multicellular organisms (Zasloff, 
2002). The diversity of antimicrobial peptides is so great that a consensus on classification and 
categorization is difficult. AMPs are generally categorized broadly in three groups on basis of 
their secondary structure.  
 
-Small Linear peptides, such as the silk moth’s cecropin and the African clawed frog’s magainin 
that adopt an amphipathic α-helical secondary structure in the membrane (Zasloff, 1987).  
7 
- Peptides with an even number of Cys, always intralinked, with a relatively rigid antiparallel β-
sheet structures like bactenecin and defensins (Selsted et al., 1985).  
- Linear Peptides with a high proportion of one or two amino acids, most often Pro, Arg. Like the 
Pro-Arg rich PR39 of the pig neutrophil (Agerberth et al., 1991) and cationic peptides such as 
cathelicidins. 
 
Naturally occurring AMPs are derived from larger precursor proteins, which contain a signal 
sequence. Post-translational modifications include proteolytic processing, and in some cases 
glycosylation, carboxy-terminal amidation, amino acid isomerization and halogenation (Zasloff, 
2002). The number of amino acid residues in most of the mature antimicrobial peptides is 
between 13 and 39. In addition to the naturally occurring AMPs, peptides with the same 
biological activity have been designed de novo (Blazyk et al., 2001), engineered from natural 
sequences (Avrahami and Shai, 2002;Hilpert et al., 2006) or selected from combinatorial 
libraries (Rathinakumar et al., 2009;Rausch et al., 2005). 
 
 Mode of action 
 
The term antimicrobial peptide includes peptides with a range of additional biological activities 
such as antiviral, antifungal, and antitumor. Also the locations of expression of antimicrobial 
peptides are diverse; AMPs have been found to be produced by the epithelia of amphibian, 
mammals, and insects. They are secreted into internal body fluids in arthropods and stored in the 
cytoplasmic granules of professional phagocytes of mammals and birds (Zanetti et al., 1995). 
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AMPs are cationic, amphipathic peptides with broad spectrum microbicidal activity which is 
associated with membrane permeabilization. Unlike nonspecific membrane lytic peptide toxins, 
such as melittin from the venom of the Honey Bee (Apis mellifera), AMPs have little cytolytic or 
cytotoxic activity against host cells (Herrera et al., 2009;Wimley, 2010). Most AMPs are 
believed to kill microorganisms via a non receptor-mediated mechanism. These peptides are 
active in vitro at micromolar concentration, which is their biologic concentration at the sites of 
infections. Most AMPs can be subjected to pronounced sequence alterations without affecting 
significantly their function. 
 
AMPs target a fundamental difference between the membranes of microbes and multicellular 
animals for their preferential binding affinity. Microbial membranes are organized such that the 
outermost leaflet of the bilayer, the surface exposed to the outer environment, is populated by 
lipids with negatively charged phospholipid headgroups (phosphatidylglycerol, cardiolipin), in 
contrast the outer leaflet of the membranes in plants and animals is composed mainly of lipids 
with no net charge (phosphatidylethanolamine, cholesterol, sphingomyelin). Most of the lipids 
with negatively charged headgroups are segregated into the inner leaflet (Zasloff, 2002). This 
characteristic gives AMPs a greater affinity for microbial membranes than for eukaryotic 
membranes. The binding forces between the AMPs and the membrane are: electrostatic 
interactions (charged residues to negative charges in head groups of the lipids), and hydrophobic 
interactions (non-polar residues to the membrane core). There is direct evidence that most AMPs 
permeabilize the cytoplasmic membrane of the target and that often this permeabilization 
increases in severity with time. AMPs have the ability to dissipate the electrochemical gradient 
of the microbial plasma membranes within seconds after contact (Matsuzaki et al., 1997). In 
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order to achieve their intended activity in the observed time frame, AMPs must be able to rapidly 
pass through the proteoglycan layer of Gram positive bacteria and the outer membrane 
lipopolysaccharide layer of Gram negative bacteria. The timescale for the AMP induced 
permeation of larger markers, including dye markers, metabolites and cytosolic proteins, through 
the cytoplasmic membrane is of minutes to tens of minutes (Rathinakumar et al., 2009;Rausch et 
al., 2007). A numbers of models have been proposed to explain the mechanism by which AMPs 
permeate the phospholipids membrane. The amount of evidence supporting different models for 
different AMPs, suggests diversity on the mode of action within the compendium of AMPs 




Figure 1-1. Pore Models of action of AMPs. A. Barrel Stave Model B. Torodial Model. 
Adapted with permission from Describing the Mechanism of Antimicrobial Peptide Action 
with the Interfacial Activity Model. Copyright 2010 American Chemical Society 
 
The pore models implicate the formation of a transient transmembrane pore or channel. In the 
barrel stave model, the interior of the formed pore is lined by the hydrophilic surfaces of the 
AMP, while peptides interact with each other laterally, in a manner similar to the channels 
formed by membrane proteins (Figure 1-1A). The other classic pore forming model is the 
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Toroidal model. According to this model the peptide interaction with the bilayer affect the local 
curvature inducing a continuous bend through the pore, there are no specific peptide-peptide 




Figure 1-2. Non-pore models of action for AMPs. A. Carpet Model B. Detergent Model. 
Adapted with permission from Describing the Mechanism of Antimicrobial Peptide Action 
with the Interfacial Activity Model. Copyright 2010 American Chemical Society 
 
A model by Gazit et al. proposes an AMP mode of action where the formation of a pore is not 
necessary. It is suggested that peptides are always oriented parallel to the membrane surface and 
at high concentration the peptides form a “carpet” that distorts the bilayer enough to allow 
permeation (Figure 1-2A) (Gazit et al., 1996). The other commonly cited non-pore forming 
model is the “detergent model”, that describes the catastrophic collapse of the membrane 
integrity and a probe-size independent permeation observed at high peptide concentration for 
some AMPs (Figure 1-2B) (Hristova et al., 1997). 
 
11 
The descriptive models of AMP action have a limited predicting potential and applicability in 
optimization or design of engineered peptides. Recently a new set of descriptions aimed to 
provide a physicochemical understanding that would be potentially more comprehensive and 
useful has been proposed. A model based on molecular shape that describes the physical 
chemistry of AMPs and membranes in a phase diagram was presented by Bechinger and Lohner 
(Bechinger, 2009;Bechinger and Lohner, 2006). Experimental evidence supporting that 
membrane leakage could occur at phase boundary defects has been presented by Epand et al., 
they proposed that lateral lipid phase separation, or lipid clustering, induced by cationic 
antimicrobial peptides explains the AMPs biophysical properties as well as their selectivity and 
biological activity. (Epand et al., 2010;Epand and Epand, 2009).  
 
The computational simulations of uncharged small molecule release from single vesicles through 
single pores predict complete release of the vesicular content within a few tenths of a second. 
However, available experimental data on vesicle-based leakage studies show that vesicles with 
1000 bound AMPs typically release only a portion of their content over several minutes. Based 
on these discrepancies, Wimley in 2009 postulated that most AMPs do note ever form true pores 
in unilamellar vesicles, instead content leaking occurs by transient disruption of the membrane 
integrity. To describe the non-equilibrium events that allow content release Wimley proposed the 
“interfacial activity model” (Rathinakumar et al., 2009;Wimley, 2010). Interfacial activity was 
defined as “the ability of a molecule to bind to a membrane, partition into the membrane-water 
interface, and to alter the packing and organization of the lipids”. Interfacial activity is a 
quantifiable property assigned to a peptide based on amino acid sequence, structure and the 
physical chemical balance between hydrophobic and polar groups. According to this model an 
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imperfect amphipathic peptide would have a greater interfacial activity comparted to a perfect 
amphipathic one because the membrane packing and arrangement would have to be further 
disturbed to accommodate the imperfections. The structural and biological findings of our 
studies on AMPs identified from the chicken genome support the concept of interfacial activity 
(Herrera et al., 2009;Xiao et al., 2006). 
 
 Recent developments 
 
Although in the last decade a number of AMPs had been considered promising candidates for 
antibacterial drug development, currently the only AMPs approved for medical use are 
gramicidin, nisin, daptomycin, and polymyxins (Carmona-Ribeiro and Carrasco, 2014), all of 
them restricted to topical agents. AMP based applications of magainins, cecropins and defensins 
have failed to translate into approved anti-infective agents. However interest in the development 
of AMP based antibiotic agents has seen resurgence with recent policy changes and incentives. 
Recognizing that approval of new antibiotics was declining, FDA officials launched the 
Antibacterial Drug Development Task Force to address a mandate that was part of the 2012 FDA 
Safety and Innovation Act (FDASIA), also called PDUFA 5, which incorporated parts of the 
Generating Antibiotic Incentives Now (GAIN) Act (Fox, 2012).  
 
The current approach for the development of successful clinical agents based on AMPs is 
centered on new formulations that could potentially overcome the challenge of delivering the 
peptides to the site of infection with sufficient bioavailability, while protecting their activity. The 
potential use of electrospun nanofibers as a drug delivery system has been explored. The release 
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properties and the loading density of the synthetic AMP fluorescein incorporated into 
electrospun nanofibres of poly(ε-caprolactone) were studied by Eriksen et al. (Eriksen et al., 
2013), a release of 85% of the AMP after 60 minutes was reported. Recently Zaat reported on 
behalf of the European Union’s Biofilm Alliance (BALI), the development of novel synthetic 
antimicrobial antibiofilm peptides (SAAPs) based on the primary structures of the antimicrobial 
proteins LL-37 and thrombocidin-1. SAAPs are a solution against infection of inserted and 
implanted medical devices predominantly caused by staphylococci. The novel peptides kill a 
wide spectrum of Gram-positive and -negative (antibiotic resistant) bacteria at concentrations 
ranging from 0.8 - 8 μM in phosphate-buffered saline. The SAAPs have been shown to prevent 
biofilm formation of Staphylococcus aureus at concentrations of 3.2 – 12.8 μM. These peptides 
also have potent anti-inflammatory activity: they inhibit production of IL-12 and IL-8 by cells in 
whole blood upon stimulation with lipopolysaccharide and UV-killed S. aureus (Zaat, 2014). 
The conjugation of AMPs to magnetic nanoparticles has also been suggested (Lopez-Abarrategui 
et al., 2013). 
 
Advances have also been made in the use of the antitumor activity found in some AMPs, LeBeau 
et al. reported on a protease-activated pore-forming peptide for the treatment and imaging of 
prostate cancer (LeBeau and Denmeade, 2014). Taking advantage of the peritumoral proteolytic 
activity of prostate cancer, a propeptide construct made of a cationic diastereomeric pore-
forming peptide linked to an inactivating acidic peptide domain, gets activated by the serine 
protease prostate specific antigen (PSA) or the transmembrane metalloprotease prostate-specific 
membrane antigen (PSMA)). PSA and PSMA activated propeptides were found to be cytotoxic 
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to prostate cancer cells in vitro. In vivo, PSMA activated propeptide also proved to be an 
effective optical imaging probe when labeled with a near-infrared fluorophore. 
 
New fields of action and modes of application for AMPs are been explored - e.g. recently 
Veldhuizen reported the in ovo administration of chicken cathelicidin peptide analog DCATH-2 
and its efficacy to reduce experimentally induced salmonellosis in young broiler chickens 
(Ordonez et al., 2014), In another study Li et al. reported the development of a peptide-based 
biosensor for the detection of Escherichia coli O157:H7 using a ruthenium complex labeled 
Magainin I peptide as capture/signal probe (Li et al., 2015). Puig et al. published the successful 
use in vitro of 12 synthetic AMPs against the fungal disease produced by Stemphylium 
vesicarium that causes brown spots in pears (Puig et al., 2014) 
 
A new universal classification system (UC) intended to facilitate the study and development of 
AMPs has been proposed (Wang, 2015). The UC groups AMPs into four classes based on the 
covalent bonding pattern of polypeptide chains: 1) UCLL- linear one-chain peptides (e.g. LL-37 
and magainins) or two linear peptides not connected via a covalent bond (e.g. enterocin L50); 2) 
UCSS -sidechain-linked peptides (e.g. disulfide-containing defensins or ether bond-containing 
lantibiotics); 3) UCSB -polypeptide chains with a sidechain to backbone connection (e.g. 
bacterial lassos and fusaricidins); 4) UCBB -circular polypeptides with a peptide bond between 
the N- and C-termini ( e.g. bacterial AS-48, plant cyclotides, animal theta-defensins). The new 
classification system aims to unify innate immunity peptides from a variety of biological 
sources; implemented into the AMP database the new classification improves its search engine 
and the usability of the database on the design of novel antimicrobials. 
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Though AMPs have been touted as a potential solution to the antibiotic drug resistance crisis, 
concerns have been raised about the risk of developing AMPs based therapeutics. In a 2012 
report, S. aureus was shown to rapidly evolve resistance to pexiganan (currently at Phase 3 
clinical studies as Locilex) under laboratory conditions (Habets and Brockhurst, 2012). In some 
of the populations studied in this report, the adaptation to pexiganan provided S. aureus with 
cross-resistance to human-neutrophil-defensin-1, a key component of the innate immune 
response to infection; presenting the potential risk of compromising the innate human immune 
system. 
 
 Cell-Penetrating Peptides 
 
Cell-Penetrating Peptides (CPPs) are generally comprised of 40 amino acids residues of less, and 
have the ability to translocate cell membranes and enter cells promoting the delivery of a variety 
of cargos. The property of CCPs to deliver therapeutic molecules (nucleic acids, drugs, imaging 
agents and even proteins) to cells and tissues in a nontoxic manner makes them potential 
components of future drugs and disease diagnostic agents (Copolovici et al., 2014). 
 
 Historical overview 
 
The HIV Tat factor discovered in 1988 and the Drosophila Antennapedia transcription factor a 
few years later, were the first sequences reported to translocate molecules across cell membranes 
into cells (Derossi et al., 1994;Frankel and Pabo, 1988). Shorter sequences derived from these 
16 
natural peptides (16 residues from third helix homeodomain of Antennapedia named penetratin 
and 11 residues from Tat) preserve the cell penetrating activity. Tat and penetratin were the basis 
for the study and development of CPPs, as a new type of molecular vectors with the ability to 
promote the delivery of a variety of cargos (Copolovici et al., 2014). In 1997, the first non-
covalent CPP for delivery of nucleic acids, Pep-1, was designed by the group of Heitz and Divita 
(Morris et al., 1997). The development of Pep-1 for non-covalent cellular delivery of proteins 
and peptides was reported a few years later (Morris et al., 2001). This sequence is commercially 
available under the trade name Chariot (Active Motif, Carlsbad, California). Polyarginine 
sequences (R8) were also demonstrated to be sufficient to drive molecules into cells by Wender 
and Fukati (Futaki et al., 2001;Wender et al., 2000). Since then, many novels synthetic or 
chimeric CPPs have been discovered and tested. Table 1-1 presents the amino acid sequence of 
some common CPPs (Farkhani et al., 2014). 
 
Table 1-1. Amino Acid sequence of some common CPPs 
Type Name Amino acid sequence 
Amphipathic Transportan GWTLNSAGYLLGKINLKALAALAKKIL 
 Pep-1 KETWWETWWTEWSQPKKKRKV 
 MPG GLAFLGFLGAAGSTMGAWSQPKKKRKV 
 pVEC LLIILRRRIRKQAHAHSK 
 MAP KLALKLALKALKAALKLA 
 CADY GLWRALWRLLRSLWRLLWRA 
Cationic Polyarginine R8, R9, R10, R12 
 Tat 49–57 RKKRRQRRR 
 Penetratin RQIKIWFQNRRMKWKK 
 P22N NAKTRRHERRRKLAIER 
 DPV3 RKKRRRESRKKRRRES 
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 DPV6 GRPRESGKKRKRKRLKP 
Hydrophobic K-FGF AAVLLPVLLAAP 
 C105Y CSIPPEVKFNKPFVYLI 
 
 Mode of action 
 
The characteristics of CPPs include: low cytotoxicity, dose-dependent efficiency, the ability to 
be taken up by a variety of cell types and no restriction on the size or type of cargo (Heitz et al., 
2009). CPPs have been reported in the delivery of multiple types of cargo like: nucleic acids, 
liposomes, low molecular weight drugs, nanoparticles and polymers. One group even delivered a 
small protein using a Tat-fusion (Watanabe et al., 2003). CPPs are grouped into two main classes 
according to the nature of the association between the peptide and the cargo. The first group 
requires chemical linkage between peptide and cargo, and the second involves the formation of 
stable, non-covalent complexes. From a structural point of view CPPs can be classified into 
amphipathic, cationic (containing clusters of polyarginine or polylysine), or amphipathic (Heitz 
et al., 2009).  
 
For CPPs that are covalently linked to the cargo, the formation of the covalent conjugate between 
the cargo and the carrier peptide is achieved by chemical cross-linking or by cloning followed by 
expression of a CPP fusion protein (Moulton, 2012;Zatsepin et al., 2005). Different chemical 
compositions have been reported for stable or cleavable conjugation mostly involving disulfide 
or thio-esters linkages (Heitz et al., 2009). Covalent strategies have been mainly reported for the 
delivery of DNA mimic molecules or steric block oligonucleotides (Abes et al., 2008;Lebleu et 
al., 2008). Conjugation methods offer reproducibility of the procedure, rationalization, and 
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control over the stoichiometry of the CPP-cargo; however the conjugation technology risks 
altering the biological activity of the cargo. The non-covalent strategy is mainly based on short 
amphipathic peptide carriers, where the amphipathic character may be a result of the primary 
structure or of the secondary structure. Non-covalent CPPs form stable complexes with their 
respective cargo (oligonucleotide or protein/peptide) through non-covalent electrostatic and 
hydrophobic interactions (Gros et al., 2006;Munoz-Morris et al., 2007). 
 
Elucidation of the mechanism of internalization of CPPs proved puzzling for a long time, as it 
had early been reported as independent of endocytosis, of energy and of specific receptor. These 
studies, however, were showed to be affected by experimental artifacts (Copolovici et al., 2014). 
For example, contradictory results are obtained through the use of different peptide 
concentrations, cell types, incubation time, and various physiochemical parameters of the CPPs, 
including hydrophobicity and net charge (Jones and Sayers, 2012;Madani et al., 2011). It has 
been proposed that some CPPs, like Tat, Antennapedia, Poly-Arg, and Pep-1, can pass through 
the plasma membrane via at least one energy-independent pathway (Vives et al., 2008). It is 
likely that CPPs without cargo can be taken up by cells via multiple pathways, including direct 
penetration of the plasma. In 2014, Herce et al. described a complete cellular uptake mechanism 
for arginine-rich peptides based on the interplay between fatty acids and the plasma membrane 
pH gradient. They proposed that at high pH fatty acids bind extracellular arginine-rich peptides, 
mediate their membrane transport, and release them into the lower-pH environment of the 
cytosol. In vitro experiments showed the major steps of this mechanism. Computational 
simulations showed that deprotonated fatty acids reduce the free energy of insertion of the 
arginine-rich peptides into model phospholipid bilayers and that this insertion leads to the 
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formation of a channel across the lipid bilayer (Herce et al., 2014). Figure 1-3 shows the steps of 
the proposed mechanisms as: (a) the peptide located in the extracellular medium is attracted by 
electrostatics; (b) the peptide binds to deprotonated fatty acids; (c) the peptide–fatty acid 
complex nucleates a water channel; (d) the peptide–fatty acid complex diffuses across the 
channel while simultaneously protons from the cytosolic side compete for the binding of the 
guanidinium groups to fatty acids; (e) the high density of protons in the cytosol protonates the 
fatty acids, and the peptide gets released into the cytosol; (f) the channel closes, and neutral fatty 
acids freely diffuse across the plasma membrane. 
 
 
Figure 1-3. Cellular Uptake Mechanism for Arginine-Rich Cell-Penetrating Peptides. 
Adapted with permission from Fundamental Molecular Mechanism for the Cellular 
Uptake of Guanidinium-Rich Molecules. Copyright 2014 American Chemical Society 
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 There is still no consensus on the mechanisms of cellular uptake and internalization of CPP-
-cargo complexes. Many researches claim that most CPP-cargo complexes do not translocate by 
direct penetration of the plasma membrane, instead they are taken up by various types of 
endocytosis. Endocytosis occurs through the action of various pathways and can be classified 
into: caveolae and/or lipid-raft-mediated endocytosis, macropinocytosis, cholesterol-dependent 
clathrin-mediated endocytosis, or caveolae- and clathrin-independent endocytosis. It is proposed 
that the mechanism of entry into the cell is influenced by a variety of factors, including the 
nature of the conjugated cargo (type, size, charge), differences in the physicochemical properties 
of CPPs (such as molecule length, charge delocalization, and hydrophobicity), the cell line being 
utilized, and the concentration of the CPP (Copolovici et al., 2014). 
 
By endocytosis, CPPs may or may not be released into the cytosol or can even end up in 
intracellular vesicular compartments (Patel et al., 2007). The presence of membrane-associated 
proteoglycans has been reported as an important factor for both uptake and micropinocytosis 
(Futaki et al., 2007). Macropinocytosis is activated only when a specific stimuli is applied (e.g. 
growth factors or viruses). Membrane associated proteoglycans serve as one of the primary 
receptors that induce macropinocytosis. Macropinocytosis may be one of the preferred pathways 
in some cell types for the uptake of arginine-rich CPPs and larger CPP conjugates. A general 
scheme for CPP uptake mechanisms is still a matter of investigation and debate; nonetheless, 
there is consensus that the initial contact between the CPPs and proteoglycans on the cellular 
surface takes place through electrostatic interactions. After initial interaction the cellular uptake 
pathways are driven by several parameters: -the primary and secondary structure of the CPP; - 
The CPP’s ability to interact with cell surface and membrane lipid components; - the nature, 
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type, and active concentration of the cargo; -the cell type and membrane composition 
(Copolovici et al., 2014). 
 
 Recent developments 
 
Advances in drug delivery have been reported using CPPs to address the challenges in targeted 
delivery of pharmaceutical compounds having low efficacy in vivo for the treatment of cancer 
(Araki et al., 2010;Ueda et al., 2012;Wender et al., 2012). One particularly novel approach is the 
system made using CPPs as part of a combinatorial approach. Ringhieri et al. reported the 
synthesis of a dual-ligand liposomal doxorubicin delivery system, which couples targeting to 
enhanced cellular uptake by anchoring cell penetrating peptide R8 and targeting peptide CCK8 
to the surface of liposomes. A characterization by spectroscopic methods confirmed the 
obtainment of liposomes in which both peptides are durably linked to the external liposome 
surface while doxorubicin is efficiently loaded in the inner water liposome compartment, 
effectiveness of the system in vivo is yet to be demonstrated (Ringhieri et al., 2015). 
 
A major limitation in using CPPs as a delivery system is limited release of the cargo to the 
cytoplasm once the peptide-cargo complex has enter the cell via the endocytosis mediated 
mechanism. In the search of more efficient cargo delivery peptides, a method for high-
throughput screening of spontaneous membrane-translocating peptides has been proposed 
(Marks et al., 2011). He et al. reported the effectiveness of three peptides (TP1, TP2 and TP3) 
identified by the high-throughput screening method, to deliver the zwitterionic, membrane-
impermeant dye tetramethylrhodamine to cells under conditions not permissive for endocytosis 
22 
(He et al., 2013). Peptide TP2 was reported to translocate lipid bilayers at a concentration 
independent rate and without significant bilayer perturbations (Cruz et al., 2013). 
 
Jianquan et al. reported the development of a CPP based approach for the delivery of quantum 
dots into mammalian cells with high reproducibility and efficiency, and with minimal 
cytotoxicity (Jianquan et al., 2014). Advantages of quantum dots over traditional dyes consist of 
high quantum yield, narrow emission peak, excellent resistance to photobleaching, and broad 
size-dependent photoluminescence (Chen and Gerion, 2004). These unique fluorescence 
properties make quantum dots desirable biological imaging probes, however, reliable and 
efficient cellular delivery of quantum dots has proven technically challenging. To address this 
problem the authors conjugated Tat and HA2 peptides to quantum dots (CPP-QDs) and analyzed 
their internalization and endosomal trapping and release in mammalian PC12 cells using high-
resolution live cell imaging. It was found that the CPP-QDs were mainly internalized through the 
endocytosis pathway. However, a small number of CPP-QDs were internalized through direct 
membrane permeation. It was also reported that CPP-QDs could be released to the cytoplasm 
when conjugated to membrane disrupting HA2 peptide (Jianquan et al., 2014). 
 
Recently, several studies have explored the possibility of using CPPs as a nonviral gene delivery 
system (Bolhassani, 2011). Liu et al. reported the use of arginine-rich CPPs for gene delivery 
into human cells in a noncovalent fashion (Liu et al., 2012), while Chen et al. reported a similar 
approach for gene delivery into insect cells (Chen et al., 2012). They indicated that SR9, PR9 
and especially HR9 CPPs are able to transfer plasmid DNA into the target cells with the 
following transfection efficiencies: HR9 (18.76 ± 1.09%) > PR9 (2.73 ± 0.25%) > SR9 (2.03 ± 
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0.21%). Liu et al also reported that although treatment with CaCl2 did not facilitate the CPP-
mediated transfection efficiency, it improved the gene expression intensity. 
 
Another field where CPPs present promising prospects is the development of antiviral 
applications; the most widely used antiviral cargos conjugated to CPPs are phosphorodiamidate 
morpholino oligomers (PMOs) (Delcroix and Riley, 2010). Peptide-conjugated PMOs are water-
soluble, nuclease-resistant, and act as steric-blocking antisense agents due to the formation of 
stable duplexes with complementary RNA. CPP-PMOs conjugates act on non-retroviral RNA 
virus infections in a dose dependent and highly specific on the nature of the CPP and PMOs 
manner. These conjugates act by reducing viral replication and significantly increase survival in 
mice experimentally infected with polio virus, coxsackie virus B2 and B3, dengue virus, West 
Nile virus, Japanese and St. Louis encephalitis virus, Venezuelan equine encephalitis virus, 
equine encephalitis virus, respiratory syncytial virus, Ebola virus, SARS coronavirus, mouse 
hepatitis virus, porcine reproductive and respiratory syndrome virus, human rhinovirus 14, foot 
and mouth disease virus, measles virus, and the influenza A virus (Delcroix and Riley, 2010). A 
new cationic lipid peptide, Deca-(R)8, was demonstrated to inhibit duck hepatitis B virus 
replication, the peptide led to a decrease in virus secretion in HepG2.2.15 cells without targeting 
the viral polymerase (Abdul et al., 2012). 
 
Channel/pore Forming Peptides 
 
Channel/pore Forming Peptides (CFPs) are designed peptides (de novo or derived from the 
sequence of a channel protein) with less than 40 amino acid residues. CFPs have the ability to 
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insert into lipid bilayers adopting an amphipathic helical conformation. CFPs associate and 
assemble to form ion conducting channels. CFPs synthesized with D-enantiomers conserve the 
channel forming capability of their L-enantiomer versions, suggesting CFP’s interact with the 
membrane without the need for receptors (Wade et al., 1990). CFPs differ from AMPs as their 
intended purpose is not the destruction of the target cell, but the creation a transient membrane 
ion channels. This differentiation is somehow arbitrary, as cytotoxicity could be achieved with 
most CFPs at high enough concentration.  
 
A special class of CFP uses a peptide scaffold to create co-facial organization of crown ethers 
(Fyles, 2007). The ion conductance of these synthetic ion channels is achieved through the 
interior of the crown ethers, while the peptide elements serve a structural function. Peptides that 
are part of the immune complement system are not included in this category because their pore 




The first peptides belonging to this category to be studied were de novo simple sequences, based 
on the amphipathic side chain distribution of transmembrane  helices. These peptides were 
created in order to evaluate the basic principles of CFPs. Ion channel forming peptide P from 
1985 with 12 leucines out of its18 residue (Spach et al., 1985) and from 1988 peptides 
[LSSLLSL]3, and [LSLLLSL]3 (Lear et al., 1988) are two of the earliest efforts to understand the 
role of the individual sidechains in the interaction of peptides with the lipid bilayer. 
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Since the late 1980s a number of peptides with sequences derived from the pore lining segments 
of naturally occurring ion channels have been shown to have the ability to spontaneously insert 
into lipid bilayers and to self-assemble into ion channels that retain some of the characteristics of 
the parent ion channel. A 23 amino acid residues peptide from the M2 transmembrane segment 
of the acetylcholine receptor (AcChoR) δ subunit was reported to form cationic channels in 
phosphatidylcholine bilayers (Oiki et al., 1988). A synthetic peptide modelled after the 
transmembrane domain M2 of the Glycine receptor (M2GlyR) channel was reported to form ion 
channels in lipid bilayers (Langosch et al., 1991). In 1997, Tomich’s lab first suggested delivery 
of Cl
-
 channel-forming peptides derived from the M2GlyR, to the apical membranes of airway 
epithelial cells of patients suffering from cystic fibrosis (CF) (Wallace et al., 1997). The 
formulation of efficient peptides with pharmaceutical applications has been an ongoing project at 
this lab and advances on this task are discussed in the following sections (Tomich et al., 2012). 
 
 Mode of action 
 
Channel forming peptides in solution spontaneously insert into lipid bilayers on a matter 
dependent of aqueous solubility, and lipid composition of the bilayer (Tomich et al., 1998). The 
peptides undergo a conformational change, from unstructured in the aqueous environment to an 
amphipathic helical structure when inserted into lipid bilayers (Bukovnik et al., 2012;Cook et al., 
2004;Herrera et al., 2010). In order to form functional ion channels monomers need to assemble 
into an oligomeric functional state. The question of successive order on which the events of 
folding, insertion and assembly formation occur, or whether these events occur independently or 
coupled is still unresolved. Figure 1-4 shows the possible routes to get to the functional ion 
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channel. The path to the right has the peptide insertion and folding as a single step followed by 
assembly. The path to the left has peptide folding occurring at the bilayer surface followed by 
assembly before insertion (Tomich et al., 2012). In addition folded states could be sampled by 
the peptide prior to membrane interaction; the folded states would be stabilized by binding to the 
bilayer surface.  
 
Figure 1-4. Possible paths for the assembly of CFP monomers into ion conducting channels. 
Figure from Tomich et at., 2012 (Intech Open access) 
 
The formation of assembled channels is concentration dependent (Wallace et al., 2000). The 
number of monomers that comprise an individual channel is dependent on the peptide sequence, 
and in the case of sequences derived from naturally occurring ion channels, is related to the 
number of helices lining the interior of the parent channel (Krittanai and Panyim, 2004;Reddy et 
al., 1993;Wallace et al., 1997). Ion selectivity, voltage dependence and ion conductance are also 
dependent of the peptide sequence, and although these properties are related to those of the 
parent channel, they are not always conserved (Bukovnik et al., 2012;Cook et al., 2004;Wallace 
et al., 2000).  
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Ions and other molecules that fit through the channel diffuse driven by its particular 
concentration gradient. The ion conductance and ion selectivity of a single assembled channel 
depends primarily of the amino acid residue side chains oriented to the lumen of the channel 
(Bukovnik et al., 2012). The ion conductance measured on cells also depends on the rates of 
folding, insertion, and assembly. These rates are dependent to some degree on every amino acid 
residue in the peptide (Broughman et al., 2002;Cook et al., 2004;Herrera et al., 2010;Shank et al., 
2006). The ion conductance induced by CPPs is transitory, possibly due to membrane recycling 
and proteolytic activity. 
 
 Recent developments 
 
By covalently attaching functional groups to CFPs, new analytical applications have been 
developed. Mayer et al. reported a method to quantify protein-ligand interactions by measuring 
the flux of ions through pores of a synthetically-modified, CFP in planar lipid bilayers. The 
method is based on the reduction of conductivity through the channels of a derivative of 
alamethicin, which carries a covalently attached benzenesulfonamide group on its C-terminus. In 
the assay reported, reduction of the ion current is triggered by binding of carbonic anhydrase II 
to the sulfonamide moiety on the CFP (Mayer et al., 2008). Another application of covalently 
attaching functional groups to CFPs was reported by the Voyer’s laboratory in 2012. By 
attaching a fluorescent marker (fluorescein isothiocyanate) to LS2 and LS3 CFPs, the authors 
were able to study by attenuated total reflectance the incorporation equilibrium of the peptide 
between two forms: adsorbed at the surface or incorporated within the bilayer. These results 
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showed that the incorporation equilibrium is highly dependent on the lipid composition, with a 
lower incorporation level when lipids have longer alkyl chains. Confocal microscopy studies also 
showed that fluorescent CFP analogs internalized into HeLa cells and localized into both the 
membranes of inner organelles and the cell membrane (Arseneault et al., 2012). 
 
With the purpose of developing artificial sensing systems Futaki et al. attached leucine-zipper 
extra-membrane peptide segments to CFP alamethicin. The idea being that the extra-membrane 
segment would acts in a similar way to the large extra-membrane domains present in natural-ion 
channel proteins. Ligand binding could alter the structure of the extra-membrane domains and 
influence the association states or association numbers of alamethicin in the membranes. Using 
conformationally switchable leucine-zipper extra-membrane segments that respond to Fe
3+
, 
Futaki et al. fabricated an artificial Fe
3+
-sensitive ion channel, and showed that a decrease in the 
helical content of the extra-membrane segment led to an increase in the channel current (Futaki 
et al., 2013). 
 
Recently novel medical uses of CFPs have also been reported and efforts have been made to 
study the effect of CFP NC-1059 on riboflavin diffusion across an intact corneal epithelium. 
Efficient riboflavin diffusion is needed for the corneal cross-linking treatment of the vision 
disorder Keratoconus. The study demonstrated that peptide NC-1059 enhances the diffusion of 
riboflavin into the corneal stroma, without causing any measurable cytotoxicity to corneal 
epithelial cells (Zhang et al., 2012). 
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Ion channels formed by CFPs are composed of simple elements and contain fewer atoms 
compared with natural ion channels; this makes them a suitable subject for computational 
studies. Li-Hu et al. performed a computational fine-grained docking with molecular dynamics 
simulations, to explore the geometry and orientation of homo-pentameric bundles of CFP 
Vpu1-32. The Vpu1-32 sequence comes from channel-forming membrane protein Vpu of the HIV 
virus. Computational methods have also been used by Dr. Chen’s lab to evaluate the charge 
selectivity of M2GlyR derived ion channels (Chen and Tomich, 2014). In 2013 Bukovnik et al. 
reported increased conductivity of NK4-M2GlyR p22 T19R, S22W channels by the substitution 
of pore lining threonine residues 13, 17 and 20 by non-encoding amino acid 2,3-
diaminopropionic acid (Dap) (Bukovnik et al., 2013). The increase in conductivity was 
accompanied by decreased ion selectivity, to analyze the conductance and charge selectivity of 
M2GlyR-derived synthetic channels Chen et al. performed free energy simulations on the 
peptide assembly. The simulations showed the pentameric p22 pores to be non-selective, with 




 dominated by the desolvation cost (Chen 
and Tomich, 2014). 
 
CFPs have also found applications into unexpected fields, in 2012 Gudlur et al. first reported the 
development of peptide nanovesicles formed by the self-assembly of branched amphiphilic 
peptides (BAPCs) (Gudlur et al., 2012). The hydrophobic core sequences of the nanovesicle 
forming peptides are derived from an internal fragment of CaIVS3, the human dihydropyridine 
sensitive L-type calcium channel segment. BAPCs have potential as a novel cellular delivery 
system, as they are taken up by cells. BAPCs undergo thermosensitive conformational transitions 
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as a function of both time and temperature; the properties of BAPCs vary based on the 
temperature of assembly (Sukthankar et al., 2015). 
 
 Amyloid Peptides 
 
Amyloid peptides (AP) are a class of proteins characterized by their ability to form stable -
sheet-rich structures known as amyloid fibrils (Sunde and Blake, 1998). APs are involved in a 
number of degenerative diseases, and despite of origin and amino acid sequence differences they 
behave structurally on a similar way. Non-fibrillar oligomers of APs are known to alter 
membrane structure, and are suspected to be the main disease causative agent of amyloidoses 
(Bartels et al., 2011;Hebda et al., 2009;Nerelius et al., 2009). 
 
 Historical overview 
 
The term ‘amyloid’ was coined initially by Schleiden and then by Virchow in the mid-19th 
century to describe the iodine stained deposits seen in liver at autopsy (Virchow, 1854). 
Consequently the deposits were thought to be carbohydrate in nature (Latin word for starch: 
amylum) until their high nitrogen content was later established, and their proteinaceous nature 
determined (Friedrich and Kekulé, 1859). Amyloid deposits bind to Congo Red dye producing 
an apple green birefringence when examined between cross polarizers in a light microscope 
(Divry and Florkin, 1927). This characteristic suggested that amyloid had a fibrillary structure, 
which was confirmed by electron micrographs (Cohen and Calkins, 1959). The -sheet nature of 
the fibrils was determined by X-ray diffraction studies (Eanes and Glenner, 1968). 
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In 1906, Alois Alzheimer gave a lecture, in which he described for the first time a form of 
dementia that subsequently, at the suggestion of Emil Kraepelin, became known as Alzheimer’s 
disease. In his lecture Alzheimer described a patient called Auguste D, a 51-year-old woman 
who had shown progressive cognitive impairment, focal symptoms, hallucinations, delusions, 
and psychosocial incompetence. Autopsy of the brain tissue revealed the presence of plaques, 
neurofibrillary tangles, and arteriosclerotic changes. Alzheimer mentioned the miliary foci (later 
called senile plaques), which represented the sites of deposition of an amyloid protein (Maurer et 
al., 1997). In a similar way many other diseases were described to be associated with amyloid 
deposits, collectively these disorders became known as amyloidoses. Amino acid composition 
and sequence analysis of the proteins comprising a range of ex vivo amyloid fibrils revealed that 
each amyloid disorder was associated with a particular protein or peptide (Glenner et al., 1971).  
Amyloidoses have traditionally been defined as diseases in which normally soluble proteins 
accumulate in the extracellular space of various tissues as insoluble deposits of fibrils (Selkoe, 
2003). Another general feature of these protein-folding disorders is the prolonged period before 
clinical manifestations appear. To date more than 20 diseases have been associated with amyloid 
formation. Many amyloid forming peptides are produced by the proteolytic processing of a 
precursor protein. Table 1-2 presents a list of the most common amyloidoses with their 




Table 1-2. Amyloidoses with their precursor protein and amyloid peptide 
Disease Precursor protein Amyloid Peptide 
Alzheimer’s disease Amyloid precursor protein Aβ peptides 
Atrial amyloidosis Atrial natriuretic factor (ANF) Amyloid ANF 
Spongiform encephalopathies Prion protein (PrPc) PrPsc 
Primary systemic amyloidosis Immunoglobulin light and 
heavy chains 
AL and AH 
Senile systemic amyloidosis Wild-type transthyretin ATTR 
Haemodialysis-related amyloidosis β2-microglobulin Aβ2M 
Hereditary nonneuropathic systemic 
amyloidosis 
Lysozyme ALys 
Type II diabetes Pro-IAPP IAPP or “amylin” 
Injection-localized amyloidosis Insulin AIns 
Secondary systemic amyloidosis (Apo) serum amyloid A Serum amyloid A 
Hereditary cerebral amyloid angiopathy Cystatin C ACys 
Finnish hereditary systemic amyloidosis Gelsolin AGel 
Familial amyloid polyneuropathy  Transthyretin variants ATTR 
Parkinson’s disease  -synuclein 
Ageing pituitary, prolactinomas Prolactin APro 
Familial amyloidosis Fibrinogen αA-chain AFib 
British familial dementia Amyloid Bri Precursor Protein ABri 
Adapted from (Rambaran and Serpell, 2008) 
 
Prusiner in 1982 proposed the ‘prion’ hypothesis that described an infectious protein particle 
capable of causing a fatal neurodegenerative disease in sheep (scrapie) (Prusiner, 1982) .The 
causative peptide of scrapie was amyloidogenic but unlike other amyloid forming proteins it was 
infective and was termed: prion. In 1984 the Aβ peptide that composes the bulk of amyloid 
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plaques in Alzheimer’s disease was identified and biochemically characterized (Glenner and 
Wong, 1984). Not all amyloid forming peptides are disease related. Amyloids play a role in 
functional biological process including: biofilm formation (Barnhart and Chapman, 2006), 
hormone storage (Maji et al., 2009), and gas vesicles formation (Bayro et al., 2012). 
 
Historically the main focus of amyloid research has been the fibrillary state, as it has been 
considered a hallmark of disease progression, and a probable causative agent. Recently, however, 
it has been shown that nonfibrillar preamyloid toxins induce membrane disruptions in cells and 
in synthetic liposomes. These nonfibrillar forms of APs are known now to be the toxic species, 
while the fibers are considered relatively benign (Hebda and Miranker, 2009). Here the focus is 
the interactions between APs and cellular plasma membranes, in particular peptides that are 
disease related, like A, -Syn and IAPP. 
 
 Mode of action 
 
Development of a single antibody selective for the amyloid oligomers of a variety of APs has 
suggested that there is a structural commonality among oligomers of different APs (Kayed et al., 
2003). However, amyloid precursor proteins have been observed to form a number of unique 
structures on membranes. A large number of oligomer structures has been observed for A 
peptides ranging from dimers to large oligomers (Schauerte et al., 2010). Structures that are 
unique to preamyloid states on membranes have been identified in a number of studies, 
interestingly the prefibrilar membrane-bound states, that precede rapid formation of -sheet 
filaments, were found to be -helical for many AP including A(Kayed et al., 2003), IAPP 
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(Apostolidou et al., 2008) and -Syn (Jao et al., 2008). Membrane binding has been determined 
to be driven predominantly by electrostatic forces for these slightly cationic helixes (Knight and 
Miranker, 2004;Shvadchak et al., 2011). It has been proposed that in the case of A peptides the 
specific interaction with gangliosides (Yanagisawa et al., 1995), a major lipid component in 
neural cell membranes, cholesterol (Simons et al., 1998;Yip et al., 2001) or with 
phosphatidylinositol (McLaurin et al., 1998) is involved in cytotoxicity. 
 
The helical structures of APs have been strongly correlated with cytotoxicity, small molecules 
designed to interact with the helical portions of A reduce toxicity (Nerelius et al., 2009). A 
tetramer of helically folded -Syn is capable of binding to membranes or existing in solution 
(Bartels et al., 2011). A mutant of IAPP that affect helix formation presents no toxicity to insulin 
secreting cell lines (Hebda et al., 2009). 
 
The actual mechanism of membrane disruption and cytotoxicity by APs has yet to be elucidated. 
One possibility is that the AP oligomers form a well-defined pore; another is that bilayer 
permeation could be caused by interactions that induce distortions to the membrane like removal 
of one leaf of the bilayer by the detergent effect of the amphipathic helices. A third possibility is 
the induction of curvature changes to the bilayer upon peptide binding (Last and Miranker, 
2013). Preference for membrane regions of negative or increased positive curvature have been 
reported for A (Matsuzaki and Horikiri, 1999) IAPP (Smith et al., 2009) and -Syn 




 Recent developments 
 
Since APs are studied mainly because of their role in diseases, recent developments on the area 
of APs are mostly related to the development of treatment options for the corresponding 
diseases. One treatment option being explored is the modulation of the oligomeric state of APs, 
in order to decrease toxicity. Smaoui et al. worked on a computational binding affinity method 
that optimizes mutations of the IAPP sequence in order to produce an analog with increased 
affinity for the natural IAPP. Their rational is that the analog will bind IAPP oligomers and 
promote extension of their length, favoring the formation of fibrils (Smaoui et al., 2015). On the 
opposite end of oligomeric modulation efforts, Xiong et at. have developed a peptide 
functionalized nanoparticle that shows inhibitory capability against Aβ42 aggregation, and fibril 
formation (Xiong et al., 2015). Although the aforementioned reports concern different APs 
(IAPP and Aβ), clearly their approaches are mutually contradictory. This highlights the need for 
better understanding of the role that the different sizes of AP oligomers play in cytotoxic, and of 
the details of the peptide-membrane interactions involved. 
 
Conflicting results reported on the folding state of the monomeric and oligomeric APs have 
made it harder to have a complete and definitive understanding of the conformational transitions 
APs undergo, and their role on cytotoxicity (Bartels et al., 2011;Fauvet et al., 2012). Bartels et al. 
have recently addressed this issue, bringing attention to the importance of post-translational 
modifications to APs in their natural environment. The authors showed that N-terminal 
acetylation, the predominant post-translational modification of mammalian -Syn, increases the 
helical folding propensity and resistance to aggregation of -Syn (Bartels et al., 2014). This 
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result suggests that the absence of post-translational modification of -Syn peptides used in 
some in vitro studies is a probable cause of conflicting results.  
 
A different approach to treat Alzheimer’s disease with a potential of extension to other 
amyloidoses, has been recently reported with promising prospects. A large collaborative group 
headed by Dr. Sudhir Paul, from the Department of Pathology and Laboratory Medicine, at the 
University of Texas Medical School reported on the specificity and A clearing effect of a 
catabody (catalytic antibody) construct engineered from innate immunity principles. Intravenous 
catabody treatment reduced brain A deposits in an Alzheimer’s disease model mouse without 
inducing microgliosis or microhemorrhages (Planque et al., 2015).  
 
 Concluding remarks 
 
This review of membrane active peptides highlights the diversity of origins as well as activities 
found for these macromolecules. Membrane active peptides appear to be as ubiquitous in nature 
as membranes themselves. Many peptides share the activity of more than one membrane active 
category, e.g. Human AMP LL-37 can transfer DNA into cells (Sandgren et al., 2004) , 
Aamyloid also shows antimicrobial activity against a wide spectrum of bacteria and fungi 
(Soscia et al., 2010), Protegrin-1 a porcine AMP has been found to form amyloid fibrils upon 
deposition on hydrophilic surfaces (Jang et al., 2011), IAPP the AP related with Type II diabetes 
has been found to be able to cross plasma membranes to access mitochondrial membranes 
(Magzoub and Miranker, 2012). 
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The classification presented here, shows how biophysical knowledge about each group has 
developed on an independent manner, but as better understanding of the mechanisms of 
interaction for each group emerges similarities and commonalties become more evident. Helixes 
as the predominant structural feature for membrane interaction, amphipathic distribution of 
residues, and high content of one or two amino acids residues are common in all peptide classes, 
and are likely to have common mechanistic significance. This has motivated a number of groups 
to propose a general model for peptide-membrane interaction, based on a small set of governing 
principals. The proposed models focus on the membrane as an active participant in the formation 
of pores (Fuertes et al., 2011;Lee et al., 2004;Wimley, 2010). 
 
 
Figure 1-5. The Effect of peptide binding on the lipid bilayer integrity. Figure from Last 
and Miranker, 2013 
 
Figure 1-5 illustrates the energetics of the proposed membrane centric models: (i) an intact 
phospholipid bilayer is the reference state for energy change. (ii) Spontaneous fluctuations result 
in the sampling of energetically unfavorable membrane defects. (iii) Widening of the defect to 
permit leakage results in a further energetic penalty. (iv) Peptide binding to the surface induces 
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membrane tension. (v) Peptide binding increases the frequency of defect formation. (vi) Surface 
tension is released by pore formation. (vii) Stabilization by peptide binding results in equilibrium 
pore formation (Last and Miranker, 2013). 
 
This review establishes a framework for the experimental undertakings presented on a family of 
CFPs in the following chapters of this dissertation. It intends to aid in the interpretation, and 
underline the relevance of the structural and biophysical finding, within the context of not only 
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Chapter 2 - Structural characterization and consequences of 
introducing a C-terminal tryptophan to a Monomeric Channel-




Membrane ion channels are transmembrane proteins that allow the flow of ions following their 
electrochemical gradient across the membranes of cells and organelles, this flow generates an 
electrical current that is required for the modulation of membrane potential and the regulation of 
multiple cellular activities, like signal transduction, neurotransmission, hormone secretion, 
motility, and regulation of extracellular conditions (Kim, 2014). Defective ion channels have 
been implicated in many human diseases collectively known as channelopathies. This diseases 
affect different systems, including the nervous system (generalized epilepsy with febrile seizures, 
familial hemiplegic migraine, episodic ataxia), the cardiovascular system (Brugada syndrome, 
catecholaminergic polymorphic ventricular tachycardia), the respiratory system (cystic fibrosis), 
the endocrine system (neonatal diabetes mellitus, familial hyperinsulinemic hypoglycemia, 
familial hyperaldosteronism), the urinary system (Bartter syndrome, nephrogenic diabetes 
insipidus, autosomal-dominant polycystic kidney disease), and the immune system (myasthenia 
gravis, neuromyelitis optica, Isaac syndrome) (Cannon, 2007;Jentsch et al., 2002;Kim, 
2014;Welsh and Smith, 1993). Cystic fibrosis is cause by suboptimal synthesis, folding, 
transport, or gating of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR); an 
ATP-gated anion channel. Defects in the CFTR are caused by various genotypes (Tomich et al., 
2012). 
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Epithelia, one of the tissues potentially affected by channelopathies act as regulated barriers to 
the movement between body compartments of small molecules including ions and drugs. 
Defective ion channels disrupt the proper function and regulation of the epithelial surfaces casing 
the disease states. Most ions cross the epithelial apical and basolateral membranes via tightly 
regulated ion-specific transporters and channels. Peptide-based channel replacement therapy has 
been proposed as a treatment modality for correcting genetically based channelopathies (Tomich 
et al., 1998;Wallace et al., 2000;Wallace et al., 1997). A particularly attractive strategy is to 
deliver an aqueous soluble monomeric membrane-active channel forming peptide to the apical 
surface of affected epithelia. Channel forming peptides have the ability to spontaneously insert 
and undergo supramolecular assembly to form functioning homo-oligomeric ion-conducting 
pores upon interaction with the apical cell membrane. As a treatment for the symptomatology 
found in the airways of individuals with cystic fibrosis, the potential therapeutic peptide 
sequence should make up for the lost function of the CFTR, with high anion conduction rates 
and high chloride selectivity. For effective delivery of a therapeutic peptide, high aqueous 
solubility with minimal solution aggregation is essential. With the purpose of finding an optimal 
amino acid sequence for the cystic fibrosis therapeutic peptide, a series of channel forming 
peptides derived from the second transmembrane domain of the 1-subunit of the glycine 
receptor (M2GlyR) were designed, synthesized and tested over recent years (Broughman et al., 
2004;Broughman et al., 2001;Broughman et al., 2002a;Broughman et al., 2002b;Bukovnik et al., 
2012;Bukovnik et al., 2013;Cook et al., 2004;Gao et al., 2001;Herrera et al., 2010;Shank et al., 
2006;Wallace et al., 2000). The NK4-M2GlyR-p22 sequence (KKKKP ARVGL GITTV LTMTT 
QS) has been determined to be a good candidate, in that it has high solubility in physiological 
buffers, controls the orientation of the inserted sequence, and at the same time, has assembled 
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channel properties similar to the full length M2GlyR segment (Broughman et al., 2002b). In the 
open state, the channels formed by NK4-M2GlyR-p22 peptides are able to sustain anion transport 
rates across Madin–Darby canine kidney (MDCK) epithelial monolayers with a maximum short 
circuit current (Imax) of 23.7 ± 5.6 A cm
-2
. However, NK4-M2GlyR-p22 peptide forms soluble 
associations that greatly reduce the concentration of membrane active monomer, requiring a 
concentration of 210 ± 70M to reach one-half Imax (K1/2). Whole cell patch clamp measurements 
of the current-voltage relation revealed inward rectification at positive voltages, (Shank et al., 
2006) suggesting that the assembled channel has a substantial degree of structural flexibility and 
can undergo conformational changes at different voltages. A later designed modification of the 
peptide intended to define the lipid-water boundary of the peptide by replacing serine residue 22 
with a membrane anchoring tryptophan (NK4-M2GlyR-p22 S22W) eliminates nonproductive 
solution assemblies and decreases the peptide concentration required for channel activity. For 
this substituted peptide pore formation can occur at a lower peptide concentration with a K1/2 of 
45 ± 6 M (Tomich et al., 2012). However, there is a substantial decrease of the ion current 
across the membrane (Imax=13.0 ± 1.0 A cm
-2
) at saturating peptide concentrations (Figure 2-1) 
(See Chapter 3 Materials and Methods for experimental determination details), and the inward 
rectification observed for NK4-M2GlyR-p22 is abolished, possibly because the membrane 
anchoring by the tryptophan residue at the C-terminus is as expected restricting certain 
conformational states (and flexibility) of the assembled channel. 
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Figure 2-1. Concentration-dependence of Isc induced by NK4-M2GlyR-p22 and NK4-
M2GlyR-p22 S22W on MDCK epithelial monolayers. NK4-M2GlyR-p22 (●), NK4-
M2GlyR-p22 S22W (▲). Data from (Cook et al., 2004)  
 
Interestingly M2GlyR-derived peptides do not appear to cause immune or inflammatory 
responses at clinically relevant doses (van Ginkel et al., 2008). However, a drawback shared by 
both NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W is that the enhanced ion conductivity 
seems to be accomplished at the cost of much weaker anion permselectivity compared with 
channels formed by the full length M2GlyR segment (Shank et al., 2006). This represents an 
important limitation for any potential therapeutic applications of such peptides. Further 
understanding of the consequences that sequence substitution has onto the overall peptide 
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structure, both in solution and in the membrane environment, is needed to improve the design of 
a monomeric channel-forming peptide with therapeutic application. 
 
In our efforts to determine the monomeric structures of the M2GlyR peptides in solution we used 
proton (
1
H) Nuclear Magnetic Resonance (NMR) spectroscopy, which has been considered as 
one of the most powerful experimental techniques for the investigation of molecular structures at 
the atomic level in solution and membrane like environments (Wüthrich, 1986). The one-
dimensional (1D) 
1
H NMR spectra of peptides are often complex due to the large number of 
signals from the abundant hydrogen atoms. Although, important structural information is 
contained in these NMR spectra, that information is crammed into a relatively small frequency 
range, making assignment of the peaks impractical and most of the time impossible. The first 
step required for the interpretation of 
1
H NMR spectra is the identification of the molecular 
groupings that give rise to the proton resonances. This step has been made possible for peptides 
and other biological macromolecules with the development of multi-dimensional NMR 
techniques, that separate all the resonances detected from the molecules being studied into 






N, etc..), or the type of interaction between the nuclei (through bond, through space ). 
 
The molecular weight of the M2GlyR peptides is within the experimental range that allows the 
use of a combination of two-dimensional (2D) proton-proton NMR techniques without the need 




C) like the 
one required for the study of larger proteins. For NMR signal assignments we use 2D NMR 
experiments, determining through bond connectivities such as 2D homonuclear spin correlated 
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spectroscopy (COSY) (Bax and Freeman, 1981) and 2D Total Correlation Spectroscopy 
(TOCSY) (Bax and Davis, 1985) followed by 2D NMR experiments determining through space 
connectivities such as 2D proton - proton nuclear Overhauser effect spectroscopy (NOESY) 
(Kumar et al., 1980). Since the different secondary structure elements in a peptide, protein and 
macromolecule produce different NOESY signal patterns (Billeter et al., 1982), therefore, 
NOESY spectra analyses can lead to the identification of secondary structure. The quantitative 
analysis of NOESY data is used to estimate proton - proton distance constraints with the help of 
isolated spin pair approximation method. For the calculation of the 3D structure of M2GlyR 
derived peptides on the basis of the experimental constraints, we use a computational approach 
developed by Clore et al., which combines distance geometry algorithms (Braun and Go, 
1985;Havel et al., 1983), dynamical simulated annealing (Nilges et al., 1988a;Nilges et al., 
1988b) and restrained molecular dynamics (Clore and Gronenborn, 1989). Computer programs: 
CNS, MOLMOL and VMD were used for structure calculations and molecular graphics 
(Brunger et al., 1998;Humphrey et al., 1996;Koradi et al., 1996).  
 
For NK4-M2GlyR-p22 peptide the resonance assignments were performed mainly by the 
analysis of a TOCSY experiment spectrum. The pulse sequence for the TOCSY experiment 
contains a 90° pulse, two trim pulses and a MLEV-17 composite pulse. The trim pulse defocuses 
magnetization transverse to the x-axis and allows easy phasing of the 2D spectrum in the 
absorption mode. The MLEV-17 sequence consist of the following: ABBA BBAA BAAB 
AABB, where A and B are the composite pulses of (90°-y 180°x -90°-y) and (90°y 180°-x -90°y). 
An integer number n repetitions of MLEV-17 are used to transfer magnetization between 
homonuclear coupled spins (Bax and Davis, 1985). Cross peaks in a TOCSY spectrum connect 
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protons within a coupled spin network, making the TOCSY experiment ideal for extracting 
connectivities between protons belonging to the same spin system, in this case belonging to the 
same amino acid residue.  
 
Information extracted from the spectra of NOESY experiments is used to stablish sequential 
connectivities that allow for the differentiation of resonances belonging to residues that are 
repeated in the sequence (K2, K3, K4, V8, V15, G9, G11, L10, L16, T13, T14, T17, T19, T20). 
In the basic NOESY experiment the frequency-labeled magnetization is transferred from one 
proton to another during the mixing time via through-space dipolar spin relaxation interactions 
(Kumar et al., 1980). The NOESY spectra contain a main diagonal and cross peaks which 
represent dipole-dipole couplings between nuclei which are at 5 Å or less from each other, 
allowing for the detection of sequential cross peaks between the protons of neighbor amino acid 
residues like the ones presented in Figure 2-2, that contribute to the assignment of ambiguous 
spin systems. 
 
The bulk of the structural information used during the structure calculations is also derived from 
the NOESY spectra, cross peaks identified in these spectra not only come from amino acid 
residues adjacent in the peptide sequence, but are produced by any pair of protons that come 
within a distance of 5 Å due to the molecular conformation. The intensity of the NOESY cross 
peak is related to the distance r between interacting protons by the following proportion: 
 






Where 𝑓(𝜏𝐶) is a function of the rotational correlation time (𝜏𝐶), and represents the influence of 
the motion of the molecule on the observed NOE. The rotational correlation time 𝜏𝐶 can be 
defined as the average time it takes a particular molecule to rotate one radian (McNaught and 
Wilkinson, 1997). The correlation time of a molecule in solution will be affected by the 




Figure 2-2. Notation of sequential proton-proton distances in peptide chains 
 
Concurrently with the analysis of the TOCSY and NOESY spectra, the spectrum obtained from a 
2D double-quantum-filtered correlation spectroscopy (DQF-COSY) experiment was also used in 
the completion of the resonance assignments. In a DQF-COSY experiment a first 90° pulse flips 
the magnetization into the transverse plane, and the various magnetization components are 
labeled during the evolution time (t1). A second 90° pulse excites multiple quantum coherences, 
and is followed by a third 90° pulse after a delay of several microseconds that allows time for 
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phase shifting of the radiofrequency between the second and third pulses. Appropriate phase 
cycling is used to select specific multiple-quantum coherence transfer pathways. For a 
double-quantum filter, the phase is cycled through the values of 0°, 90°, 180° and 270° (Bax and 
Freeman, 1981). A DQF-COSY spectrum provides information on the J-connectivities between 
protons linked via two or three bonds in the covalent structure, the same way a COSY spectrum 
does, however in a DQF-COSY spectrum, both cross diagonal and cross peaks have absorption 
line shapes in both dimensions. This characteristic makes the cross peaks near the diagonal 
observable because the intensity of the tails of the diagonal peaks are reduced by the elimination 
of the dispersive character of the diagonal peaks, also singlets are suppressed by the double-
quantum filer, making the DQF version of the COSY experiment preferable for resonance 
assignments of peptides. 
 
From the assigned DQF-COSY spectrum it is possible to obtain coupling constant (
3
J) values. 
Based on the Karplus equation it is possible to calculate the torsion angles in the protein or 




 region are used to determine the  
angles that make up the peptide backbone. From 
3
J values it is possible to predict the secondary 
structure based on the hertz difference of peak splitting. Extremes of the Karplus scale, which 
ranges from 3 to10, can indicate helix formation (<6 Hz) or the presence of  strand (>8 Hz) in 
the conformation (Nanzer et al., 1994). Coupling constants residing within these extremes can 
represent a turn, loop or an average of different secondary structures. The dihedral angle 
constraints derived from the DQF-COSY spectrum were used during the structural calculations. 
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Using the two dimensional NMR experimental techniques discussed above the monomeric 
solution structures of peptides NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W were reported in 
a 2,2,2-trifluoroethanol (TFE):water solvent system (Cook et al., 2004). The structure of peptide 
NK4-M2GlyR-p22 S22W was later calculated in a Sodium Dodecyl Sulfate (SDS) micelle 
environment, while the determination of the structure of peptide NK4-M2GlyR-p22 in SDS 
micelles had remained elusive due to technical challenges in the sample preparation and 
experimental optimization. Here the monomeric solution structure determination using 2D NMR 
methodology in SDS micelles and the 3D structure calculations of NK4-M2GlyR-p22 using 
molecular dynamics simulations are presented. The obtained 3D structure has been compared to 
the 3D structure obtained for the same peptide in the TFE:water environment. Furthermore, a 
comparison between solution structures of NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W in 
the membrane like environment is also discussed.  
 
The NMR structural information on NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W, existing 
biophysical data, and molecular modeling were combined to construct atomistic models of the 
putative pentameric channels of these peptides. Molecular dynamics (MD) simulations were 
performed to refine and validate these structural models. These studies help in the rationalization 
of the functional consequences of introducing a single C-terminal tryptophan, and the availability 
of these structural models paves the way for future studies to rationally modify and improve 
M2GlyR-derived peptides toward potential peptide-based channel replacement therapy. The 




 Materials and Methods 
 
 Peptide Synthesis and Purification 
 
Peptides NK4-M2GlyR-p22 (NH2-KKKKPARVGLGITTVLTMTTQS-CONH2; MW = 2356.9 
Da) and NK4-M2GlyR-p22 S22W (NH2-KKKKPARVGLGITTVLTMTTQW-CONH2; MW = 
2456.0 Da) were chemically synthesized by solid phase peptide synthesis methodology on an 
Applied Biosystems model 431A peptide synthesizer (Applied Biosystems, Foster City, CA) 
using 9-fluorenylmethoxycarbonyl (Fmoc) chemistry at a synthesis scale of 0.1-0.2 mmol, 
CLEAR amide resin (0.3 mmol/g) purchased from Peptides International Inc. (Louisville, KY) 
was preloaded with the first amino acid and N

-Fmoc amino acids were purchased from Anaspec 
(Fremont, CA), Bachem Inc. (Torrance, CA), and Peptides International Inc. (Louisville, KY) 
(Tomich et al., 1998). All peptides were purified using a Phenomenex (Torrance, CA) reversed-
phase C-18 column on a System Gold HPLC system (Beckman Instruments Inc., Fullerton, CA). 
Peptides were eluted from the column using a linear gradient of 3.0% min
-1
 of 10–90% 
acetonitrile containing 0.1% trifluoroacetic acid (TFA) at 1 mL/min. HPLC-purified peptides 
were characterized by matrix-assisted-laser desorption time-of-flight mass spectroscopy 
(MALDI-TOF/TOF) using a Bruker Ultraflex II mass spectrometer (Bruker Instruments Inc., 
Billerica, MA). After characterization, peptides were lyophilized and stored as dry powders until 
used. The purity of the samples and connectivity of amino acid residues in NK4-M2GlyR-p22 
and NK4-M2GlyR-p22 S22W were further indicated by the complete analysis of the TOCSY and 
NOESY NMR spectra of each peptide.  
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 NMR Sample Preparation 
 
Lyophilized peptide was dissolved in 1.0 mL of a (1:1) mixture of 1,1,1,3,3,3-hexafluoro-2-
propanol:TFE. The solution was transferred to a glass test tube and dried with a stream of 
nitrogen gas in order to dry the peptide into a thin film on the wall of the test tube. Once the 
peptide was considered dry by visual inspection, the test tube containing the peptide was put in a 
lyophilizer overnight to remove any remaining solvent and moisture. The following day, the 
peptide was dissolved in 250l of 1 M SDS-d25 in water. Once the peptide appeared dissolved, 
250l of an 80%H2O:20% D2O mixture was added (Cambridge Isotope Labs, Andover, MA), for 
a final SDS-d25 concentration of 500mM in 90%H2O-10% D2O and a peptide concentration of 
2.5 mM.  
 






H TOCSY experiments were performed with the 11.75 tesla 500 MHz Varian 
VNMRS spectrometer (Varian now Agilent Inc., Palo Alto, CA), running VNMRj version 2.3 at 
the Biomolecular NMR facility of the Biochemistry and Biophysics Department at Kansas State 
University, using a room temperature 3mm (sample tube diameter) inverse detection Penta 
probe. The obtained spectra did not have the needed quality for resonance analysis due to signal 
broadening. The prepared peptide sample was sent to the Biomolecular NMR laboratory at the 












H NOESY spectra were recorded with a 18.8 tesla Bruker Avance 800 MHz NMR spectrometer 
(Bruker Instruments, Billerica, MA) equipped with an inverse detection TCI cryoprobe running 
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Topspin 1.3. Experiments were performed at 45°C, the elevated data acquisition temperature was 
chosen to reduce the molecular tumbling time and improve spectral quality, CD measurements 
show minimal structural differences with the temperature increase (Tomich et al., 1998). Raw 
NMR data obtained from the 800 MHz instrument was processed using NMRPipe (Delaglio et 
al., 1995) and analyzed with Sparky software (Goddard and Kneller, 2004) using a Dell 
Precision 690 workstation (Round Rock, TX). NOE cross peaks were classified as strong, 
medium, weak and very weak based on the observed number of contour lines. Spin-lock time of 




H TOCSY experiments using MLEV-




H NOESY experiments. For all 2D experiments 1024 complex data points were collected in 
the direct dimension and 256 in the indirect dimension. Linear prediction and zero filling were 
used during NMR data processing; the suppression of the solvent peak was achieved using the 
WATERGATE pulse scheme during acquisition (Piotto et al., 1992) and the residual water peak 
(4.61 ppm) was used as reference for chemical shift values. 
 
 NMR Structure Calculations 
 
A previously established protocol was used for structure calculations (Cook et al., 2004). 
Unambiguously identified NOE cross peaks were converted into inter-proton distance upper 
bounds using the following classifications: strong (2.7 Å), medium (3.5 Å), weak (4.0 Å), and 
very weak (5.0 Å) (Wüthrich et al., 1983). Upper distance limits for NOEs involving methyl 
protons and nonstereo specifically assigned methylene protons, were corrected appropriately for 
center averaging by adding 1 Å to the maximum distance constraint (Wüthrich et al., 1983). 
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Backbone dihedral angle restraints were derived from the distance restraints and 
3
JHNH coupling 
constants using the program HABAS (Guntert et al., 1989). The obtained distance and dihedral 
restraints were used to calculate peptide structures using the crystallography and NMR system 
(CNS) software version 1.1, (Brunger et al., 1998). The protocol involved combined simulated 
annealing in torsional space and MD refinement in Cartesian space to produce structures with 
minimal restraint violations (Stein et al., 1997). A total of 100 accepted structures were subjected 
to energy minimization in the AMBER force field (Cornell et al., 1995;D.A. Case, 2002) using 
SYBYL 7.1 (Tripos Inc., St. Louis, MO). The minimized structures were then clustered based on 
mutual heavy-atom root mean square deviation (RMSD). The resulting structures were evaluated 
with the program Procheck v.3.5.4 (European Bioinformatics Institute, Cambridge, UK). The 
cluster of 10 structures with no restraint violation and the lowest energies were selected as the 
representative NMR structures.  
 
 Results and Discussion 
 
 NMR Data Analysis 
 
Several unsuccessful attempts to acquire good quality data of NK4-M2GlyR-p22 peptide in SDS 
micelles using the 500 MHz NMR instrument located at the Biomolecular NMR facility of the 
Biochemistry and Biophysics Department at Kansas State University were performed. These 
failures were attributed to a combination of instrumental limitations along with challenges on 
proper NMR sample preparation in SDS micelles. Optimization of the NMR sample preparation 
procedure to maximize peptide solubility, micelle formation and peptide insertion into the 
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H TOCSY spectrum on the NK4-M2GlyR-p22 sample in SDS micelles using the 500 MHz 
NMR instrument equipped with a room temperature probe, the spectrum showed broadening of 




 finger print region of the TOCSY spectrum 
displaying severe overlapping due to broadening of most of the cross peaks. 
 
 




) of TOCSY spectra collected on (A) 500 MHz room 
temperature probe and (B) 800 MHz cryogenic probe  
 
The signal broadening found in the spectrum is not expected for a peptide of the size of NK4-
M2GlyR-p22 (MW = 2356.9 Da), it is the consequence of the slow tumbling caused by the 
effective particle size present in the sample. The aggregation number (AN) of SDS in pure water 
at room temperature has been reported to be around 62, and expected to increase in the presence 
of impurities (Bales et al., 1998). In another report the temperature effect on the aggregation of 
SDS micelles was studied using solutions in D2O at different concentrations, according to this 
report the AN for a 500 mM solution of SDS at 45 °C is around 90 (Hammouda, 2013). With a 
diameter of the SDS micelles reported to be of at least 34 Å, and a concentration of micelles in 
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the sample of at least twice the peptide concentration (SDS concentration /AN), we assumed that 
the majority of micelles is the sample have one inserted peptide at the most. These considerations 
make the molecular weight of the particles in the samples to be at least 25,000 Da, and the 
observed proton linewidths more consistent with that of a 25 kDa protein. To overcome this 
limitation, 2D NMR spectra were acquired using a higher magnetic field spectrometer, where the 
signals are spread over a larger frequency range (normalized in the ppm scale for comparison). 
Figure 2-3 B shows the same spectral region as in part A, of a TOCSY spectrum collected at the 
Biomolecular NMR laboratory at the University of Kansas using a Bruker Avance 800 MHz 
NMR spectrometer, reduction of the signal overlapping allowed the interpretation of the spectra. 
Additional gain in spectral quality was obtained from the use of a cryogenically refrigerated 
NMR probe, these probes use a closed refrigeration helium system to cool the electronics of the 
probe (coils, pre-amplifiers) to a temperate near 25K (while keeping the sample at the desired 
experimental temperature). Decreasing the thermal vibrations responsible for most of the noise in 
the NMR signal increases the signal to noise ratio of the acquired signal up to 10 times compared 




H TOCSY spectrum after 
processing of NK4-M2GlyR-p22 in SDS micelles, acquired with an 800 MHz spectrometer is 

















H TOCSY Spectrum of NK4-M2GlyR-p22 in SDS micelles 
 

















/and sidechain proton 

















 intra-residue spin connectivity which was used to determine residue type in the 
















 cross peak assignments in the 
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finger print region of the TOCSY spectrum used for residue identification. In the same way the 




 cross peaks in 2D NOESY spectra were used to identify 
dN(i,i+1) proton connectivity for sequential assignments and differentiation of repeated amino 
acid residues (e.g. K 1-4 T 13, 14, 17, 19, 20). The resulting chemical shift values for the 
unambiguously assigned proton resonances are presented in Table 2-1. 
 








H DQF-COSY spectrum of NK4-






















 and side chain protons) spectral region 
for NK4-M2GlyR-p22. Showing individual amino acid spin systems connected with a 
vertical line and labeled assignments 
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Table 2-1. Chemical Shift Values (ppm) for NK4-M2GlyR-p22 in SDS micelles 
 
 




 protons indicate a folded structure for the peptide in 
the micelle environment. The nature of the parent sequence as well as the previously determined 
Residue 










K1   2.12 2.08 1.69  1.91  3.19 
K2 8.44 4.53 1.97 1.60  1.93 
K3 8.58 4.51 2.01 1.96 1.66  1.88  3.18 
K4 8.12 4.50 2.02 1.96  1.86  3.18 
P5  4.62 2.51 2.19 2.12  4.01 3.76 
A6 8.30 4.44 1.59   
R7 8.18 4.46 2.04 1.84  3.37 NH 7.26 
V8 7.85 4.15 2.31 1.15 1.11  
G9 8.37 4.11    
L10 8.05 4.42 1.89 1.82  1.08 
G11 8.51 4.07    
I12 8.29 4.02 2.12 1.38 1.12  1.09 
T13 8.00 4.53 4.44 1.42  
T14 8.05 4.21 4.50 1.41  
V15 7.96 4.00 2.37 1.21 1.12  
L16 8.24 4.37 1.99 1.77  
T17 8.10 4.34 4.50 1.41  
M18 8.09 4.55 2.36 2.85 2.78  
T19 8.23 4.14 4.45 1.45  
T20 7.97 4.57 4.46 1.42  
Q21 8.18 4.59 2.57 2.19 2.36  
S22 8.21 4.62 4.1 4.06   
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structure of the NK4-M2GlyR-p22 S22W make the overall structure of NK4-M2GlyR-p22 
expected to be of mostly helical nature in SDS micelles. The Chemical Shift Index (CSI) was 
calculated based on the shifted H

 resonances as the difference in chemical shift compared to the 
random coil values reported by Wishart et al. (Wishart and Nip, 1998). A negative CSI value (<-
0.10 ppm, upfield shift) suggests a turn in the structure and several consecutive residues with 
negative CSI values indicate a presence of a helix. A series of positive CSI values (>0.10 ppm, 
downfield shift) suggest the presence of a -strand. Since the random coil chemical shifts used 
are reported for an aqueous solution at 25°C, a more pertinent source of references values was 
selected, the new values were calculated based on the peptide sequence with a sequence-
dependent correction and a temperature correction as well, (Kjaergaard et al., 2011;Kjaergaard 
and Poulsen, 2011) the resulting corrected CSI values are reported in Table 2-2. The resulting 
CSI plot for NK4-M2GlyR-p22 H

 protons is shown in Figure 2-7. 
 

















K2 4.53 4.29 0.24 
K3 4.51 4.31 0.20 
K4 4.50 4.60 -0.09 
P5 4.62 4.41 0.21 
A6 4.44 4.29 0.15 
R7 4.46 4.39 0.07 
V8 4.15 4.11 0.04 
G9 4.11 4.02 0.09 
L10 4.42 4.37 0.05 
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G11 4.07 4.03 0.04 
I12 4.02 4.27 -0.26 
T13 4.53 4.48 0.06 
T14 4.21 4.40 -0.19 
V15 4.00 4.14 -0.14 
L16 4.37 4.44 -0.07 
T17 4.34 4.36 -0.02 
M18 4.55 4.61 -0.06 
T19 4.14 4.45 -0.31 
T20 4.57 4.38 0.19 
Q21 4.59 4.42 0.16 
S22 4.62 4.43 0.20 
 
 
Figure 2-7. Chemical Shift Index (CSI) plot for H

 protons of NK4-M2GlyR-p22 calculated 













Residue number  
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Most of the calculated CSI values have an absolute value under 0.1 making them not suitable for 
a prediction of secondary structure. The residues with CSI absolute value greater than 0.1 (2-3, 
5-6, 2, 14-15, 19, 20-22) are in short stretches of mostly 1 or 2 residues, also making any 
prediction of secondary structure for this residues unreliable. The calculation of the CSI was not 
able to provide the prediction of secondary structure that was expected, and has been reported 
during the structure calculations of M2GlyR derived peptides before (Cook et al., 2004). 
 
Detailed analysis of the NOESY data, by concurrently evaluating the 300 ms and 400 ms mixing 
time spectra ( to confirm or reject ambiguous NOESY peaks) revealed short and medium range 
connectivities including, dN(i, i+1), dN(i, i+1), dNN(i, i+1), dN(i, i+2) and dN(i, i+3) that are 
consistent with a helical conformation (Wüthrich, 1986). An example of NOESY spectra 
showing inter-residue as well as intra-residue cross peaks including sequential and medium range 
connectivities is presented in Figure 2-8 overlaid with the TOCSY spectrum in order to highlight 
the presence of pure NOESY peaks. Cross peaks corresponding to dNN(i, i+1) connectivities 
indicative of helical conformation are shown in Figure 2-9. A graphic summary of all sequential 
and medium range NOE connectivity for NK4-M2GlyR-p22 in SDS micelles is presented in 
Figure 2-10. NOE characteristic of helical conformation are observed from residues alanine 6 to 
threonine 20.These results suggest a continuous stretch of helical conformation for NK4-
M2GlyR-p22 in SDS micelles. 
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H TOCSY spectrum 















H NOESY spectrum acquired with 400ms mixing time, 
showing dNN(i,i+1) connectivities 
 
 
Figure 2-10: Summary of NOE connectivity for peptide NK4-M2GlyR-p22 in SDS micelles. 
Line thickness indicates peak intensity, and dotted line indicates ambiguity due to peak 
overlapping 
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 NMR Structure Calculations 
 
For the structure calculations unambiguously assigned NOE cross peaks, from both the 400 ms 




H NOESY spectra, were classified as: intra-residue, sequential, medium 
range (between protons from four or less, but more than two residues apart), and long range 
(between proton from more than four residues apart); and converted into a total of 117 distance 
constraints as described in the methods section. Among the distance constraints generated, 38 





spectrum 18 dihedral angle constraints were obtained. The generated distance and dihedral angle 
constraints summarized in Table 2-3 were used to calculate structure ensembles with help of 
CNS software. The cluster of 10 structures with the lowest total energies, and no distance 
violation >0.5 Å or dihedral violation >5° for NK4-M2GlyR-p22 in SDS micelles is shown in 
Figure 2-11.The backbone ψ and φ angles distribution of the calculated energy-minimized 
structures were evaluated against the Ramachandran Plot values using the PROCHECK program 
(Laskowski et al., 1996). More than 99% of the ψ and φ angles of the peptide backbone cluster 
were found to reside within the allowed regions; these results are also summarized in Table 2-3. 
The average structure of NK4-M2GlyR-p22 after molecular dynamics refinement in implicit 
membrane is shown in Figure 2-12a. This refined monomer structure was used as the starting 







Table 2-3. Structural Statistics for peptide NK4-M2GlyR-p22 in SDS micelles 
Experimental NMR Constraints  
 NOE Distance Constraints  
  Intra-residue 38 
  Sequential 53 
  Medium Range 26 
  Long Range 0 




 Etotal -52.9±16.08 
RMSD from the mean structure (Å)  
  Backbone of the helical 
segment (residues 6-20) 
0.46 ± 0.12 
Ramachandran statistics  
 Residues in allowed regions > 99% 
 Residues in generously allowed 
regions 
< 1% 






Figure 2-11. Solution monomeric structure of peptide NK4-M2GlyR-p22 in SDS micelles. 
Cluster of the 10 calculated structures with the lowest energies superimposed  
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 Discussion and Analysis 
 
The determined NMR structure for NK4-M2GlyR-p22 peptide in SDS micelles clearly shows a 
linear and mostly helical conformation from residues 6-20. The N-terminal lysine residues are 
largely unstructured and flexible. The hydrophobic and hydrophilic side chains of the residues in 
the helix are segregated to different sides of the helix, as expected for a channel forming 
transmembrane segment. The average structure of NK4-M2GlyR-p22 in SDS micelles has the 
same characteristics (unstructured N-terminus, amphipathic helix) as the solution structure 
previously determined in a 40% TFE solution (Cook et al., 2004). The structure in micelles 
appears better defined for residues proline 5 to arginine 7 when compared with the 40% TFE 
structure, potentially due to a more restrictive environment found in the interior of the micelles. 
The whole structure in micelles is better defined, as the calculated structures in TFE solution 
showed a RMSD to the mean structure for residues 9-20 of 1.95± 0.6 Å (Cook et al., 2004), 
whereas the cluster of structures in SDS micelles showed a RMSD to the mean structure 
(residues 6-20) of 0.46 ± 0.12 Å. 
 
Although the structure determined in SDS micelles has the expected conformation, the CSI 
calculation was not able to predict it even when the best available reference chemical shifts for 
random coil were used. The prediction of secondary structure by calculation of the CSI is based 
on a statistical analysis of calculated structures and comparison of their corresponding residue 
assignments with the chemical shift values found for extended peptides in a simple solvent 
system (Mielke and Krishnan, 2004). This method has been found useful even in solid-state 
NMR, but the results presented here show that a prediction cannot always be made for a 
compartmentalized solution system like micelles in an aqueous solution. 
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The average structure for peptide NK4-M2GlyR-p22 in SDS micelles also shows resemblance to 
the average structure calculated for peptide NK4-M2GlyR-p22 S22W (Figure 2-12b) in a similar 
environment (Herrera et al., 2010). Figure 2-12 shows the two average structures side by side, 
with the backbone as a blue tube. In the average structures it can be visualized that both peptides 
have a similar helical conformation on most of the length (residue 6-20) of the peptide. The NK4-
M2GlyR-p22 S22W shows a convexity while NK4-M2GlyR-p22 has a more linear axis in the 
central portion of the structure. For both peptides a relative unstructured state of the N-terminal 
lysines is observed, that is more pronounced for the NK4-M2GlyR-p22 sequence. These lysines 
are predicted to be out of the micelle exposed to the aqueous environment and/or interacting with 
the sulfate groups from the SDS molecules, the C-terminus of NK4-M2GlyR-p22 also shows 
greater variability compared with NK4-M2GlyR-p22 S22W possibly due to lacking the 
anchoring tryptophan residue. As mentioned in the methods section, the acquisition of the 
spectra for NK4-M2GlyR-p22 was particularly challenging, as the spectra suffered from peak 
broadening and decreased signal to noise ratio (compared to the same peptide in TFE:water 
solution and NK4-M2GlyR-p22 S22W in SDS micelles); this could be due to a greater flexibility 
or freedom for NK4-M2GlyR-p22 compared with NK4-M2GlyR-p22 S22W in the membrane-




Figure 2-12. Average monomeric solution structures in SDS micelles for peptides: (A) NK4-
M2GlyR-p22; (B) NK4-M2GlyR-p22 S22W 
 
The flexibility found in the N-terminus as well as in the C-terminal residues is consistent with 
the findings of the whole cell patch clamp measurements of the current-voltage relation that 
showed inward rectification at positive voltages, (Shank et al., 2006) as this flexibility can play a 
role in allowing the channel assembly the required conformational changes at different 
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transmembrane voltages. Furthermore the higher peptide concentration required by NK4-
M2GlyR-p22 compared with NK4-M2GlyR-p22 S22W to reach one-half Imax on epithelial 
monolayers (210 ± 70 μM for NK4-M2GlyR-p22 to 45 ± 6 μM for NK4-M2GlyR-p22 S22W) , 
(Figure 2-1) could be attributed not only to the soluble associations formed by the peptide in the 
aqueous environment, but also to the higher conformational flexibility in the membrane 
environment, that may negatively impact the stability of the assembled ion channel. 
 
Appendix A - Chapter 2 describes the computational assemblies and molecular dynamics 
simulations performed on the ion channels formed by NK4-M2GlyR peptides, based on the 
calculated NMR solution structures. Computational studies refine and validate NMR structural 
models, and characterize the structural and dynamic properties of the channel in fully solvated 
model membrane bilayers. A key validation is to examine how a single S22W mutation impacts 
the channel characteristics and subsequently membrane insertion efficacy, assembly and channel 
properties.  
 
In summary, the determined NMR structures of NK4-M2GlyR-p22 in SDS micelles and in TFE 
solution show many similarities. However the NMR structure of NK4-M2GlyR-p22 in SDS 
micelles shows some similarities to the structure determined for the NK4-M2GLYR-p22 S22W 
peptide, but with notable differences that can help explain the physical and biological differences 
found between the two peptides. These results serve to better understand the determining factors 
for the desired characteristics of an optimized therapeutic peptide. The structural characterization 
supports the initial postulation that the S22W mutation helps in anchoring the pore to the 
membrane and reduces the flexibility of the whole assembly. The implied increased stability of 
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the NK4-M2GlyR-p22 S22W channel explains the steeper short circuit current-concentration 
slope measured experimentally (Figure 2-1). Furthermore, according to the simulations, the 
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Appendix A - Chapter 2 
 
The work described in this section was performed by Drs. Chen and Al-Rawi in the Department 
of Biochemistry and Molecular Biophysics at Kansas State University. The purpose of these 
studies was to construct, characterize, and validate initial high-resolution structural models of the 
putative pentameric channels formed by peptides NK4-M2GlyR-p22 and NK4-M2GlyR-p22 p22-
S22W.  
 
The initial step was the further refinement of the average structures from the ensembles 
calculated by CNS based on the NMR data, using the GBSW implicit membrane model (Im et 
al., 2003) in CHARMM (Brooks et al., 2009;Brooks et al., 1983). Distortions to covalent 
geometry due to averaging were corrected by short energy minimization while harmonic 
positional restrains on heavy atoms. These refinements might be particularly useful to remove 
potential structural distortions due to difference between micelle and bilayer membrane 
environments, which facilitates subsequent assembly of monomer structures into channels. The 
refinement protocol involves 100 ps restrained molecular dynamics simulation at 300 K followed 
by energy minimization. Default GBSW implicit membrane parameters were used with a 
hydrophobic membrane thickness of 35 Å. All NMR restraints were imposed with force 
constants of 50 kcal/mol/Å
2
 for NOE distances and 100 kcal/mol/Å
2
 for dihedral angles during 
MD refinement. The force constants of NOE distances were increased to 100 kcal/mol/Å
2
 during 
the final energy minimization. 
 
96 
Starting from refined monomer NMR structures, the peptides structures were assembled into 
pentamers using CHARMM based on the following experimental and theoretical considerations: 
First, previous experimental work indicate that this family of peptides spontaneously assembled 
into pentameric structures when inserted into synthetic bilayers or cell membranes (Reddy et al., 
1993). Second, cysteine-scanning experiments on a related peptide sequence (NK4-M2GlyR p22-
T19R/S22W) have identified residues A6, L10, T13, and T17 as pore lining residues (Bukovnik 
et al., 2012). Third, solid-state NMR and free-energy calculations suggest that transmembrane 
helix tilt angles most likely fall in the range 10°–15° (Lee and Im, 2008;Montal and Opella, 
2002) for peptides of similar length, as a result of balance between helix procession entropy and 
peptide-membrane interactions. Fourth, when the monomers are aligned to form the pentamer, 
the adjacent peptides should be in contact with each other while maintaining a pore cavity 
sufficiently large for ions to traverse. 
 
Multiple initial models were generated for each sequence with different handiness of helix 
packing. The assembled channels were subject to energy minimization in presence of harmonic 
positional restraints on all heavy atoms and then solvated in a pre-equilibrated POPC bilayer 
membrane using the CHARMM-GUI automated Membrane Builder (Jo et al., 2007;Jo et al., 
2008). A six-cycle equilibration protocol was applied to equilibrate the system at 303 K using 
CHARMM, during equilibration, two cycles of NVT simulation (constant volume and 
temperature) were performed for 25 ps each, followed by three cycles of NPT simulation 
(constant pressure and temperature) of 25– 100 ps. A final NPT equilibration cycle was 
performed for 100 ps where only the protein backbone atoms were held with weak harmonic 
positional restraints. SHAKE was used to fix the length of hydrogen-attaching bonds (Ryckaert 
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et al., 1977) to allow for a two femtosecond (fs) dynamic time step during cycles 4–6. Periodic 
boundary conditions were enforced. Particle Mesh Ewald (PME) (Darden et al., 1993) was used 
for treatment of long-range electrostatic interactions, and van der Waals interactions were 
smoothly switched off from 10 to 12 Å. The fluctuations in temperature, volume, and energy 
were examined, and all were within reasonable ranges. The protein, water, and lipids were 
monitored during the equilibration to ensure that the water did not penetrate the lipid bilayer. 
 
The final structure from the CHARMM equilibration simulation was used in the NAMD 
software package (Phillips et al., 2005) for the production simulation. Another 100 ps 





) in the NAMD simulations was used to suppress potential strains during subtle 
differences between CHARMM and NAMD. Setups equivalent or identical to those described 
above were used, unless otherwise noted below. Electrostatic interactions were evaluated based 
on a multiple-time-stepping algorithm (Han et al., 2007) implemented in NAMD, where bonded 
interactions were updated every time step, short-range non-bonded electrostatic and van der 
Waals interactions every two steps, and long-range interactions every four steps. After the 
system was equilibrated, all restraints were released. A NPAT (constant pressure and membrane 
area) production simulation was carried out for 20 nanoseconds for each structural model, with 
the coordinates saved every 1 ps. 
 
The channel structures are stable in the POPC membrane bilayers within the 20 ns NAMD 
production simulations, the whole channel drifts upward relative to the membrane, presumably to 
allow better solvent exposure of the charged N-terminal lysines. The positively charged lysine 
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side chains also interact extensively with lipid phosphate groups. The drift results in substantial 
distortions in the local membrane environment, particularly, thinning of the bilayer adjacent to 
the channel. The helical segments of all five peptides are stable (at the secondary structure level). 
In fact, the peptide structures become more helical compared with the monomeric NMR 
structures in SDS micelles, reaching ~75%. The increase in helicity is due primarily to the 
formation of more regular helices within residues 6–20. The averaged helix tilt angles with 
respect to the membrane normal (computed using residues 6–20) increase to ~25°. This tilt angle 
is larger than expected for short helices, repulsion among positively charged side chains (K1–4 
and R7), coupled with unstructured N-termini and local membrane thinning, is likely the main 
driving force for the large helix tilt angle. 
 
To directly test that the membrane-anchoring tryptophan residue at the C-terminus of peptide 
NK4-M2GlyR-p22 S22W increases the channel stability and rigidity, the whole channel C root 
mean square fluctuation (RMSF) was calculated using the last 5 ns of the production simulation. 
As it is shown in Figure A-1(a), the results support that the NK4-M2GlyR-p22 pore is more 
flexible than NK4-M2GlyR-p22 S22W. The presence of the C-terminal tryptophan not only 
reduces the channel flexibility near the C-terminus, but also leads to a global reduction of 
flexibility including the unstructured N-termini. Figure A-1 (b, c) shows how the C-terminal 
tryptophan mainly restricts the translational motion along the membrane normal and might thus 
enhance the overall integrity of the channel assembly. Tryptophan residues might also contribute 
further to the channel stability by restricting rotation around the helix principle axis (White and 
von Heijne, 2005). Although reduced flexibility does not necessarily reflect increased stability, 
these two properties are often positively correlated. An increased stability of the NK4-M2GlyR-
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p22 S22W channel as suggested by reduced flexibility is consistent with the difference in 
concentration dependence of short circuit current induced by NK4-M2GlyR-p22 and NK4-
M2GlyR-p22 S22W measured in MDCK cell monolayers (Figure 2-1). 
 
 
Figure A-1. a) C RMSF of NK4-M2GlyR channels. b,c) Position of N-terminus, C-
terminus and center of mass as a function of time during simulation 
 
During the course of the simulations, several incidences of spontaneous Cl
-
 diffusion through the 
channels were observed. This is probably due to substantial local Cl
-
 concentration enrichment at 
the N-terminal opening of the channels due to the presence of large number of lysine residues. 
This observation allows us to qualitatively understand the nature of chloride conduction and 
possible mechanism of anion selectivity of these synthetic channels. Figure A-2 shows the time 
evolution of the position of a single Cl
-
 along the membrane normal during an incidence of its 
spontaneous diffusion through the NK4-M2GlyR-p22 channel, together with a snapshot where 
this particular Cl
-
 locates inside the channel around the narrowest point (near Thr17). Cl
-
 ions 
remain highly solvated throughout the diffusion process, in fact, both p22 and p22-S22W pores 




Figure A-2. A) Position of Cl
-
 as a function of simulation time during diffusion through the 
NK4-M2GlyR-p22 channel B) Snapshot of the interactions between Cl
-
 and water molecules 




Chapter 3 - Structural and functional characterization of a shorter 
length (20 amino acid residues) membrane spanning Channel-




The analysis of the structural and physiological characteristics of 22 residues containing peptides 
NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W (Cook et al., 2004;Herrera et al., 2010) showed 
that the substitution of tryptophan residue 22 for a serine residue was advantageous due to the 
reduction in the concentration required to reach one-half Imax, but since the actual Imax was 
reduced compared with the unsustituted sequence, new modificationes that would restore Imax 
were explored. The next step in the pursue of find an optimal channel forming peptide, derived 
from the M2GlyR sequence, that would be functional as a potential cystic fibrosis therapeutic 
was to introduce a second substitution, with a charged amino acid, near the C-terminus. Out of 
the many tested posibilities the substitution of threonine 19 for an arginie residue was found to 
be the position that gave the best results (Shank et al., 2006). The structural and biophysical 
properties of peptide NK4-M2GlyR-p22 T19R S22W were extensively characterized (Bukovnik 
et al., 2012), notably this peptide induces an Imax of 33.7 ± 1.3 μA/cm
2
 across MDCK epithelial 
monolayers with a concentration of 71 ±5 M to reach one-half Imax (K1/2) (See Table 4-2 and 
Figure 4-2). Monomeric structures determined by NMR, together with a cysteine scanning study 
suggested that threonine residues at positions 13, 17, and 20 line the pore of the assembled 
channel of NK4-M2GlyR-p22 T19R S22W peptides (Bukovnik et al., 2012). 
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One direction explored subsequently for improving the channel forming sequence’s performance 
was making the peptide sequences shorter, effectively making the ion conduction path shorter, 
and the synthesis of the peptide easier and more economical. In order to preserve the membrane 
anchoring effect of the C-terminal residues and the spacial distribution of the pore lining side 
chains, the sequence was modified by eleminating the first two residues after the four N-terminal 
lysines namely proline 5 and alanine 6. Sequences shorter than 20 residues were previously 
found to be inefective in forming ion channels (Broughman et al., 2002). The resulting peptide 
sequence was: KKKKR VGLGI TTVLT MRTQW and it was named 
NK4-M2GlyR-p20 T17R S20W, a comparison of this amino acid sequence with other M2GlyR 
derived channel forming peptides can be seen in Figure 3-1. 
 
 
Figure 3-1. M2GlyR-p20 T17 S20W peptide sequence compared to other M2GlyR derived 
channel forming peptides 
 
This chapter presents the efforts in the determination of an atomic level monomeric structure by 
multidimensional NMR methodology in two different solvent systems and the characterization of 
the ion conductance of NK4-M2GlyR-p20 T17R S20W channels across MDCK epithelial 
monolayers. The results obtained from the shorter peptide NK4-M2GlyR-p20 T17R S20W 
showed an improvement in ion conductance over the sequences previous reported.  
 
103 
Dissolving peptides in 2,2,2-trifluoroethanol (TFE) solutions has been used by several 
investigators for the structural study of peptides and proteins as a way of mimicking the 
hydrophobic environment of the membrane (Cammers-Goodwin et al., 1998;Jasanoff and Fersht, 
1994;MacPhee et al., 1997). TFE:water mixtures often stabilize secondary structural elements of 
peptides including -helices. The TFE molecules displace water molecules by clustering around 
the peptide. This displacement of water molecules prevents hydrogen bonding of the CO and NH 
groups of the peptide backbone to water molecules providing a low dielectric environment which 
encourages the formation of intramolecular hydrogen bonds that stabilize the secondary structure 
of the peptide (Roccatano et al., 2002).  
 
The low dielectric environment in the TFE solution homogeneously surrounds the peptide, which 
limits the applicability of the determined structures, since a protein containing a transmembrane 
segment experiences at least three surrounding environments, one for the bulk of the solution, 
akin of a water solution, one for the hydrophobic interior of the cellular membrane, and one for 
the membrane-solution interface where the charged or hydrophilic head groups of the 
phospholipids reside. Detergents like Sodium Dodecyl Sulfate (SDS) have been used to better 
mimic membrane environments in order to acquire structure information of membrane spanning 
segments of proteins or peptides (Arseniev et al., 1985;Pervushin et al., 1991;Rizo et al., 1993). 
Detergent molecules in an aqueous solution at the critical micelle concentration or higher will 
assemble to form micelles with the polar head groups on the outside and the hydrophobic tails on 
the inside providing a compartmentalized environment similar to that of a membrane bilayer. For 
NMR experiments additional consideration should be taken to the micelle size because fast 
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tumbling of the peptide-SDS micelles, which is a requirement for rapid isotropic motions, is 
needed for good quality of the generated NMR spectra. 
 
In order to test the presence of secondary structure for the peptide monomers in the solvent 
systems to be used, before running lengthy NMR experiments, the peptide was dissolved in both 
TFE:water and SDS micelles and analyzed by circular dichroism (CD) spectroscopy 
 
 Materials and Methods 
 
 Peptide Synthesis and Purification 
 
Peptide NK4-M2GlyR-p20 T17R S20W (NH2-KKKKRVGLGITTVLTMRTQW-CONH2; MW 
= 2344.9 Da) was chemically synthesized at the Biotechnology Core Facility of Kansas State 
University by solid phase peptide synthesis methodology on an Applied Biosystems model 431A 
peptide synthesizer (Foster City, CA) using 9-fluorenylmethoxycarbonyl (Fmoc) chemistry as 
described in Chapter 2 (Tomich et al., 1998). CLEAR amide resin (0.3 mmol/g) was purchased 
from Peptides International Inc. (Louisville, KY) and N

-Fmoc amino acids were purchased 
from Anaspec (Fremont, CA), Bachem Inc. (Torrance, CA), and Peptides International 
Inc.(Louisville, KY). The peptide was purified using a Phenomenex, (Torrance, CA) reversed-
phase C-18 column on a System Gold HPLC system (Beckman Instruments Inc., Fullerton, CA). 
The peptide was eluted from the column using a linear gradient of 3.0% min
-1
 of 5–90% 
acetonitrile containing 0.1% trifluoroacetic acid (TFA) at 1 mL/min. HPLC-purified peptide was 
characterized by matrix-assisted-laser desorption time-of-flight mass spectroscopy (MALDI-
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TOF/TOF) using a Bruker Ultraflex II mass spectrometer (Bruker Instruments Inc., Billerica, 
MA). After characterization, the peptide was lyophilized and stored as dry powder until used. 
 
 Transepithelial ion transport measurements  
 
For the transepithelial ion transport measurements Madin-Darby canine kidney (MDCK) 
epithelial cells cultured from parental cells that were a generous gift of Dr. Lawrence Sullivan 
(KUMC, Kansas City, KS) were used. Cells were maintained as sub-confluent monolayers in a 
1:1 mixture of Dulbecco’s modified Eagle medium and Ham’s F-12 nutrient mixture (DMEM/F-
12) (Life Technologies, Carlsbad, CA), supplemented with 5% fetal bovine serum (FBS) 
(BioWhittaker, Walkersville, MD), and 105 units/L penicillin and 100 mg/L streptomycin (P/S) 
(Life Technologies, Grand Island, NY), cells were allowed to propagate until they were 
harvested under 5% CO2 and 37°C conditions. MDCK cells (2.5 x 10
5
 cells) were plated onto 
permeable culture support wells (Snapwell, 12 mm diameter. CoStar, Cambridge, MA). 
Snapwell supports were placed in a six-well plate with DMEM/F-12 plus P/S and FBS, 
monolayers of MDCK cells were used 7-14 days after reaching confluency. Transepithelial ion 
transport was evaluated with the use of a modified Ussing chambers (Model DCV9, Navicyte, 
San Diego, CA). Confluent MDCK cells in the Snapwells were mounted vertically in the Ussing 
chambers. Apical and basolateral surfaces of the monolayers were bathed in a modified Ringer 
solution (120 mM NaCl, 25 mM NaHCO3, 3.3 mM KH2PO4, 0.8 mM K2HPO4, 1.2 mM MgCl2, 
and 1.2 mM CaCl2), which was prepared daily, all components were purchased from Sigma-
Aldrich (St. Louis, MO). The solution bathing the monolayers was kept at 37 °C and 
continuously bubbled with 5% CO2/ 95% O2 to maintain pH, provide aeration and guarantee 
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rapid mix of the fluids in the chambers. 1-ethyl-2-benzimidazolinone (1-EBIO; Acros, Morris 
Plains, NJ) was prepared as a 1 M stock solution in dimethyl sulfoxide (DMSO). (Grantham et 
al., 1989;Wallace et al., 1997) Experiments were conducted on monolayers with a resistance of 
at least 800 Ohms cm
2
. The transepithelial voltage was measured with glass capillary probe tubes 
containing a plug of 5% agar in 3 M KCl and Ag-AgCl electrodes. The electrodes were situated 
near the apical and the basolateral surfaces of the cell monolayers, the transepithelial membrane 
potential (VTE) was clamped to 0 mV and the short-circuit current (ISC; the current necessary to 
clamp the voltage to zero) measured continuously with a voltage clamp apparatus (Model 558C, 
University of Iowa, Department of Bioengineering, Iowa City, IA).  
 
MDCK monolayers mounted into the Ussing chambers were treated with 300 M 1-EBIO 10 
minutes prior to addition of the peptide solution. 1-EBIO activates of Ca
2+
 dependent basolateral 
K
+
 channels, which hyperpolarizes the cell (Devor et al., 1996) thus increasing the 
electrochemical driving force for Cl
−
 conductance through any open channels capable of chloride 
transport in the apical membrane (Broughman et al., 2001). The increase in endogenous 
transepithelial ion current induced by the EBIO serves as a baseline correction to the currents 
induced by the tested peptide solutions. Corresponding volumes of stock peptide solution in 
water were added to the apical bath to obtain NK4-M2GlyR-p20 T17R S20W peptide 
concentrations of: 10, 30, 60, 100, 200, 300 and 500 μM in the apical bathing solution. Data 
acquisition was performed at 1 Hz with a Macintosh computer (Apple Computers, Cuppertino, 
CA) using Aqknowledge software (ver. 3.2.6, BIOPAC Systems, Santa Barbara, CA) with an 
MP100A-CE interface. The raw ISC data correspond to steady-state flux levels. At the end of the 
experimental run 1 μL of forskolin from 10 mM stock solution is added to the apical and 
basolateral sides of the MDCK monolayer to indicate that cells at the end of the experiment are 
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still intact and responsive. Forskolin is an adenylyl cyclase activator that catalyzes the 
conversion of ATP to cAMP, thereby activating protein kinase A. This in turn activates 
components of active ion transport pathways, such as CFTR, and results in increased anion 







-cotransporter (D'Andrea-Winslow et al., 2001). The data points reported in Figure 3-3 
for each peptide concentration represent the mean peak ISC stimulated by the peptide at that 
concentration; bars indicate the standard error of the mean. Continuous lines presented in the 
figure represent the best fit of the data to the modified Hill equation:  
 






Where K1/2 is the concentration of peptide that provides a half maximal ISC , IMAX the maximal 
current induced and n represents the Hill coefficient. 
 
 
Figure 3-2. Typical Ussing chamber experimental run with peptide NK4-M2GlyR-
p20 T17R S20W 
 
Figure 3-2 shows the data trace for an individual channel/chamber during a typical Ussing 
chamber experimental run with peptide NK4-M2GlyR-p20 T17R S20W (30M). The changes in 
ISC due to the addition of 1-EBIO, peptide solution, and forkskolin to the media can be 
appreciated at the indicated times as sudden perturbations of the trace. 
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 Circular Dichroism 
 
To obtain a first indication of peptide secondary structure in TFE-water solutions and SDS 
micelles in water, CD spectroscopy measurements were performed on a Jasco J-815 
spectropolarimeter (Jasco Inc., Tokyo, Japan) using a 0.1 mm path length cylindrical quartz 
cuvette (Fisher Scientific, Waltham, MA). All spectra were recorded from 260 to 190 nm using a 
1.0 nm spectral bandwidth, 0.2 nm step resolution, 20 nm/min scan speed, and 2 second response 
time. Also a baseline measurement was performed at the beginning of every run to check 
instrument stability. The CD spectra presented for the peptide solutions are an average of eight 
scans with background subtraction. Peptide stock solution was prepared to a concentration of 1 
mM in water, stock solution concentration was determined using fluorescence at 278 nm, and 
final peptide concentration in all CD samples was 50 M. Bovine serum albumin (BSA) served 
as the protein standard. The DI-distilled H2O peptide sample (0% TFE) was prepared by diluting 
50 L peptide stock solution with 950 L DI H2O. TFE-water peptide samples were prepared by 
vortexing 50 L peptide stock solution with calculated volumes of TFE (Sigma-Aldrich, St. 
Louis, MO) and DI-distilled H2O to produce a final TFE concentration of 25% and 50% by 
volume. The SDS micelles peptide sample was prepared by adding 50 L of peptide stock 
solution with two minute sonication to calculated volumes to yield 10 mM SDS, 10 mM NaCl, 





 NMR Sample Preparation 
 
For the preparation of the NMR sample in TFE:water solvent system, 4 mg of purified 
lyophilized peptide was added to 300 μL of a solvent mixture containing 50% Deuterated TFE 
(TFE-d3 Cambridge Isotope Labs, Andover, MA), and 50% H2O (by volume) followed by one 
minute sonication to prepare an NMR sample with peptide concentration of 5.7 mM. For the 
preparation of the NMR samples in SDS micelles, the lyophilized peptide was dissolved in 1.0 
mL solvent mixture of 1,1,1,3,3,3-hexafluoro-2-propanol:TFE (1:1). The solution was 
transferred to a glass test tube and a stream of nitrogen gas was passed into the solution to dry 
the peptide into a thin film on the wall of the test tube. Once the peptide was seen dried by visual 
inspection, the test tube containing the peptide was put in a lyophilizer overnight to remove any 
remaining solvent and moisture. The following day, the peptide was dissolved in 250L of 1 M 
SDS-d25 solution in water. Once the peptide appeared dissolved, 250L of an 80% H2O:20% 
D2O solvent mixture was added (Cambridge Isotope Labs, Andover, MA), for a final SDS-d25 
concentration of 500 mM in 90% H2O:10% D2O and a peptide concentration of 2.5 mM.  
 
 NMR Spectroscopy 
 
Experiments on the NMR samples of peptide in TFE solution were performed with a 11.75 tesla 
500 MHz Varian UNITYplus spectrometer (Varian now Agilent Inc., Palo Alto, CA), running 
VNMR version 6.1C at the Biomolecular NMR facility of the Biochemistry and Biophysics 









H NOESY experiments were performed at 15°C. Water peak 
suppression was obtained by low-power irradiation of the H2O resonance. A total of 256 
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increments of 4K data points were recorded for all the 2D experiments. All data sets were 




H TOCSY spectra were recorded by 





NOESY experiments were performed with 200, 300, and 400 ms mixing times. The residual TFE 
methylene peak was used as reference for the chemical shift values. Varian software VNMR 
6.1C on a Silicon Graphics Octane workstation (Mountain View, CA) was used for data 
processing, data analysis was performed with Sparky software (Goddard and Kneller, 2004) 
using a Dell Precision 690 workstation (Round Rock, TX).  
 
The peptide sample dissolved in SDS micelles was sent to the Biomolecular NMR laboratory at 
the University of Kansas (Lawrence, KS) for high-resolution NMR data collections. The NMR 
spectra were recorded with the 18.8 tesla Bruker Avance 800 MHz NMR spectrometer (Bruker 
Instruments Inc., Billerica, MA) equipped with an inverse detection TCI cryoprobe running 
Topspin 1.3. Experiments were performed at 25°C. The NMR data obtained from 800 MHz 
instrument was processed using NMRPipe (Delaglio et al., 1995) and analyzed with Sparky 
software (Goddard and Kneller, 2004) using a Dell Precision 690 workstation (Round Rock, 









H NOESY experiments. 
For all 2D experiments, 1024 complex data points were collected in the direct dimension and 256 
in the indirect dimension. Linear prediction and zero filling were used during processing. The 
suppression of the solvent peak was achieved using the WATERGATE pulse scheme during 
acquisition (Piotto et al., 1992), and the residual water peak (4.74 ppm) was used as reference for 
chemical shift assignments. 
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 NMR Structure Calculations 
 
The protocol described in Chapter 2 was also used for the structure calculations (Cook et al., 
2004;Kirnarsky et al., 2000). NOESY cross peaks were classified as strong, medium, weak and 
very weak based on the observed relative intensity and volume integration of the corresponding 
peaks. Unambiguously identified NOESY cross peaks were converted into inter-proton distance 
upper bounds using the following classifications: strong, medium, weak, and very weak. Upper 
distance limits for NOEs involving methyl protons and nonstereo specifically assigned 
methylene protons, were corrected appropriately for center averaging by adding 0.5-1 Å to the 
maximum distance constraint for center averaging (Wüthrich et al., 1983). The obtained distance 
restraints were used to calculate peptide structures using the crystallography and NMR system 
(CNS) version 1.1, (Brunger et al., 1998). The protocol combines simulated annealing in 
torsional angle space and MD refinement in Cartesian space to produce structures with minimal 
restraint violations (Stein et al., 1997). A total of 100 accepted structures were subjected to 
energy minimization in the AMBER force field (Cornell et al., 1995;D.A. Case, 2002) using 
SYBYL 7.1 (Tripos Inc. St. Louis, MO). The minimized structures were then clustered based on 
mutual heavy-atom root mean square deviation (RMSD). The cluster of 15 structures with no 
restraint violation and the lowest energies were selected as the representative NMR structures. 
The procedure was performed independently for each sample condition (TFE solution sample 
and SDS micelle sample). 
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 Results and Discussion 
 
 Transepithelial ion transport measurements 
 
Experiments with an Ussing chamber instrument were performed to evaluate the concentration 
dependence of the ISC induced on monolayers of MDCK epithelial cells by aqueous solutions of 
NK4-M2GlyR-p20 T17R S20W peptide, Table 3-1 shows the peak current measured for peptide 
concentrations ranging from 10 M to 500M with 4 repetitions for each concentration; the 
average peak ISC and the standard error of the mean is also reported in the table. 
 
Table 3-1. ISC induced by NK4-M2GlyR-p20 T17R S20W peptide in MDCK cells 
Concentration 
(M) 
 Peak Current (A cm-2)  Average 
ISC  
Standard 
Error 1 2 3 4 
10 2.50 3.28 2.12 3.87 2.94 0.39 
30 11.60 7.15 7.63 12.98 9.84 1.81 
60 24.53 18.33 18.70 20.26 20.45 1.42 
100 36.39 37.43 32.59 33.15 34.89 1.19 
200 36.34 39.96 38.18 37.74 38.06 0.75 
300 35.77 33.33 42.44 42.85 38.60 2.39 
500 42.23 47.66 44.61 48.18 45.67 1.39 
 
In Figure 3-3 the average peak ISC induced by the NK4-M2GlyR-p20 T17R S20W peptide on 
MDCK epithelial monolayers is plotted against the concentration of the peptide in the apical 
bathing solution after peptide addition, in the presence of 1-EBIO. The continuous line is the best 
fit to the data to a modified Hill equation as detailed in the methods section. From the fitted data 
an IMAX of 43.8 ± 2.8 A/cm
2
 and K1/2 of 58M ± 8 (Hill Coefficient n=1.8) were determined for 




Figure 3-3. Concentration dependence of ISC induced by NK4-M2GlyR-p20 T17R S20W 
peptide on monolayers of epithelial MDCK cells, when applied to the apical membrane in 
the presence of 1-EBIO 
 
 Circular Dichroism 
 
The CD spectra of peptide NK4-M2GlyR-p20 T17R S20W were recorded as a function of TFE 
concentration. Figure 3-4 shows the CD spectra of this peptide in 0% TFE:water, 25% 
TFE:water, and 50% TFE:water. The shape of the CD spectrum in 0% TFE:water is similar to 
the spectrum reported for peptide NK4-M2GlyR-p22 S22W at the same conditions (Cook et al., 


























Peptide Concentration (M) 
114 
transiently structured. The spectrum in 0% TFE has a minimum at ~195nm, which is a hallmark 
for random coil. However it is missing the random coil’s characteristic positive minimum at 215 
nm. The negative band near ~195 that is observed in the absence of TFE arises from  to * 
electronic transition. As TFE concentration increases, the band shifts to 208nm and an additional 
shoulder appears around 220nm as a result of the n to * electronic transition. A strong positive 
band appears around 192 nm with increasing TFE concentration in the CD sample. The CD 
spectra of NK4-M2GlyRp20 T17R S20W peptide collected at increasing concentrations of TFE 
showed the characteristics for α-helix with double minima at 208 and 222 nm, and maximum at 
∼192 nm. The extracted information provided confidence that the NK4-M2GlyR-
p20 T17R S20W peptide is structured in the TFE:water solution and suitable for NMR studies 
for determination of the solution structure.  
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Figure 3-4. Circular dichroism spectra of peptide NK4-M2GlyR-p20 T17R S20W in TFE. 
(─) 0% TFE (─) 25% TFE (─) 50% TFE 
 
The CD spectrum of peptide NK4-M2GlyR-p20 T17R S20W in 10mM SDS solution, presented 
in Figure 3-5 is similar to the spectrum for the same peptide in 50% TFE:water, shows the 
characteristics of α-helix (double minima at 208 and 222 nm, and maximum at ∼192 nm). These 
results suggest that the peptide NK4-M2GlyR-p20 T17R S20W in SDS micelles is structured as 
well, and the NMR SDS micelle sample will be suitable for further structure studies. Advanced 
analysis of CD spectra, like spectra deconvolution, was not performed because these analyses 
have not been accurate for M2GlyR peptides in the past (Cook et al., 2004), where a predicted -
strand content has not been detected in the determined structures, and since a detailed structure 












































Figure 3-5. Circular dichroism spectra of peptide NK4-M2GlyR-p20 T17R S20W in 10 mM 
SDS Micelles 
 
 NMR Data Analysis 
 




H TOCSY spectrum of peptide NK4-M2GlyR-p20 T17R 
S20W in 50 % TFE-d3:water.This spectrum has signals with low resolution in the side chain–




 regions. As discussed before in Chapter 2, the proton chemical shift 









H NOESY for inter-residue 
































































 intra-residue spin 
connectivity and eventually to determine residue type. Where the spectral resolution did not 




H NOESY was necessary. The assignment of pure NOESY cross peaks due to sequential dN 
(i,i+1) proton connectivity aided in completing the assignment of every amino acid residue spin 
system as well as with the differentiation of repeated amino acid. Figure 3-7 shows the 








H NOESY spectrum 
acquire with 200 ms mixing time for the 50% TFE sample. The assignments of cross peaks in the 
TOCSY finger print region and identification of residue type are presented in Figure 3-8. The 









H TOCSY Spectrum of NK4-M2GlyR-p20 T17R S20W in 50% 












H NOESY spectrum for NK4-
M2GlyR-p20 T17R S20W in 50% TFE-d3 sample, acquired with 200 ms mixing time on a 








H TOCSY finger print region for NK4-M2GlyR-p20 T17R S20W in 
50% TFE-d3 acquired on a 500 MHz NMR instrument. Showing individual amino acid 
spin systems connected with a vertical line and labeled assignments of the cross peaks 
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Table 3-2. Chemical Shift Values (ppm) for NK4-M2GlyR-p20 T17R S20W in 50% TFE-d3  
Residue 










K1  3.99 1.87 1.69 1.22  1.45  2.99 
K2 8.07 4.28 1.75 1.35  1.69  2.94 
K3 8.13 4.35 1.79 1.58  1.71  3.14 
K4 8.19 4.30 1.77 1.41  1.68  2.96 
R5 7.98 4.32 1.72 1.54  3.04 
V6 7.88 4.14 2.03 0.91  
G7 8.09 3.91    
L8 7.78 4.13 2.01 1.11  0.90 
G9 8.24 3.94    
I10 7.81 4.33 1.58 1.17 0.89  0.84 
T11 7.83 4.23 4.07 1.21  
T12 7.89 4.31 4.19 1.18  
V13 7.55 3.82 2.13 0.95 0.89  
L14 7.71 4.40  1.20  0.90 0.83 
T15 7.98 4.33 4.18 0.89  
M16 7.74 4.36 2.09 1.99 2.54 2.50  
R17 7.91 4.40 2.28 1.65  2.91 
T18 7.76 4.23 4.08 1.19  
Q19 7.69 4.25 1.93 1.82 2.18  
W20 7.57 4.58 3.32 3.18   
 




H NOESY spectra (with 200 ms, 300 ms, and 400 ms 
mixing times) acquired for NK4-M2GlyR-p20 T17R S20W in 50% TFE-d3, was performed for 
characterization of cross peaks due to dipole-dipole couplings between protons in spatial 
proximity. Several cross peaks indicative of dN(i, i+1), dN(i, i+1), dNN(i, i+1), dN(i, i+2) and 
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dN(i, i+3) connectivity, which are consistent with a helical conformation (Wüthrich, 1986), were 









H NOESY spectrum with cross peak assignments. The 











H NOESY spectrum for NK4-M2GlyR-p20 
T17R S20W in 50% TFE-d3. The spectrum was acquired with 200 ms mixing time on a 500 











 Chemical Shift Index and summary of NOE connectivity for peptide 
NK4-M2GlyR-p20 T17R S20W in 50% TFE-d3. The thickness of the lines is in proportion 
to the relative NOE intensities and dotted lines indicate ambiguity due to peak overlapping 
 
The analysis of the NMR data collected for peptide NK4-M2GlyR-p20 T17R S20W in SDS 
micelles followed the same procedure as describe above for the spectra from the 50% TFE-d3 




H TOCSY spectrum for the sample in SDS micelles (Figure 3-11) 
displays broader peaks and inefficient water suppression (~4.7 ppm). As expected and discussed 
in Chapter 2, it may be due to an increase in particle size. The analysis of the spectra acquired in 
SDS micelles sample was performed independently from spectra acquired in 50% TFE-d3, 
considering that the conditions of the two samples differ substantially and errors in interpretation 
could be introduced by assuming similar chemical shifts for both conditions. 
 




/side chain protons), for 
peptide NK4-M2GlyR-p20 T17R S20W in SDS micelles. The individual amino acid spin 
systems are connected with a vertical line and labeled with residue one letter code and sequence 
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number. The chemical shift values for the unambiguously assigned resonances of this peptide 
sample in SDS micelles are presented in Table 3-3. 
 




H TOCSY Spectrum of NK4-M2GlyR-p20 T17R S20W in SDS 








H TOCSY finger print region for NK4-M2GlyR-p20 T17R S20W in SDS 
micelles acquired on an 800 MHz NMR instrument 
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Table 3-3. Chemical Shift Values (ppm) for NK4-M2GlyR-p20 T17R S20W in SDS micelles  
Residue 










K1 8.58 4.30 1.83 1.47  1.71  3.05 
K2 8.16 4.33 1.83 1.43  1.68 3.18 
K3 8.21 4.31 1.81 1.28  1.45  3.02 
K4 8.58 4.12 1.89 1.52  
R5 7.99 4.31 1.84 1.67 1.27  3.16 
V6 8.00 3.95 2.18 0.95 0.98  
G7 8.23 3.94    
L8 8.25 3.99 2.17   0.96 0.91 
G9 8.37 3.94    
I10 8.36 4.26 1.96 1.73 1.65  0.87 
T11 8.04 4.29 3.88 1.28  
T12 7.69 4.32 4.03 1.22  
V13 7.70 3.81 2.19 0.97 1.08  
L14 8.04 3.96 1.73 1.65  0.93 
T15 7.86 4.32 4.01 1.25  
M16 7.94 4.48 2.35 3.11 3.08  
R17 7.93 4.35 1.83 1.68  3.19 3.05 
T18 8.19 4.31 3.92 1.30  
Q19 7.72 4.34 1.80 2.20  












H NOESY spectrum for NK4-M2GlyR-
p20 T17R S20W in SDS micelles, acquired with 400 ms mixing time on an 800 MHz NMR 




Proton chemical shift index and summary of NOE connectivity for peptide 
NK4-M2GlyR-p20 T17R S20W in SDS micelles. Line thickness indicates relative NOE peak 







H NOESY spectra collected with 300 ms and 400 ms mixing times for NK4-M2GlyR-
p20 T17R S20W in SDS micelles were analyzed simultaneously. The observation of sequential 
cross peaks corresponding to dN(i, i+1), dN(i, i+1), dNN(i, i+1) connectivities and also the 
presence of cross peaks related to dN(i, i+3) connectivity suggested a continuous stretch of 
backbone and angle values in the helical region of conformational space (Figure 3-13). 
Several other NOESY cross peaks were identified as short and medium range connectivities in 




 region. A graphic summary of the NOE 
connectivities found for NK4-M2GlyR-p20 T17R S20W in the SDS micelles sample is presented 
in Figure 3-14. 
 
 NMR Structure Calculations 
 
The NMR structures were calculated from extended backbone conformations as starting models 





H NOESY spectra (200 ms, 300 ms, and 400 ms for the 50% TFE sample and 300 
ms and 400 ms for the SDS micelles sample) were classified as: intra-residue, sequential (i-j=1), 
and medium range (1< i-j<=4), however no long range connectivities (i-j>4) were found for 
either sample. NOE-derived inter-proton distance restraints were classified into approximate 
distance ranges of 1.8-2.5 Å; 1.8-3.5 Å, 1.8-5.0 Å, 1.8-5.0 Å and 1.8-6.0 Å corresponding to 
strong, medium, weak and very weak NOE cross peaks; an additional 0.5-1.0 Å was added to the 
upper distance bound of distance restraints involving methyl groups. A total of 112 distance 
constraints for the 50% TFE sample and 146 distance constraints for the SDS micelles sample 
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were derived from corresponding NOE data. For the 50% TFE sample we observed 22 intra-
residue, 44 sequential, and 46 medium range constraints; while the SDS micelles sample showed 
22 were intra-residue, 56 sequential, and 68 medium range constraints.  
 
 
Table 2-3 summarizes the distance constrains used during the structure calculations for peptide 
NK4-M2GlyR-p20 T17R S20W in 50% TFE and SDS micelles. The NMR structure calculations 
were performed independently for each of sample conditions as described in the methods section. 
 
Figure 3-15 shows the cluster of 15 calculated structures of peptide NK4-M2GlyR-p20 T17R 
S20W in 50% TFE with lowest average energy. These 15 structures are superimposed and 
clustered by root mean square deviation (RMSD) of the backbone atoms and may be considered 
a representation of the predominant conformation for peptide NK4-M2GlyR-p20 T17R S20W in 
TFE solution. These structures show a well-defined -helix in the central part of the peptide 
(spanning from residues arginine 5 to methionine 16) with segregation of the hydrophobic and 
hydrophilic side chains to different sides of the helix. The four N-terminal lysines seem to be 
unstructured with a less defined conformation. The four C-terminal residues (arginine 17, 
threonine 18, glutamine 19, and tryptophan 20) appear to have a bend or turn, a similar distortion 
from a purely helical structure was reported for peptide NK4-M2GlyR-p22 S22W in the structure 





Table 3-4. Structural Statistics for peptide NK4-M2GlyR-p20 T17R S20W in 50% TFE and 
in SDS Micelles 
 50% TFE SDS Micelles 
Experimental NMR Constraints   
 NOE Distance Constraints   
  Intra-residue 22 22 
  Sequential 44 56 
  Medium Range 46 68 
  Long Range 0 0 
Energy (kcal/mol
-1
)   
 Etotal -104.32 ±18.3 -58.00 ±12.9 
RMSD from the mean structure (Å)   
 Backbone atoms (residues 1-20) 1.21 ± 0.51 1.45 ± 0.35 
 Backbone atoms (residues 3-18) 0.96 ± 0.33 0.63 ± 0.24 
 
The side chains of amino acid residues threonine 11 and 15, (corresponding to threonine 13 and 
17 in the p22 sequences) expected to line the inside of the assembled channel, align with the 
hydrophobic side of the helix, while the side chain of threonine18 (threonine 20 in the p22 
sequences) is part of the observed turn and is in an orientation that would need to change during 
the process of forming the channel in order to become part of the interior surface. 
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Figure 3-15. Solution monomeric structure of peptide NK4-M2GlyR-p20 T17R S20W in 
50% TFE. Cluster of the 15 calculated structures with the lowest average energy 
superimposed (only backbone atoms are displayed) 
 
Figure 3-16 presents a cluster of 15 calculated structures for peptide NK4-M2GlyR-p20 T17R 
S20W in SDS micelles. The 15 calculated structures with lowest average total energy were 
clustered by RMSD using backbone atoms of the residues. The cluster of 15 conformers 
represents the predominant structure of peptide NK4-M2GlyR-p20 T17R S20W in SDS micelles. 
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The predominant structural features for the peptide in SDS micelles include a well-defined  
helix in the central part of the peptide (spanning from lysine 4 to methionine 16); and a 
segregation of the hydrophobic and hydrophilic side chains to different sides of the helix. The N-
terminal three lysines are unstructured, but appear to be more restricted than in the structures 
calculated for this peptide in TFE solution. The four C-terminal residues (arginine 17, threonine 
18, glutamine 19, and tryptophan 20) form an incomplete helix turn and present some variability 




Figure 3-16. Solution monomeric structure of peptide NK4-M2GlyR-p20 T17R S20W in 
SDS micelles. Cluster of the 15 calculated structures with the lowest average energy 
superimposed (only backbone atoms are displayed) 
 
 Discussion and Analysis 
 
A comparison of the concentration dependence of the ISC stimulated by peptide 
NK4-M2GlyR-p20 T17R S20W in MDCK cell, with that of other M2GlyR derived peptides 
previously reported (Broughman et al., 2004;Bukovnik et al., 2012;Cook et al., 2004;Shank et 
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al., 2006) shows that peptide NK4-M2GlyR-p20 T17R S20W has both a higher IMAX and a lower 
K1/2, characteristics that are desirable for a potential therapeutic peptide (Figure 4-2).  
 
The calculated average structure for peptide NK4-M2GlyR-p20 T17R S20W under both 
experimental conditions tested (50% TFE, SDS micelles) is predominantly -helical as is 
expected for the channel forming peptides of this family (Figure 3-17). Differences between the 
structures calculated in TFE solution and SDS micelles for peptide NK4-M2GlyR-p20 T17R 
S20W are detected. The most notable difference is in the C-terminal residues (17-20), for both 
sample conditions these residues are not part of the main  helix. For the 50% TFE sample, the 
C-terminal residues form a bend that folds back towards the helix, and that seems to be stabilized 
by a hydrogen bond between the side chain hydroxyl of threonine 12 and the carbonyl from 
threonine 18. For the structures calculated from the SDS micelles sample the C-terminal residues 
continue in the same general direction of the main  helix axis but do not come in enough 
proximity to form the characteristic hydrogen bond with the amino acids in the helix. Notable 
changes in structure between samples in TFE solution compared to in SDS micelles have 
previously been reported for peptide NK4-M2GlyR-p22 S22W another member of the family of 
M2GlyR derived peptides. The changes for NK4-M2GlyR-p22 S22W are attributed to the 
formation of a hydrophobic pocket in the central part of the peptide (Cook et al., 2004). For 
peptide NK4-M2GlyR-p20 T17R S20W this does not appear to be the case, as no hydrophobic 
side chains are located towards the inside of the bend.  
 




H TOCSY spectra for both sample conditions reveals a greater 
dispersion in the H
N
 resonances for the SDS micelles sample (Figure 3-8 and Figure 3-12 are at 
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the same scale), this dispersion in the chemical shift scale is indicative of a better defined 
secondary structure in SDS micelles, and is consistent with the calculated structures (the upfield 
shift of the resonances in the 50%TFE can be attributed to the difference in temperature). The 
calculated chemical shift index of the H

 further supports that the secondary structure adopted by 
the peptide in the micelle environment is better defined. For the SDS micelles sample the CSI is 
consistently negative for almost the full length of the peptide (Figure 3-14), whereas for the 50% 
TFE sample the CSI shows changes in sign frequently along the sequence (Figure 3-10). In 
Chapter 2 it was mentioned that the CSI was found to be of limited predicting value for the 
M2GlyR peptides, but perhaps it can be indicative of stability of the secondary structure 
elements. 
 
The apparently more restricted N-terminus for the peptide in SDS micelles compared with the 
peptide in 50% TFE can be explained by the presence of the hydrophilic heads of the SDS 
molecules around the peptide, exerting force into the lysine residues, a similar effect could be 
responsible for a more restricted structure overall for the SDS micelles sample, that was 
calculated to have a RMSD of 0.63 ± 0.24 Å in the helical region, compare to 0.96 ± 0.33 Å for 
the TFE sample (Table 2-3). Since every residue is expected to be in contact with the SDS 
molecules, the conformation adopted by the shorter peptide (2 residues less than the peptides 
previously studied) in SDS micelles could potentially be more affected by the environment than 
the conformation of the 22 residue peptides that have been postulated to have their N-terminus 




Figure 3-17. Comparison between the average determined structures for channel forming 
peptide NK4-M2GlyR-p20 T17R S20W in 50% TFE and SDS micelles 
 
The terminal lysines of NK4-M2GlyR-p20 T17R S20W are more restricted also than the terminal 
lysines reported in the NMR structures for other M2GlyR derived peptides (Cook et al., 
2004;Herrera et al., 2010), this could be explained by the shorter axial length of the NK4-
M2GlyR-p20 T17R S20W peptide when compared with 22 residue sequences. The presence of 
membrane anchoring residues in the C-terminus could force the N-terminal lysines into the 
interior of the micelle. 
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The calculated structures for the SDS micelles samples are expected to be a better representation 
of the structure adopted by the peptide in the interior of a membrane bilayer, than the structures 
calculated in the TFE solution. There are expected limitations to the SDS calculated structures as 
well, SDS molecules have 12 carbon alkyl tails whereas cellular membranes are mainly 
composed by lipids with longer acyl chains, 16 to 20 carbons mostly (Spector and Yorek, 1985)). 
With the radius of an SDS micelle reported to between 15 Å and 20 Å (Cabane et al., 
1985;Duplatre et al., 1996;Pires et al., 2012), and an axial length of the determined structure for 
NK4-M2GlyR-p20 T17R S20W of ~30 Å, the peptide is expected to barely cross the micelles. 
The structure calculated is not expected to be able to span across an unperturbed cellular 
membrane to form ion channels. 
 
The findings on peptide NK4-M2GlyR-p20 T17R S20W make it a step forward towards the 
optimization of the peptide sequence for an optimal channel forming peptide, further study of the 
permselectivity of the formed channels is needed to characterize the ion current induced by the 






Arseniev, A. S., Barsukov, I. L., Bystrov, V. F., Lomize, A. L. and Ovchinnikov Yu, A. (1985). 
1H-NMR study of gramicidin A transmembrane ion channel. Head-to-head right-handed, 
single-stranded helices. FEBS Lett 186, 168-174. 
 
Broughman, J. R., Brandt, R. M., Hastings, C., Iwamoto, T., Tomich, J. M. and Schultz, B. D. 
(2004). Channel-forming peptide modulates transepithelial electrical conductance and 
solute permeability. American journal of physiology. Cell physiology 286, C1312-1323. 
 
Broughman, J. R., Mitchell, K. E., Sedlacek, R. L., Iwamoto, T., Tomich, J. M. and Schultz, B. 
D. (2001). NH(2)-terminal modification of a channel-forming peptide increases capacity 
for epithelial anion secretion. American journal of physiology. Cell physiology 280, 
C451-458. 
 
Broughman, J. R., Shank, L. P., Takeguchi, W., Schultz, B. D., Iwamoto, T., Mitchell, K. E. and 
Tomich, J. M. (2002). Distinct structural elements that direct solution aggregation and 
membrane assembly in the channel-forming peptide M2GlyR. Biochemistry 41, 7350-
7358. 
 
Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., 
Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, 
T. and Warren, G. L. (1998). Crystallography & NMR system: A new software suite for 
macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54 ( Pt 5), 
905-921. 
 
Bukovnik, U., Gao, J., Cook, G. A., Shank, L. P., Seabra, M. B., Schultz, B. D., Iwamoto, T., 
Chen, J. and Tomich, J. M. (2012). Structural and biophysical properties of a synthetic 
channel-forming peptide: designing a clinically relevant anion selective pore. Biochimica 
et biophysica acta 1818, 1039-1048. 
 
Cabane, B., Duplessix, R. and Zemb, T. (1985). High-Resolution Neutron-Scattering on Ionic 
Surfactant Micelles - Sds in Water. Journal De Physique 46, 2161-2178. 
 
Cammers-Goodwin, A., Lee, T. C. and Walgers, R. (1998). The mechanism of fluoroalcohol-
mediated conformational purturbation of peptides. Abstracts of Papers of the American 
Chemical Society 216, U216-U216. 
139 
 
Carlin, R. W., Sedlacek, R. L., Quesnell, R. R., Pierucci-Alves, F., Grieger, D. M. and Schultz, 
B. D. (2006). PVD9902, a porcine vas deferens epithelial cell line that exhibits 
neurotransmitter-stimulated anion secretion and expresses numerous HCO3(-) 
transporters. American journal of physiology. Cell physiology 290, C1560-1571. 
 
Cook, G. A., Prakash, O., Zhang, K., Shank, L. P., Takeguchi, W. A., Robbins, A., Gong, Y. X., 
Iwamoto, T., Schultz, B. D. and Tomich, J. M. (2004). Activity and structural 
comparisons of solution associating and monomeric channel-forming peptides derived 
from the glycine receptor m2 segment. Biophys J 86, 1424-1435. 
 
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., 
Spellmeyer, D. C., Fox, T., Caldwell, J. W. and Kollman, P. A. (1995). A 2nd Generation 
Force-Field for the Simulation of Proteins, Nucleic-Acids, and Organic-Molecules. 
Journal of the American Chemical Society 117, 5179-5197. 
 
D'Andrea-Winslow, L., Strohmeier, G. R., Rossi, B. and Hofman, P. (2001). Identification of a 
sea urchin Na(+)/K(+)/2Cl(-) cotransporter (NKCC): microfilament-dependent surface 
expression is mediated by hypotonic shock and cyclic AMP. The Journal of experimental 
biology 204, 147-156. 
 
D.A. Case, D. A. P., J.W. Caldwell, T.E. Cheatham III, J. Wang, W.S. Ross, C.L. Simmerling, 
T.A. Darden, K.M. Merz, R.V. Stanton, A.L. Cheng, J.J. Vincent, M. Crowley, V. Tsui, 
H. Gohlke, R.J. Radmer, Y. Duan, J. Pitera, I. Massova, G.L. Seibel, U.C. Singh, P.K. 
Weiner and P.A. Kollman (2002). AMBER 7. 
 
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J. and Bax, A. (1995). NMRPipe: a 
multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 
277-293. 
 
Devor, D. C., Singh, A. K., Frizzell, R. A. and Bridges, R. J. (1996). Modulation of Cl- secretion 
by benzimidazolones. I. Direct activation of a Ca(2+)-dependent K+ channel. The 
American journal of physiology 271, L775-784. 
 
Duplatre, G., Marques, M. F. F. and daGracaMiguel, M. (1996). Size of sodium dodecyl sulfate 
micelles in aqueous solutions as studied by positron annihilation lifetime spectroscopy. 
Journal of Physical Chemistry 100, 16608-16612. 
 
Goddard, T. D. and Kneller, D. G. (2004). SPARKY 3. University of California, San Francisco. 
140 
 
Grantham, J. J., Uchic, M., Cragoe, E. J., Jr., Kornhaus, J., Grantham, J. A., Donoso, V., 
Mangoo-Karim, R., Evan, A. and McAteer, J. (1989). Chemical modification of cell 
proliferation and fluid secretion in renal cysts. Kidney international 35, 1379-1389. 
 
Herrera, A. I., Al-Rawi, A., Cook, G. A., Gao, J., Iwamoto, T., Prakash, O., Tomich, J. M. and 
Chen, J. (2010). Structural characterization of two pore-forming peptides: consequences 
of introducing a C-terminal tryptophan. Proteins 78, 2238-2250. 
 
Jasanoff, A. and Fersht, A. R. (1994). Quantitative determination of helical propensities from 
trifluoroethanol titration curves. Biochemistry 33, 2129-2135. 
 
Kirnarsky, L., Prakash, O., Vogen, S. M., Nomoto, M., Hollingsworth, M. A. and Sherman, S. 
(2000). Structural effects of O-glycosylation on a 15-residue peptide from the mucin 
(MUC1) core protein. Biochemistry 39, 12076-12082. 
 
MacPhee, C. E., Perugini, M. A., Sawyer, W. H. and Howlett, G. J. (1997). Trifluoroethanol 
induces the self-association of specific amphipathic peptides. Febs Letters 416, 265-268. 
 
Pervushin, K. V., Arseniev, A. S., Kozhich, A. T. and Ivanov, V. T. (1991). Two-dimensional 
NMR study of the conformation of (34-65)bacterioopsin polypeptide in SDS micelles. J 
Biomol NMR 1, 313-322. 
 
Piotto, M., Saudek, V. and Sklenar, V. (1992). Gradient-Tailored Excitation for Single-Quantum 
Nmr-Spectroscopy of Aqueous-Solutions. Journal of Biomolecular Nmr 2, 661-665. 
 
Pires, J. M., de Moura, A. F. and Freitas, L. C. G. (2012). Investigating the Spontaneous 
Formation of Sds Micelle in Aqueous Solution Using a Coarse-Grained Force Field. 
Quimica Nova 35, 978-U352. 
 
Rizo, J., Blanco, F. J., Kobe, B., Bruch, M. D. and Gierasch, L. M. (1993). Conformational 
behavior of Escherichia coli OmpA signal peptides in membrane mimetic environments. 
Biochemistry 32, 4881-4894. 
 
Roccatano, D., Colombo, G., Fioroni, M. and Mark, A. E. (2002). Mechanism by which 2,2,2-
trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a 
molecular dynamics study. Proceedings of the National Academy of Sciences of the 
United States of America 99, 12179-12184. 
141 
 
Shank, L. P., Broughman, J. R., Takeguchi, W., Cook, G., Robbins, A. S., Hahn, L., Radke, G., 
Iwamoto, T., Schultz, B. D. and Tomich, J. M. (2006). Redesigning channel-forming 
peptides: amino acid substitutions that enhance rates of supramolecular self-assembly and 
raise ion transport activity. Biophys J 90, 2138-2150. 
 
Spector, A. A. and Yorek, M. A. (1985). Membrane lipid composition and cellular function. 
Journal of lipid research 26, 1015-1035. 
 
Stein, E. G., Rice, L. M. and Brunger, A. T. (1997). Torsion-angle molecular dynamics as a new 
efficient tool for NMR structure calculation. Journal of magnetic resonance 124, 154-
164. 
 
Tomich, J. M., Wallace, D., Henderson, K., Mitchell, K. E., Radke, G., Brandt, R., Ambler, C. 
A., Scott, A. J., Grantham, J., Sullivan, L. and Iwamoto, T. (1998). Aqueous 
solubilization of transmembrane peptide sequences with retention of membrane insertion 
and function. Biophysical journal 74, 256-267. 
 
Wallace, D. P., Tomich, J. M., Iwamoto, T., Henderson, K., Grantham, J. J. and Sullivan, L. P. 
(1997). A synthetic peptide derived from glycine-gated Cl- channel induces 
transepithelial Cl- and fluid secretion. Am J Physiol 272, C1672-C1679. 
 
Wüthrich, K. (1986). NMR of proteins and nucleic acids. The George Fisher Baker non-resident 
lectureship in chemistry at Cornell University, Wiley, New York. 
 
Wüthrich, K., Billeter, M. and Braun, W. (1983). Pseudo-structures for the 20 common amino 
acids for use in studies of protein conformations by measurements of intramolecular 




Chapter 4 - Comparison between NMR determined monomeric 
structures for Channel-Forming Peptides and analysis of the 





NMR data based protein structures can provide information about the conformation of a 
molecule at atomic resolution level under solution condition. For a protein with a well-defined 
secondary and tertiary structure, an NMR determined structure describes a complex set of short, 
medium, and long range dipole interactions. Therefore NMR spectroscopy provides a very 
valuable technique for the description and study of the protein topology and function. In the case 
of small monomeric peptides the question of structure determination could be a simple one, and 
complete description could be just assigning a secondary structural elements (-helix, -strand, 
random coil) to each residue in the sequence. The molecular structure of membrane active 
peptides is much more dynamic in nature, and depends strongly on the environment surrounding 
the peptide at any given moment (e.g. extracellular space, membrane surface, membrane interior) 
(Bechinger, 2008) and on the peptide’s oligomerization state (Bartels et al., 2011).  
 
For the structure determination of any protein by NMR spectroscopy, careful consideration 
should be given to the conditions used for sample preparation. The sample conditions should be 
similar enough to the “natural” environment of the protein such that the resulting structure can be 
considered biologically relevant, but cannot go beyond the instrumental limitations of the 
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technique in general, and of the available resources. Structural studies of membrane associated 
proteins have always been considered challenging for NMR spectroscopy. Two approaches are 
available for the study of membrane associated proteins by NMR: (A) The use of oriented 
phospholipid bilayers in solid state NMR (Marassi and Opella, 1998) and (B) the use of 
membrane mimetics in solution NMR (Warschawski et al., 2011). 
 
The oligomeric state and structure of M2GlyR derived peptides in solutions was initially 
assessed by chemical cross-linking and circular dichroism studies, respectively (Broughman et 
al., 2002b). Looking for a more detail description of the structure in solution, the use of NMR 
spectroscopy was implemented, first as an indicator of secondary structure elements (Broughman 
et al., 2002a), and later in the complete determination of the solution structure (Cook et al., 
2004). Membrane mimetics were later used to determine the monomeric structure of M2GlyR 
derived peptides a membrane like environment (Herrera et al., 2010). 
 
Most NMR determined structures for M2GlyR peptides present a high degree of similarity. 
Determination of the molecular structure by NMR for newly designed M2GlyR peptides requires 
a considerable investment of both material and human resources, i.e. peptide purification, sample 
preparation, data acquisition, data analysis and structure calculations. The question has arisen of 
whether or not there is compelling need to determine the NMR structure of the peptides that 
constitute the most recent developments in the optimization of the M2GlyR family of channel 
forming peptides. This report tries to provide arguments to answer that question, taking into 
consideration all the available NMR determined structures for M2GlyR derived channel forming 
peptides, an evaluation of whether the structures provide valuable information not otherwise 
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available is attempted. How well the changes in ion conductance between peptide sequences can 
be explained by the differences in structure, the potential of the structure as a predictor of 
electrophysiological characteristics, and the usefulness of the structure as an aid in the design of 
improved peptide sequences are the characteristics evaluated. 
 
 Materials and Methods 
 
 Peptide Synthesis and Purification 
 
All peptides consider for this analysis (Figure 4-1) were chemically synthesized as described in 
the previous chapters at the Biotechnology Core Facility of Kansas State University by solid 
phase peptide synthesis methodology using 9-fluorenylmethoxycarbonyl (Fmoc) chemistry 
(Tomich et al., 1998). CLEAR amide resin (0.3 mmol/g) was purchased from Peptides 
International Inc. (Louisville, KY) and N

-Fmoc amino acids were purchased from Anaspec 
(Fremont, CA), Bachem Inc. (Torrance, CA), and Peptides International Inc. (Louisville, KY). 
The peptides were purified using a System Gold HPLC system (Beckman Instruments Inc., 
Fullerton, CA) and eluted from the column using a linear gradient of acetonitrile containing 0.1% 
trifluoroacetic acid (TFA). HPLC-purified peptides were characterized by matrix-assisted-laser 
desorption time-of-flight mass spectroscopy (MALDI-TOF/TOF) using a Bruker Ultraflex II 
mass spectrometer (Bruker Instruments Inc., Billerica, MA) and after characterization, peptides 
were lyophilized and stored as dry powder until used. 
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 Transepithelial ion transport measurements  
 
Transepithelial ion transport measurements in Madin-Darby canine kidney (MDCK) epithelial 
cells were performed as described in Chapter 3, briefly cells were maintained as subconfluent 
monolayers and were allowed to propagate until they were harvested. MDCK cells were plated 
onto permeable culture support wells (Snapwell, 12 mm diameter. CoStar, Cambridge, MA). 
Snapwell supports were placed in a six-well plate with DMEM/F-12 plus P/S and FBS, 
monolayers of MDCK cells were used 7-14 days after reaching confluency. Transepithelial ion 
transport was evaluated with the use of a modified Ussing chambers (Model DCV9, Navicyte, 
San Diego, CA). MDCK cell monolayers in the Snapwells were mounted vertically in the 
chambers. Apical and basolateral surfaces of the monolayers were bathed in a modified Ringer 
solution (120 mM NaCl, 25 mM NaHCO3, 3.3 mM KH2PO4, 0.8 mM K2HPO4, 1.2 mM MgCl2, 
and 1.2 mM CaCl2), which was prepared daily. The solution bathing the monolayers was kept at 
37 °C and continuously bubbled with 5% CO2/ 95% O2 , experiments were conducted on 
monolayers with a resistance of at least 600 Ohms cm
2
 (Grantham et al., 1989;Shank et al., 
2006;Wallace et al., 1997). The transepithelial membrane potential (VTE) was clamped to 0 mV 
and the short-circuit current measured continuously with a voltage clamp apparatus (Model 
558C, University of Iowa, Department of Bioengineering, Iowa City, IA). Data was acquired at a 
rate of 1 Hz. Reported data points represent the mean ISC stimulated by the peptide at the 
indicated concentrations; bars indicate the standard error of the mean. Continuous lines presented 




 Circular Dichroism 
 
Circular Dichroism (CD) spectroscopy measurements were performed on a Jasco J-720 or a 
Jasco J-815 spectropolarimeter (Jasco Inc., Tokyo, Japan) using a quartz cuvette with a path 
length of 0.1 mm or 1.0 mm (Fisher Scientific, Waltham, MA). All spectra were recorded from 
260 to 190 nm wavelength using a 1.0 nm spectral bandwidth, 0.2 nm step resolution, 20 nm/min 
scan speed, and 2 second response time. Also a baseline measurement was performed at the 
beginning of each run to check instrument stability. The CD spectra presented for the peptide 
solutions are an average of eight scans with background subtraction. Peptide stock solution was 
prepared to a concentration of 1 mM in water, stock solution concentration was determined using 
fluorescence at 278 nm, and final peptide concentration in all CD samples was 50 M. Bovine 
serum albumin (BSA) served as the protein standard. The DI (deionized)-distilled H2O peptide 
sample (0% TFE) was prepared by diluting 50 L peptide stock solution with 950 L DI H2O. 
TFE:water peptide samples were prepared by vortexing 50 L of peptide stock solution with 
calculated volumes of TFE (Sigma-Aldrich Inc., St. Louis, MO) and DI-distilled H2O to produce 
a final TFE concentration of 25% and 50% by volume. The SDS micelles peptide sample was 
prepared by adding 50 L of peptide stock solution with two minute sonication to calculated 






 NMR Spectroscopy 
 
NMR samples for each peptide considered in this analysis were prepared in a slightly different 
way, as a result of progressive optimization of the procedure and to the particular challenges 
presented by each peptide. NMR studies on peptide NK4-M2GlyR-p27 were performed by J.R. 
Broughman (Broughman et al., 2002a). NMR studies on peptide NK4-M2GlyR-p22 were 
performed by G. A. Cook and A. I. Herrera (Cook et al., 2004;Herrera et al., 2010). NMR studies 
on peptide NK4-M2GlyR-p22 S22W were performed by G. A. Cook (Cook et al., 2004;Herrera 
et al., 2010). NMR studies on peptide NK4-M2GlyR-p22 T19R S22W were performed by G. A. 
Cook (Bukovnik et al., 2012). NMR studies on peptide NK4-M2GlyR-p20 T17W S20W were 
performed by A. I. Herrera (Chapter 2). The protocols involved in TFE solution and SDS 
micelles sample preparation are described in the Materials and Methods section of Chapter 3. 
The peptide concentration and solvent concentration for each sample are presented in Table 4-1. 
 
Table 4-1. Sample and experimental conditions for NMR structural studies of 
NK4-M2GlyR peptides (peptide concentration, solvent concentration, sample temperature, 
NMR instrument proton frequency) 
Peptide 
Solvent System 












500 mM SDS 
45°C 
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500 mM SDS 
45°C 
600 MHz 
NK4-M2GlyR-p22 T19R S22W 
 2.5 mM 
500 mM SDS 
40°C 
800 MHz 










NMR experiments on the NK4-M2GlyR peptide samples were performed at 3 different locations, 
each one with an instrument having a different magnetic field strength. The 11.75 tesla 500 MHz 
Varian NMR spectrometer (Varian now Agilent Inc., Palo Alto, CA) is located at the 
Biomolecular NMR facility of the Biochemistry and Molecular Biophysics Department at 
Kansas State University, the 18.8 tesla 800 MHz Bruker NMR spectrometer (Bruker Instruments 
Inc., Billerica, MA) is located at the Biomolecular NMR laboratory at the University of Kansas 
(Lawrence, KS), and 14.1 tesla 600 Mhz Bruker NMR spectrometer is located at the laboratory 
of Professor Yan Xu at the University of Pittsburgh (Pittsburgh, PA). The instrument used for 
data acquisition on each sample, and the temperature of the sample during data acquisition are 
specified on Table 4-1. The use of higher field instruments (compared with the instrument 
available at Kansas State University) and higher temperatures were needed to obtain data with 
the required signal resolution for structure determination on the SDS micelles samples as 











H NOESY experiments with different mixing times 








H rotating frame nuclear Overhauser effect spectroscopy (ROESY) experiments were 
performed. Data processing and analysis were carried out using one or more of the following 
programs: Varian software VNMR versions 6.1B or 6.1C or VNMRj version 2.3, NMRPipe 
(Delaglio et al., 1995), Sparky software (Goddard and Kneller, 2004). More details on the NMR 
experiments are discussed in the corresponding publication (Broughman et al., 2002a;Bukovnik 
et al., 2012;Cook et al., 2004;Herrera et al., 2010) and in the Materials and Methods sections of 
Chapter 2 and Chapter 3.  
 
 NMR Structure Calculations 
 
NMR monomeric solution structures at the atomic resolution were calculated for each of the 
samples described in Table 4-1, except for the NK4-M2GlyR-p27 peptide sample. The structure 
calculations for all peptides were carried out following the standard protocol (Wüthrich et al., 
1983). Upper distance limits, derived from specifically assigned NOESY cross peaks, and 
dihedral angle constraints, derived from coupling constant values, were used along with the 
amino acid sequence of each peptide as the input for the structure calculations. The programs 
used for structural calculations were DYANA (DYnamics Algorithm for NMR Applications, 
Peter Güntert Scientific Software) or CNS (crystallography and NMR system), (Brunger et al., 
1998). Additional software used for energy minimization and clustering were: SYBYL versions 
6.7 and 7.1 (Tripos Inc. St. Louis, MO) and Insight II (Accelrys, San Diego, CA). Further details 
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on the structure calculations are included in the corresponding publication (Broughman et al., 
2002a;Bukovnik et al., 2012;Cook et al., 2004;Herrera et al., 2010) and in the Materials and 
Methods sections of Chapter 2 and Chapter 3. 
 
 Computational Methods 
 
Increasingly complex computational methods have been used in the study of the NK4-M2GlyR 
family of channel forming peptides. In the first attempt to simulate the structure of an M2GlyR 
derived peptide in solution, Broughman et al. built a computational model of peptide NK4-
M2GlyR-p27 using the Biopolymer module of Sybyl 6.7 (Tripos Inc., St. Louis, MO) with 
electrostatics calculated by the Kollman method (Singh and Kollman, 1984) and a distance 
dependent dielectric constant of (e = 4 · r) rather than explicit solvation. Backbone dihedral 
angles φ and ψ for residues 5 to 27 (from the M2GlyR sequence) were set to an -helical 
conformation. Lysine residues 1 to 4 were set to random coil conformation. Refinement of the 
structure was done by performing 100 iterations of steepest descent energy minimization 
followed by 5 cycles of optimization using the conjugate gradient method until convergence was 
reached. The energy minimized structure was subjected to molecular dynamics simulations for 
10 psec at 300K to create the final reported structure (Broughman et al., 2002a). 
 
Johnston et al. from the group of Dr. Sansom in the Department of Biochemistry at the 
University of Oxford UK used as starting point for molecular dynamics simulations the NMR 
solution structures calculated for peptides NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W in 
40% TFE. These simulations were performed using GROMACS v3 (Lindahl et al., 2001) with 
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ffgmx43a1 force field in four different environments: TFE:water, SDS micelles, 
dodecylphosphocholine (DPC) micelles, and a dimyristoylphosphatidylcholine (DMPC) bilayer. 
Between 0.2 and 1.0 ns of equilibration and 20 ns of production simulation were performed at a 
temperature of 300 K for TFE:water, SDS micelles, and DPC micelles simulations. A 
temperature of 310 K was used for DMPC simulations. Further experimental details can be 
found in the original report (Johnston et al., 2006). 
 
As a first attempt to constructing a computational model for the assembled ion channels formed 
by M2GlyR derived peptides in lipid bilayers, the NMR determined monomeric structures in 
deuterated SDS micelles of peptides NK4-M2GlyR-p22 S22W, and NK4-M2GlyR-p22 T19R 
S22W were assembled each into a pentameric bundle based on experimental work indicating that 
this family of peptides spontaneously assembled into pentameric structures when inserted into 
synthetic bilayers or cell membranes (Reddy et al., 1993). Starting from the energy minimized 
average structure of the corresponding peptide, the structure of the pore was modeled by placing 
five identical copies of the peptide in a radial penta-symmetric array. Peptides were oriented with 
the hydrophilic side-chains known to be in the interior of the pore facing each other and the 
hydrophobic side-chains facing the exterior of the pore. The initial distance between peptides 
was adjusted to bring the adjacent peptides into contact. Dynamic simulations were ran on a 
Silicon Graphics O2 workstation for 10 ps using AMBER7 force field (Cornell et al., 1995;D.A. 
Case, 2002) with the software Sybyl version 7.1 (Tripos Inc., St. Louis, MO) with a dielectric 
constant of 1.0, followed by 100 steps of energy minimization by Powell method (Powell, 1977). 
The resulting pore structures were analyzed by determining the average internal diameter of the 
pore at 20 positions equidistantly distributed along the pore axis. 
152 
 
Drs. Chen and Al-Rawi in the Department of Biochemistry and Molecular Biophysics at Kansas 
State University constructed structural models of the putative pentameric channels formed by 
peptides NK4-M2GlyR-p22 and NK4-M2GlyR-p22 p22-S22W as described in Appendix A- 
Chapter 2. Briefly the GBSW implicit membrane model (Im et al., 2003) was used to refine the 
structures calculated by NMR. The refined monomer NMR structures were assembled into 
pentamers using CHARMM (Brooks et al., 2009;Brooks et al., 1983). The assembled channels 
were subject to energy minimization and then solvated in a pre-equilibrated POPC bilayer 
membrane using the CHARMM-GUI automated Membrane Builder (Jo et al., 2007;Jo et al., 
2008). NAMD software(Phillips et al., 2005) was used for 20 ns of production simulation. 
 
 Results and Discussion 
 
Monomeric peptide structures have been calculated using NMR data or predicted based on NMR 
data for the M2GlyR peptides described in Figure 4-1. Two solvent systems were used: 
deuterated TFE:water mixtures and deuterated SDS Micelles in water. A summary of the NMR 
experimental conditions is presented in Table 4-1. The data from transepithelial ion transport 
measurements using MDCK cells, CD spectra, and computer generated models are available also 




Figure 4-1. Channel forming peptides derived from M2GlyR that have NMR based 
structures 
 
The M2GlyR derived peptides included in Figure 4-1 are only a few of the many sequences 
tested throughout the project of developing a peptide based channel replacement therapeutic for 
cystic fibrosis. These sequences were selected as the leading candidates at their corresponding 
time during the evolution of the project, and because of their importance their structure was 
determined by NMR. The change in the leading sequence over time can be describe as a series of 
single differences between each peptide and the next, e.g. deletion of 5 C-terminal residues 
between NK4-M2GlyR-p27 and NK4-M2GlyR-p22, and deletion of PA at positions 5 and 6 
between NK4-M2GlyR-p22 T19R S22W and NK4-M2GlyR-p20 T17R S20W. This creates an 
opportunity to try to correlate the observed changes in the kinetic properties of the peptides with 
the changes detected from the techniques that provide structural information. 
 
 Transepithelial ion transport measurements 
 
MDCK monolayers were used to assess peptide-dependent ion transport. Short circuit current 
(ISC) is an extremely sensitive indicator of net ion flux (Tomich et al., 2012). Figure 4-2 shows 
the concentration dependence of ISC induced by NK4-M2GlyR derived peptides when applied to 
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the apical membrane of MDCK epithelial monolayers in the presence of 1-EBIO (Shank et al., 
2006 and Chapter 3).  
 
 
Figure 4-2. Concentration dependence of ISC induced by M2GlyR derived peptides on 
MDCK epithelial monolayers. ●NK4-M2GlyR-p27 ●NK4-M2GlyR-p22 ●NK4-M2GlyR-
p22 S22W ●NK4-M2GlyR-p22 T19R S22W ●NK4-M2GlyR-p20 T17R S20W. Composite 
figure with data from Shank et al. 2006 and Chapter 3 
 
The best fit of the data presented in Figure 4-2 to a modified Hill equation, as described in 
Chapter 3, produced the kinetic parameters reported in Table 4-2, where the parameters 
determined for peptide NK4-M2GlyR-p20 T17R S20W (Chapter 3) are added to the ones 
previously reported (Tomich et al., 2012). 
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Table 4-2. Kinetic properties of M2GlyR derived peptides on MDCK epithelial monolayers. 










NK4-M2GlyR-p27 26.2 ± 5.7 271 ± 71 1.9 
NK4-M2GlyR-p22 23.7 ± 5.6 210 ± 70 1.9 ± 0.6 
NK4-M2GlyR-p22 S22W 13.0 ±1.0 45 ± 6 5.4 ± 2.9 
NK4-M2GlyR-p22 T19R S22W 33.7 ± 1.3 71 ± 5 3.5 ± 0.7 
NK4-M2GlyR-p20 T17R S20W 43.8 ± 2.8 58 ± 8 1.8 ± 0.4 
 
Table 4-3. Change in kinetic properties between leading M2GlyR derived peptide 
candidates in response to change in peptide sequence 









(S23 G24 S25 R26 A27) -2.5 ± 8.0 -61 ± 100 0 ± 0.6 
S22W -10.7 ± 5.7 -166 ± 70 3.5 ± 3.0 
T19R 20.7 ± 1.6 26 ± 8 -1.9 ± 3.0 
(P5 A6) 10.1 ± 3.1 -13 ± 9 -1.7 ± 0.8 
 
 Circular Dichroism 
 
The CD spectra of all NK4-M2GlyR peptides in water show the characteristic shape of the 
spectra for peptides in random coil conformation, with a minimum near 195 nm (Broughman et 
al., 2002b;Cook et al., 2004) and (Figure 3-4). Increasing concentrations of TFE change the 
spectra to one characteristic of -helix with minima at 208 nm and 222 nm, for all peptides as 
well except for peptide NK4M2GlyR-p22 S22W that lacks the minimum at 222nm, and has a 
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spectrum indicative of only partial -helix (Broughman et al., 2002b;Cook et al., 2004) and 
(Figure 3-4). 
 
The CD spectra in 10 mM SDS micelles with peptide concentrations of 50 μM of all the peptides 
considered in this chapter is presented in Figure 4-3 and have the characteristics of the spectra 
for -helical peptides.  
 
Figure 4-3. Circular dichroism spectra of NK4-M2GlyR derived peptides in 10 mM SDS 
micelles. NK4-M2GlyR p27 WT (●), NK4-M2GlyR p22 (○), NK4-M2GlyR p22 S22W (▼), 
NK4-M2GlyR p22 T19R S22W () and NK4-M2GlyR p20 T17R S20W (─). Composite 
figure with data from Broughman et al., 2002b , Cook et al., 2004 and Chapter 3 
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CD data collected on M2GlyR derived peptides in water, TFE:water mixtures and SDS micelles 
provides reliable structural information about the peptides in each environment. CD spectra for 
all the considered peptides supports the conformational transition experimented by the peptides 
with the change in the sample conditions. The CD spectrum of peptide NK4-M2GlyR p22 S22W 
in TFE:water is a particular case, it was shown in (Cook et al., 2004) that the just partial -
helical character of the spectrum correlates with the NMR structure determined for the same 
conditions, and it was postulated there as well that the CD spectrum together with the NMR 
structure in TFE solution (Table 4-1), provide an explanation to the change in the kinetic 
properties of peptide NK4-M2GlyR p22 S22W compared with NK4-M2GlyR p22 (Table 4-3), in 
particular to the reduction of K1/2 by 166 μM. The explanation presented was that the backbone 
structure allows the C-terminus to loop over into a closed structure reducing the exposure of the 
hydrophobic residues to water; this in turn reduces the aggregation, making more monomeric 
peptide available for interaction with the membrane (Cook et al., 2004). This rational appears 
logical, but raises the question of what should be the interpretation of the NMR structure of the 
peptides in TFE solutions in the context of their physiological environment, where TFE is not 
expected to be present. The report presented the argument that since solution aggregation was 
greatly decreased the determined conformer or a similar one had to be sampled at a relatively 
high frequency in water solution. 
 
CD spectroscopy provides information about the secondary structure of a peptide but is not able 
to indicate where in the sequence the detected secondary structure elements are located. The CD 
spectra in SDS micelles, of the peptides here considered, are almost superimposable (Figure 4-3), 
provide no additional information beyond confirmation that the peptides in SDS are folded, and 
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have no potential for providing explanation to the changes in ion conductance between the 
considered sequence variations. Even though the extracted structural information is very limited, 
the small quantities of material needed and the short time required to collect CD data make it 
practical to continue its use as a preliminary test in the future. A major change in the structure 
due to an error in synthesis or due to the unexpected result of a new modification in the sequence 
could be easily detected by CD. 
 
 NMR Structures 
 
CD spectra showing that M2GlyR derived peptides are predominantly unstructured in water 
solution prompted us to use a different solvent system for 3D solution structure determination by 
NMR. A TFE:water solution system was considered based on the known secondary structure 
stabilizing property of TFE (Nelson and Kallenbach, 1989), and the expected helical secondary 
structure of the parent sequence based on earlier studies (Tomich et al., 1998). CD studies in 
TFE:water confirmed the formation of -helical structures and indicated a correlation between 
helical content in TFE solution and channel activity (Broughman et al., 2002b). These results 
made TFE solutions a convincing choice for the initial NMR solution studies.  
 
NMR was initially used to evaluate the structure of the 4 N-terminal lysines of peptide NK4-
M2GlyR-p27 in deuterated TFE solution. TOCSY spectra were used to evaluate the dispersion of 
the lysine resonances and NOESY spectra were used to detect medium range connectivities that 
would be indicative of participation of the lysines in the formation of a helix (Broughman et al., 
2002a). The molecular model shown in Table 4-4 for NK4-M2GlyR-p27 was computationally 
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constructed based on the NMR evidence as described in the methods section. The first NMR 
structures calculated for M2GlyR derived peptides were the structures of NK4-M2GlyR-p22 and 
NK4-M2GlyR-p22 S22W in TFE solution (Cook et al., 2004). The structure of NK4-M2GlyR-
p22 was described as a continuous helix with an extended N-terminal segment formed by the 
lysine residues, and having a length of more than 32 Å. NK4-M2GlyR-p22 S22W adopts a much 
less linear structure made of a single-turn helix (residues 11 – 14), a stretched beta-like turn 
(residues 14 – 17), and then another two-turn helix (residues 15 – 21) (Tomich et al., 2012). 
 
Table 4-4. Average calculated structures of M2GlyR derived peptides  
Peptide 
Solvent System 











NK4-M2GlyR-p22 T19R S22W  
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Looking for better evaluation of the molecular structure that would be a better representation of 
the conformations sampled by the M2GlyR peptides when inserted into lipid bilayers, the 
protocol for the structure determination by NMR was changed to preparing the NMR sample 
with the peptide inserted into SDS micelles. The instrumental challenges and the consequences 
on the data quality brought upon by this change were discussed in Chapter 2. 
 
The first two reported structures calculated by NMR in SDS micelles for M2GlyR derived 
peptides were the ones for peptide NK4-M2GlyR-p22 and peptide NK4-M2GlyR-p22 S22W 
(Chapter 2 and Herrera et al., 2010). The average calculated structures in SDS micelles for 
peptides NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W appear very similar (Table 4-4). Their 
most prominent features are helical conformation for residues residue 6-20 and extended 
conformation for residues 1-5. Detailed comparison between the two average structures, as 
discussed in Chapter 2 shows that NK4-M2GlyR-p22 S22W has a slight convexity, while NK4-
M2GlyR-p22 has a more linear axis in the central portion of the structure. The C-terminus of 
NK4-M2GlyR-p22 S22W appears to have a more stable configuration according to the ensemble 
of NMR structures calculated. 
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The substitution of residue 22 from a serine to a tryptophan reflected in the ion conductance 
kinetic parameter with a decrease in Imax of 10.7 ± 5.7 μA/cm
2
, a decrease in K1/2 of 166 ± 70 μM 
and an increase in the Hill coefficient of 3.5 ± 3.0 (Table 4-3). Although the NMR structures 
calculated for NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W are consistent with the kinetic 
properties of each peptide, and with the changes in those properties, the differences between the 
structures do not provide an explanation for the kinetic changes. Determination of the structure 
for NK4-M2GlyR-p22 S22W in SDS micelles alone would have not made any prediction about 
ion conductance possible apart from it being somehow comparable to the ion conductance of 
NK4-M2GlyR-p22 peptide. The explanation given to the large reduction in K1/2, as mentioned 
before is that reduced tendency to aggregation is responsible for more peptide available for 
membrane interaction. The calculated structure for NK4-M2GlyR-p22 S22W does not contradict 
this explanation. However it does not provide any additional evidence in favor either. The 
increase in the Hill coefficient (to 5.4 ± 2.9 the highest amongst the tested sequences) is 
indicative of an increase in the cooperativity of the channel assembly process. This change is 
attributed to the membrane anchoring effect of the tryptophan residue at position 22. The C-
terminal tryptophan is speculated to anchor the membrane to the bilayer interface reducing the 
possibility of peptide movement in the direction normal to the bilayer, making alignment more 
favorable during assembly (Tomich et al., 2012). The increased stability of the C-terminus of 
NK4-M2GlyR-p22 S22W described from the calculated NMR structure in SDS micelles makes a 
positive argument for this explanation. 
 
The substitution of residue 19 from a threonine to an arginine caused ion conductance kinetic 
parameters to change with an increase in Imax of 20.7 ± 1.6 μA/cm
2
 (the largest increase for a 
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single sequence change), an increase in K1/2 of 26 ± 8 μM and a decrease in the Hill coefficient 
of 3.2 ± 3.1(Table 4-3). Comparison between the calculated average structures in SDS micelles 
for peptides NK4-M2GlyR-p22 S22W and NK4-M2GlyR-p22 T19R S22W reveals no apparent 
major differences (Table 4-4). Once again their most prominent features are a helical 
conformation for residues 6-20 and an extended conformation for residues 1-5. NK4-M2GlyR-
p22 T19R S22W adopts a more linear conformation, not displaying the slight convexity reported 
for M2GlyR-p22 S22W (Bukovnik et al., 2012). The differences between the NMR structures in 
SDS micelles of peptides NK4-M2GlyR-p22 S22W and NK4-M2GlyR-p22 T19R S22W also do 
not provide an explanation for the kinetic changes in the ion conductance. The structure for NK4-
M2GlyR-p22 T19R S22W in SDS micelles also does not have predicting potential over the ion 
conductance. 
 
The deletion of residues proline 5 and alanine 6 caused the Imax to increase by 10.1 ± 3.1 μA/cm
2
, 
the K1/2 to decrease by 13 ± 9 μM and the Hill coefficient to decrease by 1.7 ± 0.8. This changes 
are among the smallest cause be a single change in the sequence (Table 4-3). Although the 
changes in Imax and K1/2 are in the favorable direction with respect to increasing ion conductance, 
it is somehow surprising that are smaller compared with the changes produced by the single 
residue substitutions (S22W and T19R).  
 
The general appearance of the average structures in SDS micelles for peptides NK4-M2GlyR-p22 
T19R S22W and NK4-M2GlyR-p20 T17R S20W seems similar with a long central helix and an 
extended N-terminus (Table 4-4). Detailed analysis of both structures reveals considerable 
differences. The structure calculated in SDS micelles for NK4-M2GlyR-p20 T17R S20W is the 
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only one that has one of the N-terminal lysines as part of the helix. Proline is known to be -
helix breaker residue, while alanine favors -helix formation (Chou and Fasman, 1974;Fujiwara 
et al., 2012). When prolines are part of an -helix, they are frequently found at the first N-
terminal turn, where the loss of the hydrogen bond to the amide nitrogen does not cause 
significant effects (Woolfson and Williams, 1990). The presence of a proline residue at position 
5 in the NK4-M2GlyR-p22 sequences is probably limiting the participation of the N-terminal 
lysines in the -helix. At the same time it has been reported that proline residues occur with 
higher frequency in transmembrane  helices, compared to  helices for soluble proteins (Cordes 
et al., 2002). It has been suggested by experimental and computational studies that proline 
containing motifs can form molecular hinges that act as conformational switches in 
transmembrane α-helices (Tieleman et al., 2001). The deletion of proline 5 and alanine 6 in NK4-
M2GlyR-p20 T17R S20W could be affecting the dynamics of the ion channels. 
 
Due to the shorter amino acid sequence of NK4-M2GlyR-p20 T17R S20W the axial length of the 
structured peptides is also shorter. The axial length of NK4-M2GlyR-p20 T17R S20W in SDS 
micelles is ~30 Å. A shorter conduction pathway for the channels is a possible explanation for 
the changes in Imax and K1/2. It should also be considered that a length of ~30 Å makes the 
peptide in the determined conformation incapable of spanning across most unperturbed cellular 
membranes (Mitra et al., 2004). Since the detection of ion current induced by the peptide gives a 
strong indication that the peptide does form ion channels, there are two possible explanations to 
how it does it. The peptide either adopts a less tilted stretched structure inside the bilayer, which 
could reduce the helical portion of the structure and affect the amphipathic distribution of the 
side chains. Or the peptide induces thinning of the lipid bilayer. Membrane thinning has been 
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reported to be involved in the mechanisms of channel forming peptides (Chen et al., 2003), and 
has been observed during simulations of channels formed by M2GlyR peptides (Herrera et al., 
2010). The reduction in the Hill coefficient observed can also be caused by the length reduction 
and needed membrane thinning. Lateral movement of the inserted peptide can be restricted by 
the need of moving not only the peptide but also the defect in the bilayer around it in order to 
find oligomerizing partners (assuming insertion occurs as a separate event to channel formation). 
 
The information that can be extracted from the NMR structure of peptide NK4-M2GlyR-p20 
T17R S20W in SDS micelles is also not sufficient to explain the changes in ion conductance, but 
correlates well with the observations. It is notable that the residue deletions ((S23 G24 S25 R26 
A27) and (P5 A6) ) produce in general smaller changes in the kinetic parameters than the 
amino acid substitutions, considering that deletions change the size, mass and even charge of the 
peptides. This observation suggests that the remaining core of the M2GlyR is a highly efficient 
ion channel forming sequence and these other residues could exist outside the bilayer in nature. 
In fact the PA N-terminal segment of the NK4-M2GlyR-p22 peptides corresponds in the glycine 
receptor channel to a segment that has been proposed to be part of an internal loop connecting 
the M2 transmembrane segment with the previous transmembrane segment M1 (Lynch, 2004).  
 
An apparently common feature of the NMR structures calculated for the peptides in SDS 
micelles is the unstructured or extended configuration of the N-terminal lysine residues. In order 
to extract more information from the NMR data about these residues, an analysis of their 
chemical shifts was carried out. 
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The standard protocol for structure determination using multidimensional NMR data is based on 
distance and angle constraints calculated from NOE cross peaks and J-couplings respectively 
(Wüthrich, 1986). Chemical shift information is used to complete the task of identifying specific 
residues, but in essence the calculation of the structure is chemical shift independent. The 
chemical shift parameter is a sensible indicator of the chemical environment that surrounds a 
nucleus, and can also be indicative of the conformation of an amino acid (Wishart and Nip, 
1998). The chemical shifts of the amide protons of the N-terminal lysine residues were collected 




H TOCSY spectra used in the 
structure determination for each NMR structure included in Table 4-4. Table 4-5 shows the 
minimum and the maximum chemical shifts values and the difference between the two numbers 
indicates the dispersion of the lysine chemical shifts. 
 
Table 4-5. Chemical shifts (ppm) and dispersion (for the amide protons of the N-
terminal lysine residues in M2GlyR derived peptides 
Peptide 
TFE SDS 
Min Max  Min Max  
Chemical Shift (ppm) 
NK4-M2GlyR-p27 8.10 8.55 0.45    
NK4-M2GlyR-p22 8.21 8.59 0.38 8.12 8.58 0.46 
NK4-M2GlyR-p22 S22W 8.21 8.59 0.38 8.02 8.54 0.52 
NK4-M2GlyR-p22 T19R S22W    7.90 8.40 0.50 
NK4-M2GlyR-p20 T17R S20W 8.07 8.19 0.12 8.16 8.58 0.42 
 
The peptide in SDS micelles with the smallest dispersion of the lysine chemical shifts is NK4-
M2GlyR-p20 T17R S20W. This observation can be interpreted as the 4 lysine residues of this 
peptide being in a more restrictive environment compared with the other peptides. This is 
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consistent with the finding that lysine 4 is part of the -helix (Chapter 3), and can be due to the 
shorter length of the peptide combined with the anchoring effect of the C-terminal tryptophan, 
pulling the hydrophobic side chains for one or more lysine residues into the hydrophobic interior 
of the micelles. The data reported in Table 4-5 also show that for each peptide the dispersion of 
the lysine chemical shifts is smaller for the sample in TFE solution than for the sample in SDS 
micelles. The possible reason may be the samples in TFE solution are surrounded by the solvent, 
and although micro-heterogeneity of the TFE:water solvent around the peptides has been 
postulated based on computer simulations (Johnston et al., 2006;Roccatano et al., 2002), any 
amino acid in an extended conformation is exposed to the solvent in a similar way.  
 
Since lysine residue 4 of the NK4-M2GlyR-p20 T17R S20W peptide participates of the -helix 
conformation and is predicted to be inside the lipid bilayer, the structure of the assembled ion 
channels should be able to accommodate for this. The deletion of amino acid residues at the 
carboxyl or amino end of an amphipathic sequence does not change the registry between amino 
acids, not affecting the amphipathic character of the sequence. The helical wheel diagrams in 
Figure 4-4 show that the amino acid distribution in NK4-M2GlyR-p20 T17R S20W and NK4-
M2GlyR-p22 T19R S22W is almost the same. The polar and non-polar residues are equally 
segregated and the membrane anchoring reside tryptophan 22 is in the same relative position, 
opposite to the polar residues, in what should be the surface of the channel that faces the interior 
of the lipid bilayer. Accommodating the lysine 4 residue should not be problematic for the 





Figure 4-4. Helical wheel diagrams of peptides A) NK4-M2GlyR-p22 T19R S22W and B) 
NK4-M2GlyR-p20 T17R S20W. Green circles represent nonpolar residues, yellow polar 
uncharged residues, blue basic residues and purple aromatic residues. Diagrams created 
using MPEx (Snider et al., 2009) 
 
A common feature to all the calculated structures by NMR for M2GlyR derived peptides in SDS 
micelles, is that the segment that could be predicted to form the transmembrane -helix, and was 
modelled as one for peptide NK4-M2GlyR-p27 (Broughman et al., 2002a), has never been 
determined by NMR to be a perfect -helix going from residue 5 to the end of the sequence. As 
it can be seen in Table 4-4 the reported helices have imperfections mostly at the start and end of 
the helix. This feature is not an artifact of the structure averaging since the individual structures 
in the clusters of reported structures present the same deviations from the canonical -helix. This 
deviation could be involved in accommodating the reported curvature of the helix, but could 
potentially also be created by the strong curvature of the SDS micelle around the peptide. 
Whether or not this feature of the NMR structures in SDS micelles has any relevance or 
biological significance is yet to be determined. 
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 Computer Simulations 
 
Representative examples of the different types of computational studies performed on M2GlyR 
derived peptides are presented to highlight their relationship to the structures determined by 
NMR. The increasing complexity of the computer simulations performed on the M2GlyR 
derived peptides is a reflection of advances in the field and of the material an human resources 
available to the project at each point in time. To help answer the question of the relevance of 
determining new NMR structures for M2GlyR derived peptides, an informal evaluation of how 
the computational results complement, or contradict or replace the NMR studies is presented 
here. 
 
As mentioned before the first atomic model of an M2GlyR derived peptide was the product of 
combining NMR derived information with a peptide building computational protocol. The 
protocol included structure refinement by energy minimization and molecular dynamics. During 
the simulation on peptide NK4-M2GlyR-p27 the N-terminal lysine residues showed some 
motion, but remained mostly extended and not interacting with the helix constructed for residues 
5 to 27. There was also very little motion of the helix during the simulation (Broughman et al., 
2002a). 
 
The first use of M2GlyR derived peptide structures determined by NMR in molecular dynamics 
simulations was reported in Johnston et al. 2006. The structures used were the TFE solution 
structures of NK4-M2GlyR-p22 and NK4-M2GlyR-p22 S22W. The stability of the helical 
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structure was evaluated in four membrane-mimetic environments, as described in the methods 
section, and in more detail in the original report (Johnston et al., 2006). The results of the 
simulation for NK4-M2GlyR-p22 S22W in SDS are not fully consistent with the structure 
calculate by NMR in the same environment. The simulation shows only a small helical fragment 
at the C-terminus with a bend in the middle region and a disordered N-terminal segment. The 
resulting structures from the simulations in DMPC bilayers are in close agreement to the 
calculated NMR structure in SDS micelles. A result of particular relevance to the present 
discussion is reproduced in Figure 4-5, where a simulation snapshot shows an M2GlyR peptide 
inside a micelle. The shape of the simulated micelle is far from the idealized sphere that is 
usually envisioned when considering the SDS micelle samples. This should be considered in the 
potential case of developing an improved protocol for the determination of NMR structures of 
M2GlyR derived peptides in a membrane-mimetic environment. 
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Figure 4-5. Snapshot of an M2GlyR derived peptide in an SDS micelle. Peptide is 
represented as van der Waals spheres and colored by residue type: white hydrophobic, 
green polar uncharged, and blue polar charged (Johnston et al., 2006)  
 
Since all the NMR structures in SDS for the M2GlyR derived peptides appear very similar, and 
seem to provide little new information about the ion conducting channels therefore a protocol 
described in the methods section was developed. Rather than a dynamic model, the constructed 
assemblies were intended to be a geometric representation of the channels that potentially could 
help in the interpretation of the information already contained in the NMR structures calculated 




Figure 4-6. Computational models of assembled channels of A) NK4-M2GlyR p22 B) NK4-
M2GlyR p22 S22W. Top, side and bottom view from left to right. Space-filing 
representation with backbone in purple, charged side chains blue, polar side chains 
magenta, and non-polar side chains grey  
 
Differences between the structures determined for NK4-M2GlyR p22 and NK4-M2GlyR p22 
S22W peptide monomers cause appreciable differences in the overall shape and interior diameter 
profile between the respective constructed channels. Information extracted from these models 
was used to analyze the modification made to the next generation of M2GlyR derived peptides. 
The complete absence of solvent interactions makes the constructed channel models of limited 
biological significance.  
 
The next generation of computational studies on ion channels formed by M2GlyR derived 
peptides, performed by Dr. Chen’s group, has been described in Appendix A- Chapter 2, and 
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briefly in the methods section of this chapter. The NMR structures in SDS along with a range of 
additional experimental data and theoretical considerations were used to create the starting points 
for these simulations (Tomich et al., 2012).  
 
 
Figure 4-7. Snapshots of NK4-M2GlyR p22 S22W channel in POPC bilayer before (left) 
and after (right) 20 ns of production simulation (Herrera et al., 2010) 
 
The channel models generated by the simulation provide a structural basis for understanding the 
differences in channel activities between the tested sequences (Figure 4-7). The membrane 
anchoring effect of the C-terminal tryptophan residue as an explanation for the changes in the 
kinetic characteristics of ion conductance caused by the S22W substitution is supported by these 
simulations. Greater stability of the M2GlyR p22 S22W channel provides an explanation for the 
large reduction in K1/2 (Herrera et al., 2010). The current protocols for computational simulation 
of the M2GlyR derived channels provide evidence that static structures determined by NMR 
cannot provide alone. 
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 Concluding remarks 
 
An essential characteristic of the optimized channel forming sequence, which has not been 
discussed, is ion selectivity. The limited availability of ion selectivity data on the peptides with 
an NMR determined structure makes it unfeasible to evaluate the correlation between changes in 
the selectivity of each peptide and the corresponding NMR structures. Anion selectivity of the 
M2GlyR peptides could be affected by changes in hydrogen bonding potential and electrostatics 
of the pore lining residues, pore length and pore rigidity. NK4-M2GlyR-p22 T17R S22W is 
known to be only slightly anion selective (Tomich et al., 2012). Changes in ion selectivity could 
have occurred on a progressive matter as the sequence was modified, or could be the 
consequence of a single sequence modification. In either case it is improbable that the NMR 
structures provide an explanation to the changes in ion selectivity. At this point the best way to 
evaluate the mechanism of ion selectivity is perhaps by computational methods that use channels 
generated from NMR structures of the peptide monomer in SDS micelles as starting point (Chen 
and Tomich, 2014). 
 
The question of the significance of the structures calculated by NMR from the TFE solution 
samples remains unanswered. Since these structures represent a condition that is not expected to 
be encountered under physiological conditions by the peptide, it could be argued that NMR 
structures for the peptides in TFE solution should no longer be determined. But the analysis 
presented here advocates for the contrary. The structure for NK4-M2GlyR-p22 S22W is the most 
distinct among all the NMR structures calculated, and is the one that has the largest capacity to 
aid in the explanation of the characteristics of that peptide in solution and the changes in the 
kinetic parameters of the corresponding channels. Not all of the calculated structures in TFE 
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solution are as informative, and perhaps calculation of an NMR structure in TFE solution should 
not be attempted for every new lead sequence. Determination of an NMR structure in TFE 
solution should be performed when a new sequence behaves in an unexpected way, or when the 
CD spectrum of a peptide predicts a conformation not predominantly helical in solution. 
 
The structures calculated by NMR for M2GlyR derived peptides in SDS micelles appear to be an 
adequate approximation to the actual structure of the peptides in the assembled channel. They are 
in agreement with the all the experimental data and the theoretical considerations on this family 
of channel forming peptides. However the capability of providing evidence for the explanation of 
changes in the ion conductance is limited. An improvement in the protocol for structure 
determination of M2GlyR derived peptides by solution NMR should be performed. One possible 
area of improvement is in the selection of the membrane mimicking agent. A screen of various 
detergents to establish which detergents prevents aggregation while supporting native structure 
as reflected by well-dispersed and well-resolved NMR spectra has been suggested as the best 
way to make a selection (Sanders and Sonnichsen, 2006). Another direction that should be 
explored is the structure determination of an oligomeric form of the M2GlyR peptides. Recently 
the structure of the human α7 nicotinic acetylcholine receptor (nAChR) transmembrane domain 
was reported using solution NMR (Bondarenko et al., 2014). Samples were made using detergent 
Lauryldimethylamine-oxide. α7 nAChR transmembrane domain contains 137 residues with 4 
transmembrane helices. Adapting this protocol to the M2GlyR derived peptides may require the 
synthesis of the transmembrane sequences attached to a scaffold element, something that has 








The calculated NMR structures have provided experimental evidence of the structure in a 
membrane-like environment for the M2GlyR family of peptides. Although the structure found 
was predictable, particularly for the later calculated structures, if the structure was never 
determined it would have remained as an unproven conjecture. Future predictions about the 
structure, in the lipid bilayer environment, for new members of this family of peptides are well 
supported. Cost effective methodologies like CD spectroscopy can provided complementary 
evidence for the prediction of the structure of a new modified sequence.  
 
The NMR structures determined for SDS micelles samples have provided a needed 
experimentally rooted starting point for computational studies. The current state of development 
of the computational techniques and the available resources give computer simulations a 
predicting ability and potential for explaining observations on M2GlyR derived channels far 
superior to the possibilities of solution NMR using the current protocol. 
 
If the optimization of the channel forming sequence continues to follow successive modifications 
has it has until now, eventually the question will arise of where or not the NMR structures now 
available can be used as evidence to predict or simulate the structure and characteristics of the 
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Chapter 5 - Summary and Final Discussion 
 
A review on membrane active peptides highlighting their ubiquitous presence in nature, and their 
diversity of origin was presented in the first chapter. Membrane active peptides were classified 
according to their function as: antimicrobial, cell-penetrating, channel/pore forming and 
amyloids. A description of the historical development, the mode of action and the recent 
developments in their field was given for each of the four categories of membrane active 
peptides. Similarities, such as the amphipathic distribution of residues, are found in the structural 
characteristics of all membrane active peptides and are likely to have common mechanistic 
significance. New general models for peptide-membrane interaction have been recently proposed 
focusing on the membrane as an active participant with regard to which peptides will interact and 
form pores. The intent of the review was to present a framework for the structural studies on a 
family of channel forming peptides presented in the other chapters of this dissertation, bringing 
attention to the involvement of membrane active peptides in diseases, immunity and the 
development of potential pharmaceutical applications.  
 
One pharmaceutical application, currently being explored in the laboratory of Dr. John Tomich 
at Kansas State University, is the development of a channel forming peptide (CFP) with the 
potential to be used in the treatment of the symptoms caused by cystic fibrosis (CF). A treatment 
for the respiratory symptoms of CF has the potential of slowing down the degenerative 
consequences of the progression of the disease, and enhancing the quality of life for CF patients. 
The starting sequence for the family of M2GlyR peptides was the second transmembrane 
segment of the  subunit of the glycine receptor. Modifications that increase solubility in 
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aqueous solution and decrease aggregation have been made to the sequence yet at the expense of 
anion specific conductance.  
 
An answer to the question, of whether or not there is compelling need to determine the NMR 
structure of the peptides that constitute the most recent developments in the optimization of the 
M2GlyR family of CFPs, has been explored by: -presenting the structures determined by solution 
NMR for NK4-M2GlyR-p22 and NK4-M2GlyR-p20 T17R S20W sequences -comparing all the 
structures determined by NMR for the M2GlyR family of peptides – looking for differences 
between structures that can correlate with the observed changes in the ion conductance between 
peptide sequences and – assessing the contribution to the project that the NMR determined 
structures have had to date. 
 
The kinetic parameters (Imax, K1/2 and Hill coefficient) derived from fitting the ISC vs 
concentration data to a modified Hill equation were used to compare the ion conductance 
properties of the different peptide sequences. Increasing Imax while decreasing K1/2 are among the 
desired results of the sequence modifications. Peptide NK4-M2GlyR-p22 has an Imax of 23.7 ± 
5.6 μA/cm
2
, a K1/2 of 210 ± 71 μM and a Hill coefficient of 1.9 ± 0.6. The determined NMR 
structure for NK4-M2GlyR-p22 peptide in SDS micelles is in a helical conformation from 
residues 6 to 20. The N-terminal lysine residues are unstructured and flexible. The hydrophobic 
and hydrophilic side chains of the residues in the helix are segregated to different sides of the 
helix. The structure of NK4-M2GlyR-p22 in SDS micelles is very similar to the previously 
reported structure in 40% TFE for the same peptides. The cluster of structures in TFE was 
reported to have a RMSD to the mean structure for residues 9-20 of 1.95± 0.6 Å (Cook et al., 
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2004), whereas the cluster of structures in SDS micelles showed a RMSD to the mean structure 
(residues 6-20) of 0.46 ± 0.12 Å. 
 
The average structure for peptide NK4-M2GlyR-p22 in SDS micelles and the average structure 
calculated for peptide NK4-M2GlyR-p22 S22W in the same environment (Herrera et al., 2010) 
both have a similar helical conformation on most of the length (residue 6-20) of the peptide. 
NK4-M2GlyR-p22 S22W shows a convexity along the axis of the helix, while NK4-M2GlyR-
p22 has a more linear axis in the central portion of the structure. Both peptides have an 
unstructured state of the N-terminal lysines that is more pronounced for the NK4-M2GlyR-p22 
sequence due to lacking the anchoring tryptophan residue. 
 
The substitution of residue 22 from a serine to a tryptophan produced a decrease in Imax of 10.7 ± 
5.7 μA/cm
2
, a decrease in K1/2 of 166 ± 70 μM and an increase in the Hill coefficient of 3.5 ± 3.0. 
These changes in the kinetic parameter could not have been predicted from the NMR structures 
alone. The higher peptide concentration required by NK4-M2GlyR-p22 compared with NK4-
M2GlyR-p22 S22W to reach one-half Imax could be attributed to the soluble associations formed 
by the peptide in the aqueous environment, and also to the higher conformational flexibility in 
the membrane environment, that may negatively impact the stability of the assembled ion 
channel. Computational assemblies and molecular dynamics simulations have been performed on 
peptide NK4-M2GlyR-p22 and peptide NK4-M2GlyR-p22 S22W based on the calculated NMR 
solution structures (as described in Appendix A – Chapter 2). According to the simulations, the 




For peptide NK4-M2GlyR-p20 T17R S20W the kinetic parameters of ion conductance across 
monolayers of MDCK cells have been determined, and the NMR solution structure was 
determined in a TFE:water solution and also in SDS micelles. The NK4-M2GlyR-p20 T17R 
S20W sequence is a modification of a previously studied leading sequence candidate 
NK4-M2GlyR-p22 T19R S22W. The shorter sequence was created by removing residues proline 
5 and alanine 6. These two residues are predicted to be part of an internal loop connecting the 
M2 transmembrane segment to the M1 transmembrane segment in the Glycine receptor channel 
sequence. 
 
Peptide NK4-M2GlyR-p20 T17R S20W has both a higher IMAX (43.8 ± 2.8 μA/cm
2
) and a lower 
K1/2 (58 ± 8 μM) compared to other M2GlyR derived peptides with calculated NMR structures. 
The average structures for peptide NK4-M2GlyR-p20 T17R S20W under both experimental 
conditions (TFE solution and SDS micelles) were calculated and were found to be predominantly 
-helical. The most notable difference between the structure calculated in TFE solution and the 
one calculate in SDS micelle is in the C-terminal region (residues 17-20). For both sample 
conditions the C-terminal residues are not part of the main  helix, but for the structure in TFE 
the C-terminal residues form a hydrogen bond stabilized bend that folds back towards the helix. 
For the structure in SDS micelles the C-terminal residues continue in the same general direction 
of the main  helix axis. 
 
Another difference between the structures calculated for NK4-M2GlyR-p20 T17R S20W, in TFE 
solution and in SDS micelles, is the apparently more restricted N-terminus for the conformation 
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in SDS. This difference could be explained by the interaction of the N-terminal lysines with the 
hydrophilic heads of the SDS molecules. A similar interaction could be responsible for a more 
restricted structure overall for the SDS micelles sample, that has a RMSD to the mean structure 
of 0.63 ± 0.24 Å in the helical region, compare to 0.96 ± 0.33 Å for the TFE sample. 
  
The presence of the membrane anchoring residue in the C-terminus of NK4-M2GlyR-p20 T17R 
S20W, combined with the shorter axial length of the peptide structure could force the 
hydrophobic side chains for one or more of the N-terminal lysines into the hydrophobic interior 
of the micelles. The location of the N-terminal lysines partially in the interior of the micelles 
explains the observed more restricted conformation of the N-terminus compared to other NMR 
structures of M2GlyR derived peptides (Cook et al., 2004;Herrera et al., 2010). Another 
suggested explanation is that the absence of the proline residue, a known helix breaker (Chou 
and Fasman, 1974;Fujiwara et al., 2012), allows lysine 4 to participate in the helix, partially 
restricting the conformation of the N-terminal residues. Proline residues are actually found in 
many transmembrane -helix sequences (e.g. CFP alamethicin, S6 from voltage-gated potassium 
channels, D5 from voltage-gated chloride channels), where they induce a hinge in the helix that 
has been associated with channel gating (Tieleman et al., 2001). The absence of the proline 
residue in NK4-M2GlyR-p20 T17R could be affecting the dynamic properties of the formed 
channels as well. 
 
The structure determined for NK4-M2GlyR-p20 T17R S20W in SDS micelles is expected to be a 
better representation of the structure adopted by the peptide in the interior of a membrane 
bilayer, than the structures calculated in the TFE solution. Even so there are expected limitations 
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to the reported structure in SDS micelles. The axial length of the structure in SDS micelles is ~30 
Å, the peptide in the reported structure would not be able to span across an unperturbed cellular 
membrane to form ion channels. 
 
The deletion of residues proline 5 and alanine 6 from the sequence of peptide NK4-M2GlyR-p22 
T19R S22W produced an increase in Imax of 10.1 ± 3.1 μA/cm
2
, a decrease in K1/2 of 13 ± 9 μM 
and a decrease in the Hill coefficient of 1.7 ± 0.8. These changes in the kinetic parameters cannot 
be fully explained by the differences in the NMR solution structures. A prediction, based on the 
NMR structure, of a shorter conduction pathway in the formed channels is a possible explanation 
to the increase in ion conductance. 
 
The characterization of the ion conductance induced by peptide NK4-M2GlyR-p20 T17R S20W 
presents this sequence as a step in the right direction towards the optimization of a channel 
forming peptide with potential as a therapeutic for the treatment of CF. Study of the ion 
selectivity of the channels formed by this peptide is needed to further characterize the ion current 
induced.  
 
The anion selectivity of the M2GlyR peptides is expected to be affected by the changes made to 
the sequence. Selective anion permeability could be affected by pore length and pore rigidity or 
changes in hydrogen bonding potential and electrostatics of the pore lining residues. The NK4-
M2GlyR-p22 T17R S22W is known to be only slightly anion selective (Tomich et al., 2012). 
Evaluation of the ion selectivity mechanism of the M2GlyR derived peptides has been reported 
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by computational methods that use the NMR structures determined in SDS micelles as starting 
point (Chen and Tomich, 2014). 
 
Having developed the ability to determine the structure of peptides from the M2GlyR family in a 
membrane mimicking environment has decreased the relevance of performing new 
determinations using the TFE solution environment. At the same time the structure in TFE 
solution of peptide M2GlyR-p22 S22W sets a precedent for the contribution to the understanding 
of the behavior in water solution that TFE solution structures can give. Not all the structures in 
TFE solution are as informative, suggesting that determination of an NMR structure in TFE 
solution should only be attempted when a new sequence behaves in an unexpected way, or when 
the CD spectrum of a peptide predicts a conformation not predominantly helical in solution. 
 
Based on theoretical considerations and all other experimental data available (CD spectra, 
structure of similar sequences, computer simulations), the structures calculated by NMR for the 
M2GlyRfamily of peptides in SDS micelles appear to be an adequate approximation to the actual 
structure of the peptides in the assembled channel. However limited capability of providing on 
their own evidence for the explanation of changes in the ion conductance has been found. The 
NMR structures currently available have provided supporting evidence for the rationalization of 
the observed differences in the solubility, oligomerization states, and ion conductance between 
the considered sequences. In nature the peptides will be paired with other transmembrane 
segments as oligomeric bundles with water-lined pores. Packing interactions will most likely 
stabilize aspects of these assemblies. Using the current protocols these interactions cannot be 
analyzed by solution NMR. 
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The contribution of the NMR structures with the largest impact is to the computer simulation of 
the ion conducting channels formed by the family of M2GlyR peptides. NMR structures for SDS 
micelles samples have provided an experimentally based starting point for computational studies. 
Future predictions about the dynamics of the channels and newly explored modifications to the 
leading peptide sequences are well supported. The current availability of computational 
techniques and resources make computer simulations the best choice as the primary source of 
structural information about the M2GlyR family of ion channels. 
 
Improvements to the protocols used for structure determination of M2GlyR derived peptides by 
solution NMR need to be considered in order to justify new structure determinations. A sample 
environment that better resembles the cellular membrane may be incorporated to the protocols. 
The use of vesicles (Warschawski et al., 2011) or phospholipid bilayer nanodiscs (Hagn et al., 
2013) as the membrane mimicking environment may be considered. The feasibility of 
determining the structure by NMR of assembled peptide channels is an important possibility to 





C) sample for multinuclei/multidimensional, triple-resonance 3D 
NMR experiments. And the implementation of Transverse Relaxation-Optimized Spectroscopy 
(TROSY) experiments, currently use to solve the structure of very large biological 
macromolecules in solution (Pervushin et al., 1997). 
 
A complementary approach for the study of the assembled peptide channels is the use of Solid 
state NMR. There are two kinds of sample preparations commonly used in the study of 
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membrane interacting proteins and peptides by solid state NMR. In one kind of samples the 
protein has to be reconstituted in micelles or vesicles and then packed in to “magic angle 
spinning” rotors. In the other kind of samples the protein is reconstituted in lipid bicelles or a 
lipid bilayer that have a determined orientation with respect to the magnetic field of the 
instrument.  
 
Structural and dynamics studies of full length channels and channels formed by CFPs have been 
reported using magic angle spinning (MAS) (Varga et al., 2007;Williams et al., 2013). For solid 




C homonuclear correlation spectra (DARR) and 3D inter-
residue (NCOCx) and intra-residue (NCCX) NMR experiments are used to perform backbone 
assignments. A typical sample preparation consists of: - expression (for proteins) or synthesis 
(for peptides) followed by purification of an isotopically labeled protein of peptide – 
reconstitution of the sample in lipid vesicles (components optimized for each sample) – dialysis 
of the proteoliposomes and – packing into MAS rotors of the NMR instrument. Using MAS 
samples the dynamics of the channels formed by M2glyR derived peptides could be studied 
following chemical shift perturbations as it has been reported in the study of the channel forming 
M2 protein from the influenza A virus (Liao et al., 2013). 
 
Solid state NMR on magnetically oriented samples can also provide useful complementary 
information on the structure of assembled channel formed by M2GlyR derived peptides. For 
solid state NMR on oriented samples the channels need to assemble in lipid bicelles or a lipid 
bilayer. The bicelles used in solid state NMR studies are a mixture of long chain lipids (e.g. 
DMPC) and short chain lipids or detergents (e.g. DHPC) (Warschawski et al., 2011). The 
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relative orientation to the magnetic field of the helical axis of the monomers can be determined 
under different sample conditions using the oriented samples (Bechinger et al., 1996). This could 
provide experimental confirmation to the packing geometries observed in the computational 
studies. 
 
In general the field of NMR currently offers possibilities that if implemented can make a 
contribution to the study and improvement of M2GlyR derived channel forming peptide 
assemblies. Substantial investment of time and resources would be needed to implement the 
required changes to the NMR protocols use in the study of the M2GlyR family of peptides. 
Collaboration with a group having experience in using the required NMR techniques on similar 
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